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Summary
Abdominal Aortic Aneurysm (AAA) is a serious, life threatening condition. AAAs are 
often asymptomatic and many remain silent until rupture. If detected early, the 
condition can be monitored and electively repaired relatively safely. Arterial disease 
is readily and routinely assessed using Doppler ultrasound. The effect of occlusive 
arterial disease on Doppler waveforms is well documented and the disease state of the 
aorto-iliac segment can be estimated by examination of the common femoral artery 
(CFA) waveform. Theoretically, aneurysmal disease should alter the blood flow 
pattern due to the localised increase in vessel diameter. It has been noted during 
routine clinical examinations of CFA Doppler waveforms, that when certain features 
were observed, an AAA was often present. Reported studies examining lower limb 
Doppler waveforms and flows through aneurysm models support these observations.
The main aim of this research study was to determine if and how the Doppler 
waveform of the CFA is changed in the presence AAA and to utilise these changes for 
the early diagnosis of AAA. The interpretation of Doppler waveforms for the 
assessment of vascular disease requires a high level of skill and training and still 
remains subjective. An automated, objective detection method to detect AAA by 
analysis of the CFA Doppler waveform was achieved by implementing a MATLAB 
software based computer program to perform CFA waveform feature based analysis 
and determine whether or not an AAA is present. The second aim of the study was to 
predict the AAA size and presence of ILT using the program results.
For patients with no significant atherosclerotic disease, automated MATLAB based 
CFA waveform analysis provided 100% sensitivity and 73.3% specificity for AAA 
detection. Additional waveform features set up by atherosclerotic disease made it 
more difficult to separate the AAA and normal patients with significant 
atherosclerotic disease. It was not possible to adequately predict the physical 
characteristics of using the AAA detection program.
In conclusion, feature analysis of the CFA Doppler waveform may provide a 
promising, alternative method for AAA detection. AAA characterisation may be 
possible using different analysis methods.
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Research Overview
Abdominal Aortic Aneurysm (AAA) is a potentially fatal condition which results in 
an estimated 10,000 deaths per year in the UK (Smith 1994). AAA is a progressive 
condition that often remains clinically silent for many years until the aneurysm is very 
large and at risk of rupture. Serious complications such as embolisation of intra­
luminal thrombus resulting in lower limb ischaemia with the possible need for 
amputation may be the first clinical indication of an AAA. Despite the seriousness of 
this condition, AAA often remains undiagnosed until rupture because there are no 
prior symptoms. Fifty percent of patients with a ruptured AAA die before reaching 
hospital and the chance of surviving emergency surgery is low. If detected early, the 
prognosis is much improved because the condition can be monitored and elective 
repair can be considered. AAAs that are diagnosed intact are often an incidental 
finding of physical examinations, x-rays or other scans performed for an unrelated 
medical condition. At present there is no national screening programme for AAA but 
studies have shown that ultrasound screening for AAA saves lives and is cost 
effective (Ashton, Buxton et al. 2002).
Arterial disease is readily and routinely assessed using colour flow duplex ultrasound 
scanning. The effect of occlusive arterial disease on the Doppler waveform is well 
documented and the disease state of the aorto-iliac segment can be estimated by 
examination of the common femoral artery waveform. The aim of this research study 
is to examine the haemodynamics of AAAs and try to determine if and how the 
Doppler waveform of the common femoral artery is changed in the presence of an 
AAA, and to utilise these changes for the early diagnosis of AAA. This work came
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about because the project supervisor Dr Neil Pugh who has over 20 years experience 
of vascular ultrasound noted during routine clinical work that when certain changes 
were observed in the CFA waveform, an AAA was often present. This is supported by 
similar observations noted in an early study by Humphries et al (Humphries, Hames et 
al. 1982). Therefore it may be feasible to detect AAA by analysis of the CFA 
waveform. The interpretation of Doppler waveforms for the assessment of vascular 
disease requires a high level of skill and training and still remains subjective. The 
overall aim of this research project was to develop an automatic, objective method to 
detect AAA by analysis of the CFA Doppler waveform. This was achieved by 
implementing a MATLAB software based computer program to perform CFA 
waveform analysis and determine whether or not an AAA is present based on the 
results.
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Chapter 1: Introduction
1.1 Arterial Circulation
Blood is circulated around the body by the action of the heart and is transported 
through the arteries, veins and capillaries which make up the vascular system. 
Oxygenated blood is pumped from the ventricles of the heart into the aorta, the largest 
artery in the body. From the aorta, the large arteries branch to form the arterial supply 
to different regions of the body. These large arteries branch repeatedly to form many 
progressively smaller arteries to supply more peripheral tissues. The aorta is generally 
described in three main sections: The ascending aorta from which the coronary 
arteries branch to supply the cardiac muscle, the aortic arch from which the 
brachiocephalic, left common carotid and left subclavian arteries branch to supply the 
head and upper limbs and the descending aorta which supplies the rest of the body. 
The descending aorta is the longest section of the aorta and extends through the thorax 
and down through the abdomen to the superior margin of the pelvis. It is divided into 
the thoracic aorta lying within the thorax and the abdominal aorta which runs distally 
from the diaphragm. The aorta terminates at the level of the fifth lumbar vertebra 
where it divides into the right and left common iliac arteries to supply the pelvis and 
lower limbs. The branches of the thoracic aorta supply the thoracic organs including 
the lungs. The abdominal aorta has several major branches supplying the abdominal 
organs: the celiac trunk, superior and inferior mesenteric arteries branch to supply the 
stomach and intestines, the paired renal arteries branch to supply the kidneys, the 
gonadal arteries supply the gonads and the lumbar arteries supply the spine (Seeley, 
Stephens et al. 2000).
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1.2 Lower Limb Arteries
The lower limbs are supplied from the right and left common iliac arteries (CIAs) 
which bifurcate from the abdominal aorta just below the level of the navel. The 
common iliac arteries run bilaterally, and bifurcate in the pelvis to form the left and 
right internal iliac arteries which supply the pelvic region and the external iliac 
arteries, which continue distally to the groin to supply the legs. The lower limb 
arteries form a continuum but change name at the level of the groin and popliteal 
fossa. At groin level the external iliac artery becomes the common femoral artery 
(CFA). At the top of the leg the common femoral artery bifurcates into the profunda 
femoris artery (PFA) which supplies the thigh and the superficial femoral artery 
(SFA) which continues distally. The superficial femoral artery becomes the popliteal 
artery at the level of the popliteal fossa. The popliteal artery trifurcates into three main 
tibial arteries: The posterior tibial artery, anterior tibial artery and the peroneal artery 
below the level of the knee joint. The dorsalis pedis and plantar arteries run from 
these arteries onto the foot.
1.3 Arterial Structure
The regulation of blood flow to tissues is in part achieved by the function of the 
arteries. Arterial structure is intricate with adaptive characteristics allowing either 
dilatation or constriction in response to alterations in haemodynamic stresses and 
environmental conditions to maintain an optimal blood supply to tissues (Zarins, Xu 
et al. 2005).
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The arterial wall consists of three distinct layers or tunis. These are the tunica intima, 
tunica media and the tunica adventitia (Seeley, Stephens et al. 2000). The inner void 
through which the blood flows is called the patent artery lumen. The innermost layer 
called the tunica intima consists of a delicate basement membrane of connective tissue 
called the endothelium and a layer of elastic fibres called the internal elastic 
membrane. This membrane separates the tunica intima from the adjacent layer the 
tunica media. The tunica media extends from this internal elastic layer and consists of 
a matrix of closely packed and predominantly elastic fibres with smooth muscle and 
collagen fibres interwoven. The elastin fibres provide extensibility, allowing for 
compliance and recoil of the artery wall in response to the fluctuation in the blood 
pressure during the cardiac cycle, and their arrangement uniformly distributes the 
tensile stress on the wall. The collagen fibres have a high elastic modulus and provide 
tensile strength to limit distension at high pressures. The tunica media extends to the 
outer layer called the tunica adventitia. This outer layer is relatively thin and is 
composed of collageneous connective tissue, the outer layers of which merge with 
the surrounding connective tissue to tether the artery ((Seeley, Stephens et al. 2000), 
(Zarins, Xu et al. 2005)).
The arteries form a continuum from the aorta to the smallest distal branches, but the 
relative thickness of each layer and the composition of elastic tissue and muscle 
within the arterial wall gradually changes through the vascular tree. Arteries are 
classified as either elastic or muscular depending on their composition. The large 
arteries proximal to and including the aorta are elastic. Their walls contain a large 
amount of elastic tissue and a comparatively small proportion of muscle. As the 
arteries branch away from the aorta, decreasing in size, there is a gradual transition in
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the wall composition from predominantly elastic to predominantly muscular wall 
composition. Therefore the smaller, more distal arteries are classed as muscular 
(Seeley, Stephens et al. 2000). Muscular arteries have relatively thick walls that 
contain relatively less collagen and elastin and more smooth muscle allowing for 
constriction or dilatation to facilitate rapid changes in diameter. In the larger elastic 
arteries the layers of elastic fibres called lamalae are tightly packed with alternating 
layers of smooth muscle and collagen fibres interwoven. The number of lamellar units 
and the intima media thickness are closely related to the tangential tension 
experienced by the wall and the luminal radius (Zarins, Xu et al. 2005).
The average tension per lamellar unit tends to be constant throughout mammalian 
species. The arterial radius increases with increasing mammal size with corresponding 
increases in the intima medial thickness and lamellar units. However, this relationship 
does not hold for the human abdominal aorta. In humans the abdominal aorta 
contains fewer lamellar units than would be expected for the load borne. This may 
explain the relatively high incidence of abdominal aortic aneurysms in humans. The 
intima media of the proximal thoracic aorta contains a larger proportion elastin and a 
lower proportion of collagen than the abdominal aorta or more distal elastic arteries. 
The proximal aorta is more compliant than the abdominal aorta but is also more prone 
to tear. Studies have suggested that failure of elastin and collagen in the abdominal 
aorta is a major factor in aneurysm development (Curci, Baxter et al. 2005; Zarins, Xu 
et al. 2005).
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1.4 Arterial Diseases
The two main types of disease affecting the arteries can be categorised into those 
which decrease the lumen diameter and those by which the arterial diameter is 
increased. Although this study is concerned with the detection of aneurysmal disease 
of the abdominal aorta, occlusive arterial disease and its effect on the blood flow must 
also be considered.
1.4.1 Atherosclerosis
Arteriosclerosis is a general term used to describe a number of conditions in which the 
walls of the arteries thicken and harden (Solomon, Schmidt et al. 1990). The most 
common form of arteriosclerosis is atherosclerosis derived form the Greek words 
‘athero’ meaning gruel and ‘sclerosis’ meaning hardness. Atherosclerosis mainly 
affects the larger arteries of the body: The coronary arteries of the heart, the carotid 
arteries supplying the brain and also the peripheral arteries supplying the limbs. It is 
the main cause of cardiovascular disease and is the leading cause of death in the 
United States (Solomon, Schmidt et al. 1990). It is a slow, progressive disease 
involving the deposition of lipids, cholesterol, calcium and other substances of the 
blood to form plaque within the lining of the arterial wall. Atherosclerotic plaque 
formation reduces the elasticity of the arterial wall and gradually narrows the lumen 
impeding the flow of blood. Lesions which cause narrowings are called stenoses. The 
severity of disease is characterised by the degree of narrowing and is usually referred 
to as the percentage of the vessel diameter which is blocked. A 50% stenosis refers to 
a narrowing of 50%. As plaque formation progresses the stenosis level increases until
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eventually the artery is blocked completely. This is called an occlusion. Both stenoses 
and occlusions can significantly reduce the blood supply to distal tissues.
1.4.2 Peripheral Arterial Disease
Peripheral arterial disease (PAD) broadly describes diseases effecting the arteries 
supplying the limbs. This is commonly atherosclerotic plaque effecting the aorto-iliac, 
femoral and popliteal arteries. The atherosclerotic lesions reduce the blood supply 
distally, therefore the symptoms of PAD depend on the location and severity of the 
disease. The most common symptom is intermittent claudication where no pain is felt 
at rest but cramp like pain is experienced in the leg muscles, most commonly the calf 
muscles on exertion. With advanced aorto-iliac disease pain may be felt at rest and the 
function of pelvic organs may also be affected. The severity of disease is classified 
according to the affect it has on the blood flow: Its haemodynamic significance. It is 
generally accepted that stenotic lesions causing less than 30-40% narrowing are not 
clinically significant as there is no real reduction to the distal flow volume. 40-50% 
stenoses are generally classed as moderately haemodynamically significant. Stenoses 
greater than 70% dramatically impede the flow of blood. Complete arterial occlusion 
is the endpoint at which the artery is completely blocked and the blood supply to 
distal tissues is reliant upon collateral circulation. Collateral arteries are the 
distributing branches of large and medium sized arteries that enlarge when a stenosis 
or occlusion develops to maintain a supply of blood distally.
Studies indicate the prevalence of PAD of the lower limbs to be around 12%. The 
disease is progressive and the prevalence has been shown to increase with age from
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around 7% for those aged 60-69 years old to around 23% for those aged over 80 years 
old (Fowkes, Housley et al. 1991; Ostchega, Paulose-Ram et al. 2007).
1.4.3 Aneurysmal Disease
An aneurysm is a gross, permanent, localised dilatation of a section of an artery. An 
enlargement greater than twice the size of the proximal artery is generally classed as 
aneurysmal. Arterial aneurysms are differentiated into three main forms as shown in 
Figure 1.1: Fusiform where the dilation is symmetrical, saccular where the dilation is 
at one side of the artery and fusiform/saccular where all sides are dilated but non- 
symmetrically. In all cases intra-luminal thrombus (ILT) may form on the artery wall 
within the dilated region.
Fusiform
aneurysm
Figure 1.1: Fusiform, saccular and
The majority of aneurysms develop slowly over many years. They are often clinically 
silent until late in their natural history, and may remain undetected until dissection, 
embolisation of ILT or rupture occurs (Curci, Baxter et al. 2005).
Saccular Fusiform/saccular
aneurysm aneurysm
fusiform/saccular aneurysms (Hennerici and Neuerburg-Heusler 
1998)
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Structural weakness and mechanical and haemodynamic forces are the basic factors 
underlying aneurysm development. The aetiology of arterial aneurysms is not entirely 
understood and involves a complex interaction of genetic, local and systemic factors. 
The development of aneurysmal disease involves changes to all three layers of the 
arterial wall, the tunica intima, tunica media and the tunica adventitia. Collagen and 
elastin are the major structural proteins within the arterial wall matrix. There are 
several pathologies which appear to be central to the initiation and progression of 
aneurysmal disease: Matrix changes within the tunica media and tunica adventitia 
with damage to the elastic intima, chronic inflammation, and the depletion of cells 
responsible for matrix repair. The interrelation between these pathologies means that 
these changes are progressive and self-propagating once established. The changes 
may be brought about by mechanical injury, congenital defects, infection and 
inflammatory conditions. Congenital defects in proteins namely elastin and collagen 
within the arterial wall matrix can predispose to aneurysm development. Two such 
inherited syndromes being Marfan syndrome and Ehlers-Danlos syndrome. In both 
these conditions collagen formation is defective causing faulty elastic tissue (Curci, 
Baxter et al. 2005).
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1.5 Abdominal Aortic Aneurysm
The normal diameter of the abdominal aorta in the average adult ranges from around 
1.2cm to 2.0cm. It is generally agreed that an aortic diameter exceeding 3cm is 
classed as aneurysmal. The most common type of aortic aneurysm is an abdominal 
aortic aneurysm (AAA), which occurs in the portion of the aorta lying below the renal 
arteries as illustrated in Figure 1.2. Aortic aneurysms may also occur in the thoracic 
cavity.
www.maybclinid .com
Figure 1.2: Abdominal Aortic Aneurysm
Most AAAs are fusiform/saccular in shape. The dilation in the anterior direction is 
usually greater than in the posterior direction which is limited by the spine. The shape 
of the aneurysm has clinical implications due to differences in prognosis, treatment 
and surgical procedures associated with the different forms (Hennerici and 
Neuerburg-Heusler 1998).
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AAA is a potentially lethal condition because if the aneurysm becomes very large it 
can rupture, and this is often fatal due to severe internal bleeding. It is estimated that 
AAAs are responsible for up to 10,000 deaths per year, approximately 1.7% of all 
deaths in England and Wales (Smith 1994). A serious complication of AAA is arterial 
embolism from the formation of ILT within the aneurysm. Embolic occlusions result 
in ischaemia of the tissues (commonly the feet and toes) supplied by the artery. 
Unless the emboli are removed by surgery or thrombolitic drugs, or bypassed, the 
occlusion may result in necrosis (tissue death) and amputation.
Common symptoms of AAA include abdominal pain, back pain, and some patients 
may experience a pulsating feeling in the abdomen. The symptoms are non-specific to 
AAA and do not usually occur until the aneurysm is very large. Patients can often 
have an aortic aneurysm for many years before any symptoms develop. In many 
cases, an aortic aneurysm will remain clinically silent until it ruptures, and around 
50% of patients with a ruptured AAA die before reaching hospital (Ashton, Buxton et 
al. 2002). The likelihood of surviving emergency rupture repair is between 30-70% 
and the overall mortality rate from ruptured AAA is between 80-90% (Smith 1994). 
Aortic aneurysms that are diagnosed prior to rupture are usually found incidentally on 
physical examinations and chest or abdominal x-rays performed for an unrelated 
condition. In some cases an acute occlusion of the lower limb arteries caused by 
emobolisation of ILT may be the first symptom of an AAA.
It is difficult to determine the prevalence of AAA because only those found 
incidentally or those that rupture are diagnosed, but screening studies have shown 
prevalences of up to 7.6% in men and 1.3% in women (Scott, Wilson et al. 1995;
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Scott, Bridgewater et al. 2002). The age-prevalence curve for women is shifted by 
about 10 years for women compared to men (Scott, Bridgewater et al. 2002). A study 
by Semmens et al indicates that on average women presenting with ruptured AAA are 
6 years older than men (Semmens, Norman et al. 2000).
1.5.1 Clinical Management of AAA
Once an AAA has been detected, the patient will usually have an ultrasound scan to 
locate and measure the aneurysm. Ultrasound can be used to image the aorta in 99% 
of people (Ashton, Buxton et al. 2002). Colour flow duplex systems which allow 
simultaneous display of Doppler blood flow information and greyscale B-mode 
images are currently the principal type of equipment used for clinical diagnosis of 
peripheral vascular disease (Hennerici and Neuerburg-Heusler 1998). The reliability 
of colour flow duplex scanning for routine surveillance of abdominal aortic 
aneurysms is well recognised (Yehuda G. Wolf 2000) and is now considered the 
accepted non-invasive method in detecting and assessing AAAs (Hennerici and 
Neuerburg-Heusler 1998). At UHW, all patients with a diagnosed AAA undergo an 
ultrasound scan every six or twelve months in a surveillance programme to monitor 
the growth of the aneurysm. The maximum diameter of the aneurysm is measured in 
both transverse and longitudinal planes. The extent of the aneurysm and its shape can 
normally be estimated. The extent of any ILT and the size of the remaining patent 
lumen is also measured.
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The treatment for AAA is surgical or endovascular repair. In these procedures the 
aneurysmal section of the artery is replaced by a synthetic graft. For elective 
aneurysm repair, the risk of rupture must justify the surgery considering the potential 
complications and expense. The survival of emergency aneurysm repair following 
rupture is low and although the surgical risk is still high, studies show the survival 
rate of elective surgery is much greater. The mortality rate for elective surgery is 2- 
6% (Ashton, Buxton et al. 2002) and therefore elective resection is considered when 
the risk of rupture exceeds the surgical risk. The risk of rupture increases with 
aneurysm diameter and becomes substantial when the diameter exceeds 5-6cm. The 
UK Small Aneurysm Trial indicated that for small aneurysms (<5.5cm diameter), the 
mortality rate due to risk of rupture in patients under ultrasound surveillance was far 
lower than the mortality rate in patients who underwent early elective surgery (Pretre 
R 1998). The vascular surgeons at the University Hospital of Wales (UHW) will 
consider patients for elective aneurysm repair if the aneurysm diameter exceeds 5.5cm 
and therefore is considered at risk from rupture. Ultrasound scanning has advantages 
over other techniques such as CT (computed x-ray tomography) and MR (magnetic 
resonance) angiography in terms of wider availability, lower cost, and it does not 
involve ionising radiation. However, in addition to measuring the aneurysm size, the 
shape, location and extension (for example, into the renal and iliac arteries) must be 
determined. Conventional, CT and MR angiography can provide this information 
which is not usually attainable with duplex scanning. This information is valuable to 
the surgeon in the selection of surgical procedure for resection (Baur G M 1978). 
Therefore, an angiographic procedure is often performed prior to elective repair.
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1.5.2 AAA Screening
At present there is no national screening programme for AAA. Several studies have 
shown that screening of the male population over the age of 65 years for AAA 
significantly reduces the mortality rate from the condition (Scott, Wilson et al. 1995; 
Heather, Poskitt et al. 2000; Ashton, Buxton et al. 2002; Wilmink, Quick et al. 2003). 
The Multicentre Aneurysm Screening Study (MASS) (Ashton, Buxton et al. 2002; 
Greenhalgh and Powell 2002) presented reliable evidence of benefit from ultrasound 
screening for AAA. The advantage of screening is that if AAAs are detected prior to 
rupture, the condition can be monitored and may be electively repaired if clinically 
viable. The study suggested a 51 % reduction of ruptured AAAs and showed that over 
four years there was a 53% mortality reduction in men who were screened for AAA. 
In addition to the increased survival for elective repair, the cost is almost half that of 
emergency repair, and therefore AAA screening was shown to be cost effective.
Although screening for AAA using conventional ultrasound techniques is cost 
effective, duplex scanning is hospital based, relatively expensive (approx. £80 per 
NHS scan) and requires a skilled operator to perform the investigation. The aim of 
this research study was to develop an alternative technique to diagnose AAA that is 
cheaper and requires reduced operator skill.
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1.5.3 Aneurysms of the Distal Arteries
Aneurysmal disease can also affect the larger arteries distal to the aorta supplying the 
lower limbs, commonly the iliac arteries at the bifurcation of the aorta and the 
popliteal arteries behind the knee. In general for these arteries, a diameter exceeding 
1.5cm is considered aneurysmal.
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1.6 Introduction to Ultrasound
Sound is audible to the human ear within the frequency range 20Hz-20KHz. 
Frequencies higher than about 20kHz are inaudible and beyond this level the sound 
wave is known as ultrasound. A sound wave is a longitudinal pressure wave which 
passes through a medium at a fixed speed (Fish 1990). The rate at which particles in 
the medium vibrate in the disturbance is the frequency of the sound. The speed at 
which an ultrasound wave is transmitted through a medium is dependant upon the
density and compressibility of the medium in the relationship c = (ms'1) where
c is the propagation speed, k is the elastic modulus (kgms'1) and p is the density
(kgm"3). The acoustic impedance ( Z ) of a material is a measure of the response of
2 1the particles in a medium to a given pressure and is given by Z = pc (kgm’ s' ) (Fish 
1990). Acoustic impedances within the human body cover a wide range from
o  i f\ i430kgm' s' for air to 6.47x10 kgm' s' for bone. Soft tissues such as kidney and liver
6 2 1 6 2 1 have acoustic impedances of 1.64x10 kgm' s’ and 1.66 xlO kgm' s' respectively and
6 2 1the acoustic impedance of blood is 1.67x10 kgm’ s" (Hoskins, Thrush et al. 2003).
1.6.1 Ultrasound Generation
Ultrasound is generated using a piezoelectric transducer which converts an electrical 
signal into a mechanical pressure wave. Piezoelectric materials expand or contract 
when a positive or negative voltage is applied across them, and generate a positive or 
negative voltage when compressed or stretched. The piezoelectric transducer can be 
used to generate an ultrasound pressure wave by applying an AC voltage with a 
frequency equal to that of the required ultrasound wave. The same or a second
17
piezoelectric crystal is used to detect incoming (reflected) ultrasound waves by 
converting the returning pressure waves back into a measurable voltage.
1.6.2 Medical Ultrasound
Ultrasound first came into routine clinical use in the early 1970’s (Cosgrove D 1993). 
These early systems provided real-time greyscale ‘B-mode’ images of structures 
within the body. Until this time, aortic aneurysms were diagnosed by physical 
examination and confirmed by conventional x-rays or arteriography. The 
development of Doppler systems in the same decade enabled blood flow within the 
body to be studied.
As ultrasound waves are transmitted through the body they are reflected at boundaries 
between tissues of different acoustic impedance with the amount of transmission and 
reflection dependent upon the difference in acoustic impedance across the boundary. 
The type of reflection is dependant on the size of the reflecting interface with respect 
to the wavelength of the ultrasound which is related to the frequency and speed of the
ultrasound by X = . For structures with dimension several wavelengths larger than
the wavelength of the ultrasound, the wave is simply reflected as described above. For 
structures smaller than the wavelength of the ultrasound the wave is scattered in all 
directions by a phenomenon known as Rayleigh scattering. In the human body the soft 
tissues and organs have very similar acoustic impedance therefore the magnitude of 
the reflected signals from organ boundaries is very small, to the order of 1/10 to 1/100 
of the incident wave intensity. Rayleigh scattering from blood cells is to the order of 
1/1000 of that from an organ boundary.
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To transmit ultrasound into the body the transducer is placed in contact with the skin 
surface with coupling gel to eliminate the air gap which would strongly reflect the 
ultrasound and reduce transmission into the body. As ultrasound propagates through 
tissue, its intensity decreases as energy is transferred into the tissue structure via a 
number of mechanisms. The absorption of ultrasound energy increases with frequency 
and the upper limit for ultrasound imaging is about 20MHz. Structures lying deep 
within the body can be difficult to image and generally the maximum depth at which a 
reasonable clinical image can be obtained is 15-20cm. Structures lying beneath bone 
or gas often cannot be imaged as the majority of ultrasound is reflected at the 
boundary rather than transmitted through to the underlying tissue. These factors can 
pose problems when imaging the aorta in obese patients or in cases where there is 
excessive bowel gas present.
There are different types of transducers with a range of operating frequencies 
available for different imaging applications. For medical imaging applications sound 
waves in the range l-15MHz are used. Because the penetration of ultrasound is 
strongly dependent on ultrasound frequency, lower frequencies are used to image 
deep lying structures such as the aorta. The array of transducer elements can be 
arranged convexly to provide a wider field of view. The type of transducer used to 
image structures such as the aorta is a low frequency curvi-linear transducer operating 
at around 4Mhz.
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1.6.3 B-Mode Ultrasound Imaging
A 2-D B-mode ultrasound image is a grey-scale image representing tissue and organ 
boundaries in a slice through the body. B-mode stands for Brightness-mode because 
all pixels in the image are intensity modulated, which means the brightness of each 
pixel is proportional to the intensity of the ultrasound reflected from the 
corresponding structure within the body.
In medical B-mode imaging the ultrasound is transmitted into the body in a series of 
short pulses typically 0.2 ps in duration. The depth of a reflecting structure in the body 
can be calculated by measuring the time lapse between the transmission of the 
ultrasound pulse and the reception of the reflected wave. To determine the lateral 
position of a structure in a 2-D image a multi-element transducer with an array of 
several hundred individual transducer elements is used. Small groups of elements are 
fired in sequence at a rate called the pulse repetition frequency (PRF) to generate a 
few hundred ‘scan lines’ in a plane through the body. The location of each pixel in the 
resulting 2-D image corresponds to a depth calculated from the assumed tissue 
velocity and a lateral position calculated from the PRF. An ultrasound image or 
‘frame’ is generated once all the transducer elements in the array have been fired. 
Modem ultrasound scanners generate around 30 frames per second enabling ‘real 
time’ imaging of structures within the body. The size of structures within the image 
can be measured using on-screen callipers. The distance between the callipers is 
calculated using the timing information stored within the image matrix. A B-mode 
image of an AAA with calliper measurements of its size is shown in Figure 1.3.
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Figure 1.3: B-mode image o f an AAA with calliper measurements o f size 
1.6.4 Doppler Ultrasound
Doppler ultrasound techniques utilise the Doppler effect and enable the motion of 
tissue and blood flow in the body to assessed. The Doppler effect is the change in 
observed frequency of a sound wave compared to the emitted frequency, which 
occurs due to the relative motion between the observer and the source of the sound 
wave. The frequency change is known as the Doppler Shift frequency. By this 
principle ultrasound can be used to assess blood flow by measuring the frequency 
shift of the ultrasound scattered from moving blood. The Doppler Shift Frequency f d 
is dependent upon the velocity of the moving blood v, the frequency of the 
transmitted ultrasound f t , and the speed of ultrasound through tissue c , in the
relationship: f d = —<-CQS ^  where 9 is the angle subtended between the ultrasound
c
beam and the direction of blood flow (angle of insonation).
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1.6.4.1 Spectral Doppler
Conventionally, Doppler Shift signals are analysed by their spectral content. The most 
common display of the Doppler signal is in the form of a Doppler spectrogram. This 
is a graphical representation in which time is displayed along the horizontal axis, 
frequency shift is displayed along the vertical axis and the power at a particular time 
and frequency is displayed as the intensity of the corresponding pixel. In systems 
where the insonation angle can be estimated, the blood flow velocity can be calculated 
using the Doppler Equation and a graph of blood flow velocity versus time can be 
displayed. Clinically useful information is extracted from the spectral shape and 
parameters of the velocity waveform or power spectrum. An example of a Doppler 
velocity waveform measured from the common femoral artery (CFA) is shown in 
Figure 1.4.
Figure 1.4: Doppler velocity waveform measured from the CFA 
1.6.4.2 Continuous Wave Doppler
In the continuous wave Doppler technique a continuous wave of ultrasound is emitted 
from a transducer and the returning reflected wave is received by a second transducer 
within the same probe head. The Doppler shift signals are measured from any
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movement along the path of the ultrasound beam. The disadvantage of continuous 
wave Doppler is that the noise level in the signals can be high because Doppler shift 
signals from movement anywhere along the beam path are measured in addition to the 
shifts from blood flow in the vessel of interest. For example in the assessment of 
blood flow in the common femoral artery, Doppler shifts from blood flow in the 
underlying common femoral vein or other smaller blood vessels within the path of the 
beam may also be measured. In most vascular applications high pass filtering is 
implemented to reduce the noise in the signal from tissue movement. The advantage 
of the continuous wave Doppler technique is that it is relatively simple, with hand 
held devices available. The technique is useful for measuring blood flow in large 
arteries from which the magnitude of the signal is sufficient to overcome noise.
1.6.4.3 Pulsed Wave Doppler
In pulsed wave Doppler techniques the ultrasound wave is not transmitted 
continuously but as a series of short, typically l-2ps pulses. This enables the Doppler 
signal to be sampled from a selected depth within the body, for example within a 
particular artery. The depth at which the Doppler signal is measured is set by the time 
at which the signal is sampled after pulse transmission. The rate at which the 
individual pulses are fired is called the pulse repetition frequency (PRF). In 
accordance with sampling theory, the PRF must be at least twice the maximum 
Doppler shift frequency to be measured to avoid misinterpretation of the signals 
called signal aliasing. The pulsed wave Doppler technique is more involved but has 
the advantage that the signal is much cleaner because only Doppler shift signals from 
the region of interest are measured with signals from the surrounding tissue and other
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blood vessels eliminated. To reduce the noise even further, pulsed Doppler systems 
often employ high pass filtering to eliminate signals arising from the movement of the 
blood vessel wall.
1.6.4.4 Duplex Imaging
Duplex imaging combines B-mode imaging and pulsed wave Doppler measurements. 
The transducer is similar to a B-mode imaging transducer but with a small group of 
the transducer elements utilised to transmit and detect pulsed Doppler signals. The 
remaining elements employ the B-mode imaging. This technique allows the blood 
vessel to be imaged and the depth at which the Doppler signal is sampled is set by 
positioning an on-screen cursor called the ‘Doppler gate’. The width of the Doppler 
gate can be altered to change the range of the depth within which the shifts are 
sampled. A second on screen ‘angle’ cursor within the Doppler gate can be aligned 
with the orientation of the vessel to give a measure of the insonation angle with the 
blood flow so that blood flow velocity can be calculated using the Doppler equation. 
This technique is clinically useful because the disease state of an artery can be imaged 
and the Doppler gate can be positioned to determine the haemodynamic significance 
of the disease.
1.6.4.5 Colour Flow Doppler Imaging
Colour flow Doppler imaging is a technique in which the Doppler shift signals are 
mapped onto a B-mode ultrasound image to give a visual representation of blood flow 
through vessels. The Doppler shift signals are colour coded often in red and blue to
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indicate flow away from (negative Doppler shift) or towards (positive Doppler Shift) 
the transducer respectively.
1.6.4.6 Colour Flow Duplex Imaging
Most modem ultrasound scanners can perform colour flow duplex (triplex) imaging. 
This is the simultaneous implementation of B-mode, colour flow mapping and pulsed 
wave Doppler. In this technique the Doppler gate can be positioned not only within 
the artery at the site of disease but at the point of maximum velocity indicated by the 
hue of the colour in the flow map. The Doppler angle cursor can be aligned with the 
flow to enable calculation of the blood flow velocity. A colour flow duplex image of 
the CFA is shown in Figure 1.5.
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Figure 1.5: Colour flow Duplex image o f blood flow in the CFA
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1.6.5 Doppler Ultrasound Assessment of Arterial Disease
Arterial disease is readily and routinely assessed using colour and spectral Doppler 
ultrasound which provide ‘real-time’ measurements of blood flow velocity. In the 
assessment of arterial disease the B-mode images, colour flow images and Doppler 
spectrograms are analysed visually to facilitate a diagnosis. Visual analysis of B-mode 
and colour flow images provide information about disease within the region of 
measurement. In the B-mode image, mural calcification, plaque, thrombus or 
aneurysms can be visualised. The superposition of the colour flow map can provide 
information as to the haemodynamic effects of the disease. To an experienced, trained 
eye the colour flow map can used to identify phasic, disturbed or damped flow. 
Different velocities are displayed as different colour hues and very high velocities 
cause aliasing of the colour.
Spectral Doppler is diagnostically very useful as it provides information about the 
haemodynamic effect of disease within the measurement region but can also indicate 
the presence and severity of proximal or distal disease. Measurement of blood flow 
velocities derived from the Doppler frequency spectrum give an estimate of the 
degree of narrowing caused by the local disease. Visual analysis of the Doppler 
waveform shape can indicate the presence of proximal or distal disease.
Analysis of the Doppler spectrogram is subjective and requires an experienced 
practitioner. The effects of atherosclerotic occlusive arterial disease on Doppler flow 
patterns (discussed in Section 1.7.5.1) are well documented. Visual assessment of 
waveform shape and quality can provide a qualitative analysis of disease state, for
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example observation of a damped waveform measured from the femoral artery 
indicates the presence of proximal disease. There are a number of parameters which 
can be extracted from a spectrogram which provide more quantitative analysis, for 
example the resistivity index (RI), pulsatility index (PI) and the Laplace damping 
factor (5) (Evans, McDicken et al. 1989).
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1.7 Arterial Haemodvnamics
Arterial blood flow is determined by the arterial anatomy, the physical characteristics 
of blood, the regulatory mechanisms controlling the heart and blood vessels and the 
pathological state of the blood vessels. Interrelationships between blood flow, 
pressure and flow impedance through vessels are critical to the function of the 
vascular system (Seeley, Stephens et al. 2000). Arteries are not ideal, straight, 
smooth, rigid vessels, but bend and branch often with irregularities to their surface. To 
complicate matters blood flow is not steady but pulsatile due to the action of the heart. 
Hence, the laws of fluid dynamics in normal rigid tubes do not strictly apply but are 
useful in the explanation and prediction of haemodynamic behaviour.
1.7.1 Blood Pressure and Impedance
Blood flow is largely dependent upon pressure. The pumping of the ventricles creates 
blood pressure, the force exerted by blood on the wall of blood vessels. The maximum 
arterial pressure occurs when the left ventricle of the heart contracts and is called the 
systolic pressure. The minimum pressure occurs when the left ventricle is relaxed and 
is called the diastolic pressure. Blood flows when there is a pressure gradient along 
the length of the vessel and the greater the pressure difference the greater the rate of 
flow. The blood flow resulting from a pressure gradient is opposed by an impedance 
to blood flow in the distal vascular bed. The relationship between flow, pressure and 
resistance in a section of a vessel (under steady state conditions) is described by
(P —P ) r4Poiseuille’s law: flow = — ---------- where P] is the pressure at the inlet to the
8v/
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section, P2 is the pressure at the outlet of the section, r is the radius of the vessel, v is 
the viscosity of the fluid and / is the length of the vessel. The blood pressure exerts a 
force (F) on the arterial wall which is governed by Laplace’s law: F = D x P  where 
D is the arterial diameter and P  is the blood pressure (Seeley, Stephens et al. 2000). 
Under this law, with constant pressure, the force exerted on the vessel wall increases 
with increased vessel diameter. This fact is of particular importance for aneurysmal 
disease. As the aneurysm diameter increases, the force exerted on the weakened wall 
increases, therefore as aneurysms enlarge, the risk of rupture increases (Sumner and 
Zierler 2005).
1.7.2 Laminar Flow and Turbulence
Laminar flow describes steady flow through a long straight, smooth vessel. Under 
these conditions blood behaves as if it is composed of an infinitely large number of 
concentric layers. The outermost layer experiences drag as it moves against the vessel 
wall. This layer in turn exerts a drag force on the next adjacent layer which exerts a 
drag on the next layer and so forth. This results in a series of concentric layers with 
the more central layers moving progressively faster than those towards the vessel wall 
creating a sheared velocity profile (Seeley, Stephens et al. 2000; Sumner and Zierler 
2005).
The velocity profile of steady flow entering a vessel is flat with all layers moving at 
the same velocity. As the flow moves along the vessel the profile becomes blunted 
and then increasingly parabolic along the vessel length until the velocity gradient 
extends to the centre of the vessel. The entrance length required to develop a
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parabolic profile is dependent upon the vessel radius and a dimensionless quantity 
called the Reynolds (Re) number in the relationship L=krRe (k is approximately 
constant for Re>50). Re is dependant upon the inertial and viscous forces within the 
fluid. According to this relationship, the entrance length of many larger arteries 
approaches the length of the artery and it has been shown that the aorta has a blunted 
velocity profile (Sumner and Zierler 2005).
Laminar flow breaks down and becomes turbulent when the blood flow velocity 
exceeds a critical value corresponding to an Re value of approximately 2000 or when 
there is an abrupt change in vessel diameter, the vessel bends sharply or the surface 
becomes irregular (Sumner and Zierler 2005). Under normal physiological and 
pathological conditions the Re value in peripheral arteries is well below the critical 
value. However, arteries within the circulatory system are not ideal, straight, smooth 
vessels but bend, and branch often with irregularities to their surface and abrupt 
changes in diameter in the presence of occlusive arterial or aneurysmal disease. These 
features disrupt the normal laminar flow pattern and therefore the pattern of blood 
flow in the arterial system is often classified as disturbed rather than turbulent or 
laminar. At bifurcations and areas where the vessel curves, the velocity profile 
becomes skewed. Any narrowing in an artery disrupts the normal laminar flow pattern 
as illustrated in Figure 1.6.
Figure 1.6: Flow disruption at a tight stenosis (based on Cosgrove D 1993).
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The extent to which flow is disrupted is proportional to the severity of the stenosis. 
The magnitude of the blood flow velocities are greatly increased through the 
narrowing and the degree of stenosis can be estimated from the peak systolic velocity. 
In the region of flow disruption just beyond the stenosis where the velocity vectors of 
the velocity profile are no longer parallel, the multiple frequencies produce a 
phenomenon called spectral broadening. Beyond a tight stenosis the laminar flow is 
most disturbed in a region of flow separation just beyond the narrowing. In flow 
separation there is a region of flow in which the velocity vectors have a different 
orientation to the main body of flow, for example flow reversal adjacent to the vessel 
wall. Within aneurysms the axial flow stream is separated from the flow within the 
bulge where velocities are low and flow reversal occurs as illustrated in Figure 1.7.
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Figure 1.7: Flow reversal within an AAA (based on Sumner and Zierler 2005)
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1.7.3 Spectral Broadening
The maximum velocity of flow through an artery under laminar conditions occurs at 
the centre of the vessel. To make a measurement of this velocity using a duplex or 
colour flow duplex machine the Doppler gate is placed at the centre of the vessel 
using the on-screen cursor and the angle cursor is aligned with the flow direction. 
Because the Doppler gate has a finite width a range of velocities around the peak is 
sampled. This range is displayed as a band of frequencies (or velocities) on the 
Doppler spectrogram. Therefore the Doppler waveform is not a narrow line but has a 
width depending on the range of velocities sampled within the gate at a point in time. 
This is called spectral broadening. Under steady flow situations in the absence of 
disease the level of spectral broadening or ‘band-width’ of the signal is relatively low. 
Flow becomes increasingly disturbed in the presence of disease due to irregularities 
on the vessel wall. Increased velocities and the level of spectral broadening can be an 
indication to the level of disease present. In the continuous wave Doppler technique, 
signals are sampled throughout the beam path resulting in an intrinsically spectrally 
broad signal.
1.7.4 Doppler Waveform Shapes
The shape of the Doppler waveform within an artery is dependent on the inflow, the 
structure and composition of the local artery, its capacity for elastic recoil and 
dilatation, and the distal impedance of the vascular tree. The inflow is dependant 
upon the function of the heart and the disease state of the proximal vascular tree. The 
impedance to flow generally increases moving down the arterial tree from the aorta.
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When the blood flow meets high impedance at the peripheral vascular bed part of the 
pressure wave is transmitted into the capillaries and part is reflected back up the 
arterial tree. The fraction of the reflected pressure wave depends on the magnitude of 
the peripheral impedance. Reflection of pressure occurs at any point along the arterial 
tree where the artery branches, bifurcates or narrows and under normal pathological 
and physiological conditions the shape of the Doppler waveform in an artery is in part 
determined by the impedance of the vascular bed it supplies. Therefore, each different 
artery within the body has a characteristic Doppler waveform which is dependent on 
the vessel size and the local, proximal and distal impedance to flow (Sumner and 
Zierler 2005).
1.7.5 Characteristic Waveform Shapes
In the normal aorta and peripheral arteries of the lower limbs the vascular bed has 
high impedance resulting in a ‘high impedance’ waveform. In the normal aorta the 
Doppler waveform shape is described as triphasic as there are three distinct flow 
phases as shown in Figure 1.8.
Figure 1.8: Doppler spectrogram o f triphasic flow in normal aorta.
33
During systole there is a forward, or antegrade flow phase as blood is propelled 
distally. This first peak is referred to as the systolic peak because it results from the 
systolic phase of the cardiac cycle. During early diastole, because the vascular bed is 
high impedance, the reflected pressure wave is relatively large resulting in an overall 
reverse, or retrograde movement of flow. In the Doppler spectrogram this is referred 
to as the reverse flow phase. In late diastole there is a second period of antegrade flow 
as blood is again propelled distally by elastic recoil of the artery wall. This peak is 
referred to as the second forward flow phase. In the common femoral artery (CFA) 
the waveform is also triphasic with both forward and reverse flow components due to 
cardiac output and elastic recoil of the artery. The shape of the waveform is 
characterised as high impedance due to the distal impedance of the vascular tree.
In the internal carotid artery which supplies the brain the impedance of the vascular 
bed is relatively low resulting in a Tow impedance’ waveform. The reflected wave is 
relatively small and causes only a transient reduction in the forward flow during 
diastole but the flow remains antegrade throughout the cycle to maintain high volume 
blood flow to the brain as shown in Figure 1.9.
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1.7.5.1 Occlusive Arterial Disease and Lower Limb Arterial Waveforms
The characteristic Doppler waveform in an artery is changed in the presence of local, 
distal or proximal disease. General hardening of the arterial wall reduces its elastic 
recoil capacity. This causes subtle changes to the waveform shape. The pulsatility of 
the waveform may be reduced and in effect the waveform becomes damped. This 
damping effect increases with the severity of the arterial disease and the second and 
third flow phases may eventually be lost. An arterial occlusion or stenosis, can 
significantly alter the waveform shape and spectral broadening both proximal and 
distal to the site of disease. A highly stenotic or occlusive lesion causes increased 
impedance. As compensation, in addition to collateral development, the vessels within 
the distal vascular bed dilate, reducing their impedance to try to maintain blood flow 
to the affected tissue. Proximal to an occlusive segment or significant stenosis the 
reflected pressure wave adds to the forward flow of systole, typically resulting in an 
upwards deflection or ‘shoulder’ on the downward slope of the Doppler waveform as 
shown in Figure 1.10.
Figure 1.10: Shoulder on CFA waveform due to SFA occlusion
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Distal to an occlusion the pressure is greatly reduced and the amplitude of the 
waveform drops. The pulsatility in the waveform is diminished, the systolic peak 
becomes rounded, during diastole the reverse flow component is lost and the flow 
approaches the baseline more gradually as shown in Figure 1.11.
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Figure 1.11: Damped flow distal to SFA occlusion
The extent of damping caused by stenotic lesions depends on the severity of the 
narrowing. With a minor to moderate stenosis, the alteration to the proximal and distal 
waveforms may be quite subtle. A significant stenosis will produce a more 
pronounced effect, with significant spectral broadening and the third and/or second 
phases of flow may be lost distally.
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1.7.5.2 Hyperaemic Waveform Changes
Doppler waveform shapes are altered by constriction or dilatation of the vascular bed 
in response to changes in environmental or systemic conditions. Dilatation of the 
vascular bed in response to an increased demand on blood flow reduces the 
impedance of the vascular bed and the waveform shape becomes lower impedance. 
The reverse flow phase is lost and there is a higher volume of antegrade flow during 
diastole. Such waveforms are described as hyperaemic. The triphasic waveform 
observed at rest in a healthy CFA can become hyperaemic for example upon exercise 
or in response to temperature changes.
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1.8 Haemodvnamics of AAA
Within an aneurysm the local impedance and pressure is reduced due to the abrupt 
increase in vessel diameter. Therefore, AAA is likely to change the normal aortic flow 
pattern but it has not been possible with current imaging modalities to investigate the 
effects in vivo. Visualisation of Doppler flow patterns within AAAs is more difficult 
than in the more superficial peripheral vessels. The sensitivity and resolution of 
colour and spectral Doppler ultrasound is poor at the depth of the aorta, and the 
assessment of aorto-iliac disease using ultrasound techniques is known to be poor. 
Observation of AAA flows using colour flow duplex imaging is limited due to the 
thickness of overlying tissue and bowel gas. The flow can sometimes be imaged in 
cases where the AAA is particularly large or superficial. In these patients, Doppler 
colour flow maps may provide a crude representation of the flow. When flow can be 
imaged a characteristic swirling pattern with simultaneous forward and reverse flow is 
often observed indicating a level of flow disturbance. However, colour flow imaging 
does not provide any detailed information about AAA flow patterns. The colour-flow 
duplex image of flow in a 7.3cm AAA is shown in Figure 1.12. The swirling pattern 
in the flow is crudely indicated by the red and blue regions of the colour-flow map. 
Doppler waveforms are very difficult to measure from within AAAs using duplex or 
colour flow duplex modes due to movement of the aorta with breathing and poor 
penetration through overlying tissue and bowel gas, resulting in weak, noisy signals. 
Therefore it is not possible to adequately examine AAA flows with current ultrasound 
techniques.
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Figure 1.12: Colour flow duplex image showing flow through large AAA.
Theoretically, the presence of an aneurysm should also affect the flow patterns in 
distal vessels. Colour flow duplex imaging of the flow patterns distal to the AAA in 
the common iliac and external iliac vessels is again very difficult due to poor 
penetration, poor beam-vessel angle and tissue movement. The CFA is generally the 
most proximal artery supplying the lower limbs from which adequate Doppler 
information can be measured.
Because it has not been possible to investigate AAA flow patterns with current 
imaging techniques, recent studies into the haemodynamics of AAA have relied on 
numerical (computer) and mechanical fluid dynamics modelling.
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1.8.1 Mechanical Fluid Dynamics Modelling of AAA
Mechanical fluid dynamics modelling of flows within AAAs involves an AAA model, 
which is usually rigid, incorporated into a flow unit containing a blood substitute 
fluid. The descending aorta is modelled as a straight cylindrical tube. The flow pattern 
entering the AAA model is controlled by a pump and valve system. In early studies 
the flow patterns within the AAA models were measured using colour flow Doppler. 
In later studies an imaging technique called laser Doppler anemometry has been used 
to obtain more detailed measurements.
In early studies, Peattie and Schrader (Schrader, Peattie et al. 1992; Peattie, Schrader 
et al. 1994) used colour flow Doppler imaging to study the flow of tap water mixed 
with bone charcoal powder through a rigid fusiform AAA model. Colour Doppler 
imaging crudely reproduced the flow patterns within the model. At low flow rates the 
flow through the model remained steady, at higher flow rates (/te>2000) turbulence 
was observed as regions of retrograde flow, which fluctuated haphazardly in size and 
shape. However, the resolution of the colour flow Doppler images was not high 
enough to observe the detail of the flow patterns. In a later study by Peattie et al 
(Peattie, Asbury et al. 1996), the colour flow Doppler visualisation of the flow was 
supported by the more detailed laser Doppler anemometry measurements. Steady 
flows at a range of flow rates were passed through a number of different sized AAA 
models to examine the effect of AAA size on the flow. The instantaneous local flow 
velocities were qualitatively evaluated from the laser Doppler measurements. The 
critical Re values for the onset of intermittent and non-intermittent turbulence were 
determined by increasing the flow rate into the model until turbulence was detected.
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This was repeated for a number of different sized AAA models. Three distinct flow 
regimes were observed within all the models. Below /te=1800, the core flow through 
the aneurysm remained laminar, surrounded by slowly recirculating fluid in the bulge. 
Above Re=2400 the flow was fully turbulent. Between /te=1800 and 2400 the flow 
was intermittently turbulent with the duration of turbulence increasing with increasing 
Reynolds number. For moderate and large AAAs (4.3cm and 6.3cm diameter), at 
Re=500 the flow was laminar with slowly recirculating vortices surrounding the core 
flow. The most rapid retrograde velocities occurred in the distal half of the models. 
The flow was turbulent at Re=2600. The turbulence spread outwardly as it travelled 
through the aneurysm until it was reconstricted at the distal end of the aneurysm 
model by the exit tube. The critical conditions for turbulence were found to be a 
decreasing function of AAA diameter. Larger AAA models became turbulent at lower 
Re values than smaller AAAs, and larger AAAs were more likely to develop higher 
intensity turbulent flow patterns. The largest models produced velocity fluctuations as 
great as 40% of the time averaged centre line velocities. In all cases, the strongest 
turbulence was found in the distal half of the AAA and the turbulent bursts increased 
in size as they travelled through the AAA model. These early studies of steady flows 
through AAA models suggest that AAAs are likely to disrupt normal aortic flow 
patterns. It is very difficult to reproduce truly physiologically representative flow 
patterns but the following later studies went on to investigate more realistic flow 
patterns.
Yip and Yu have published several papers on their work investigating flows through 
rigid aortic aneurysm models using laser Doppler anemometry. Yu (Yu 2000) 
examined steady flow through an axis-symmetric (fusiform) AAA model and
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observed the formation of a recirculating vortex occupying the entire circular bulge 
with the core located towards the distal end. The same model was then used to 
examine the effect of more realistic pulsatile flows. In this case, Yu observed vortex 
formation towards the proximal end of the bulge during the early acceleration phase 
of the flow cycle. This vortex increased in strength and moved towards the distal end 
of the AAA model during the deceleration phase. The vortex rapidly decayed during 
the subsequent acceleration phase. The study was conduced using two different size 
AAA models of 4cm and 8cm diameter to simulate early and late stage aneurysms. 
For steady flow, bulge dimension did not largely affect the flow characteristics. For 
pulsatile flow the vortex strength was greater in the larger aneurysm.
In a later study (Yip and Yu 2001), a similar experimental set up was used to 
investigate the transition to turbulence within aneurysm models for more realistic 
oscillatory flows. Axis-symmetric (fusiform) AAA models of 32mm and 64mm 
diameter and 80mm and 100mm respectively in length were used to model early and 
late stage AAAs. The input flows were based on physiological measurements of aortic 
flow taken by Moore et al. The reverse components of the oscillatory flow were 
removed by a valve system. The experiments were performed for two different 
simulated flow conditions: fully laminar flow (Re<500), and transitional flow 
(500</te<1310). For the advanced stage AAA model, turbulence was observed within 
the AAA for fully laminar (/te<500) aortic (input) flow. Recirculating vortices were 
formed at the proximal end of the model as the flow entered the bulge. These 
increased in size and moved towards the distal end, separating from the wall. The 
strength of the vortices was almost completely dissipated on arrival at the distal end. 
The onset of turbulence occurred at the distal neck immediately after the flow began
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to decelerate. The turbulence was not sustained, because the flow was relaminarised 
when the flow began to accelerate in the subsequent flow cycle. This flow regime 
measured by Yip and Yu is illustrated in Figure 1.13, which shows the development 
of flow through the aneurysm during a complete flow cycle.
Figure 1.13: Flow development during a flow cycle (Yip and Yu 2001).
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In the small AAA model, input flow with a higher Re number was needed to produce 
turbulence within the AAA. With Re=806, vortices formed inside the bulge half way 
into the acceleration phase. The vortices were confined to the proximal half of the 
bulge. Turbulence was detected within the vortex region during the deceleration 
phase. Unlike the larger model, the vortices did not detach from the wall or move 
towards the distal end. The study showed that disturbed flow occurred in the AAA 
models and for laminar input flows, the greater the aneurysm model diameter, the 
lower the Reynolds number for the onset of turbulence. This agrees with the findings 
of Peattie and Schrader.
To investigate the effect of forward and reverse input flows on AAA flow patterns, 
Yip and Yu (Yip and Yu 2002) studied sinusoidal flows through the models. Axial 
velocities were measured at successive cross sectional planes through the bulge and 
the cyclic flow development at different phases within the flow cycle was determined. 
The flow within both the large and small AAA models become increasingly unstable 
during the forward and reverse acceleration phases and the transition to turbulence 
occurred shortly after the forward and reverse deceleration phases commenced. The 
turbulence dissipated during the remainder of each deceleration phase and was 
destroyed by flow acceleration of the subsequent cycle. In the large AAA model, the 
flow pattern in the positive half of the flow cycle was similar to that observed in the 
pulsatile and oscillatory flow regimes: a vortex formed at the proximal end as flow 
entered the bulge, increased in size and moved towards the distal end during the 
positive acceleration phase. In the reverse half of the flow cycle, the pattern repeated, 
but in the opposite direction: a vortex formed at the distal end as flow accelerated in 
the reverse direction. This vortex grew in size and moved towards the proximal end
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during the negative (reverse) acceleration phase. Turbulence was detected at both 
ends during the positive and negative deceleration phases. The turbulence at both ends 
of the model rapidly dissipated as the flow decelerated towards zero. During positive 
deceleration, the turbulence at the distal end was stronger and more widely spread 
than at the proximal end. During the negative deceleration phase, the turbulence at the 
proximal end of the AAA model was stronger and more widely spread than at the 
distal end. This flow regime was repeated for each flow cycle within the large AAA 
model. In the small AAA model, three recirculation vortices were formed during the 
positive acceleration phase as the flow entered the bulge. The recirculation regions 
increased in size until the end of the acceleration phase. Steep velocity gradients were 
formed as the flow decelerated and transition to turbulence occurred in the proximal 
end of the bulge. The turbulence spread along the AAA model wall and its strength 
decreased as the bulk flow continued to decelerate. During the reverse half of the flow 
cycle, three recirculation vortices were formed at the distal half of the bulge, and 
turbulence was detected in this region during the deceleration phase. Again, for each 
flow cycle the turbulence increased in size and decreased in strength as the bulk flow 
decelerated, and was destroyed as the flow accelerated.
In vivo, AAAs are seldom symmetrical but more asymmetrical (commonly 
fusiform/saccular) in nature. Egelhoff et al (Egelhoff, Budwig et al. 1999) compared 
pulsatile flows in rigid asymmetric and symmetric AAA models of different sizes. 
Five different size early stage (2-4cm diameter) symmetric AAA models with aspect 
ratios typical of fusiform aneurysms, and one asymmetric model with one straight and 
one fusiform shaped side were studied. For the moderate sized symmetric AAA 
models, vortex formation occurred during late ‘systole’ (flow acceleration) with
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vortex growth and translation towards the distal end during ‘diastole’ (flow 
deceleration). By mid ‘diastole’, a secondary vortex had formed in the straight inlet 
tube proximal to the bulge. By late ‘diastole’, the flow was vortex dominated. The 
vortex filled the bulge centre and inlet tube proximal to the AAA, and turbulence was 
observed at these locations. The flow in the large symmetric model was similar to 
these observations, except that the vortex strength and translation speed were 
considerably higher. In addition, the vortex was forced out into the exit tube by the 
accelerating flow of early ‘systole’. In the asymmetric AAA model, vortex formation 
occurred during early systole as for the symmetric situation. However, the strength of 
the vortex was weaker, there was no transition to turbulence observed and the vortex 
was not convected into the exit tube.
Yip and Yu (Yip and Yu 2003) also extended their work to investigate sinusoidal 
flows within idealised, rigid, asymmetric AAA models. They observed that as flow 
entered the asymmetric AAA model, recirculating vortices were formed either side of 
the proximal neck, with the vortex on the bulge side larger than on the straight side. 
As observed in the symmetric model, the vortices grew in size and detached from the 
walls and moved towards the distal end during the acceleration phase. The vortex on 
the bulge size was relatively larger at all times. In both the symmetric and asymmetric 
models, the flow at the distal neck was least stable. In the large symmetric model, 
turbulence was observed during flow deceleration at the distal end only. In the large 
asymmetric model, turbulence was observed during flow deceleration at three 
locations: at the proximal entrance, at the sidewall of the bulge and at the distal neck. 
The turbulence at the distal neck was double the size of turbulence at the other 
locations.
46
Blood flow patterns are complex and are not easily reproducible because blood 
vessels are not straight or rigid but are elastic and provide recoil. Therefore, 
mechanical modelling studies do not strictly reproduce in vivo conditions. However, 
such studies provide a useful insight into AAA flows which so far have not been 
successfully studied in vivo.
These modelling studies suggest that disturbed and even turbulent flows are set up 
within AAAs, altering the normal aortic flow profile. The study by Egelhoff et al 
suggests that these flow disturbances may be transported into more distal vessels. It 
may therefore be possible for flow disturbances generated within AAAs to be 
transported distally into the iliac and femoral arteries.
The main aims of this research project were to determine whether flow disturbances 
from an AAA can be detected in the common femoral artery at the top of the leg using 
Doppler ultrasound, and whether detection of the flow disturbances could be used as 
an alternative method for AAA detection.
1.8.1.1 Physiological Effects of AAA Flow Patterns
The mechanical modelling studies also indicated that the type of flow within an AAA 
model is dependant on the physical aspects of the AAA. In all models, the bulk flow 
acceleration reduced flow instabilities inside the AAA, but deceleration facilitated 
instability growth. The flows observed in the models have physiological implications 
and may contribute to the development and rupture of AAAs. The aortic wall is 
subjected to cyclic and turbulent, normal and shear stresses due to the cyclic and
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turbulent flow patterns set up within the aneurysm. During acceleration, the flow is 
stable and the walls experience laminar shear stresses only. During deceleration, 
turbulent flows subject the walls to high turbulent shear stresses. For sinusoidal flows 
Yip and Yu (Yip and Yu 2002; Yip and Yu 2003) estimated the wall shear stress from 
the instantaneous velocity profiles at different phases in the flow cycles. The peak 
stress was observed at the distal end of the aneurysm models during the deceleration 
phase. This is because the onset of turbulence at the distal neck during the 
deceleration phase subjected the wall at this location to high turbulent shear stresses. 
This correlates with clinical observation that most aneurysms rupture at the distal end.
It is understood that cells sense and respond to their biomechanical environment. 
Endothelial cells respond to the shearing forces from flowing blood and mechanical 
stretch from arterial pulsation. Therefore, biomechanics plays a key role in the 
development, enlargement and rupture of aortic aneurysms (Steinman, Vorp et al. 
2003). Turbulent shear stresses are much more damaging to endothelial cells than 
laminar shear stresses of the same magnitude (Yip and Yu 2003). Turbulent fluid 
stress is known to induce and promote vascular endothelial cell turnover and may 
cause blood cell and platelet damage. Therefore, the turbulence observed in the AAA 
models may explain the observed build up of intra-luminal thrombus (ILT) on the 
AAA wall in vivo. The turbulent flows in large AAAs are less damaging to free 
moving blood cells and platelets but still cause endothelial layer damage (Yip and Yu 
2001).
At present, elective repair is based on the maximum diameter of the aneurysm. 
However, AAAs with the same diameter may have different wall thickness, shape and
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mechanical properties which effect the growth and likelihood of rupture. From a 
biomechanical point of view, the critical state of an AAA is when the mechanical 
stress within the aneurysmal wall exceeds the tensile strength of the tissue (Vorp, 
Raghavan et al. 1998). It is suggested that evaluation of wall stress distribution may 
provide a predictor for rupture risk. Therefore, in addition to detecting AAA from 
disturbances in distal flow, the disturbance patterns may possibly also provide an 
indication of rupture risk.
1.8.2 Numerical Fluid Dynamics Modelling
Sophisticated image processing and computational fluid dynamics (CFD) modelling 
techniques can provide reconstruction of the time varying, three dimensional blood 
flow patterns within realistic arterial models (Steinman 2002). The first image based 
CFD studies of arterial geometries were based on angiographic x-ray images. More 
recently, CT angiography and MRI have been used to reconstruct more anatomically 
realistic arterial geometries. MRI has become increasingly popular for imaging blood 
vessels because it does not require the administration of intravenous contrast agents. 
This is because the contrast is achieved by exploiting the differences in magnetic spin 
relaxation properties between tissue types. The properties of blood itself provides 
contrast with the surrounding tissue. MRI is also a powerful technique for imaging in 
vivo blood velocity using a method called phase-contrast MRI (PC-MRI). In this 
technique, the blood flow velocity is encoded into the phase of the complex MRI 
signal. Time-resolved 2-D or 3-D images of one or more velocity components can be 
displayed. Spatially resolved velocity maps can be produced but at the expense of the 
temporal resolution. PC-MRI can measure time-varying velocities under steady flow
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conditions, however the velocity images can become distorted by a number of 
atrifacts in the presence of complex flow patterns (Steinman 2002). It has therefore 
not been possible to use this technique to examine the flow disturbances within 
AAAs.
Ultrasound imaging of vascular anatomy, although clinically widely used, does not 
play a significant role in CFD analysis. This is because 2-D ultrasound images are 
usually acquired manually without reference to a fixed co-ordinate system, making it 
difficult to accurately reconstruct 3-D views. 3-D ultrasound systems that sweep the 
beam either mechanically or electronically to acquire a series of orthogonal 2-D 
images through a 3-D volume are available, however, the overall image quality is not 
sufficient for reliable CFD calculations. Therefore, MRI and CT angiography are the 
preferred techniques for producing anatomically realistic arterial models. Doppler 
ultrasound is useful in CFD to provide real-time measurements of blood flow 
velocity, vessel diameter and flow rates. To date, fluid dynamics modelling has 
mainly been used to predict AAA wall stress rather than to investigate flow patterns.
Vorp et al (Vorp, Raghavan et al. 1998) used finite element analysis to determine the 
effects of AAA shape and diameter on the wall stress distribution in AAAs. The 
results indicated that the asymmetry of an AAA in addition to aneurysm diameter is 
important for determining mechanical wall stress. Aneurysms with the same diameter 
do not necessarily have the same likelihood of rupture. This may be important to 
consider in the clinical management of AAAs.
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Hua et al (Hua and Mower 2001) applied linear finite element analysis to 
mathematical AAA models to investigate the relationship between peak wall stresses 
and AAA volume, maximum diameter (for symmetrical AAAs), maximum radius (for 
asymmetrical AAAs), aspect ratio and maximum wall distension. The results showed 
an increase in peak wall stress as the AAA became increasingly asymmetrical. This is 
in agreement with the analysis by Vorp.
Fillinger et al (Fillinger, Raghavan et al. 2002) used finite element analysis on AAA 
models reconstructed using CT scan data to calculate AAA wall stresses in vivo for 
ruptured and electively repaired AAAs. The location of the maximum stress was on 
the postero-lateral wall where clinically most ruptures occur, not at the site of 
maximum diameter. Again, it was concluded that the AAA geometry appears to 
assess rupture risk more accurately than AAA diameter.
1.8.2.1 Effect of Intra-luminal Thrombus
The role of intra-luminal thrombus (ILT) within aneurysms is controversial. 
Embolisation of thrombus from within an AAA is common and can cause ischemia 
and necrosis of tissues. Many factors contribute to the stress within an AAA wall 
including surface curvature, wall tissue characteristics and the presence of ILT (Di 
Martino and Vorp 2003). A number of mechanical, numerical and in vivo experiments 
have been performed to evaluate the effect of intra-luminal thrombus on the pressure 
exerted on the aneurysm wall and the stress distribution. Schurink et al (Schurink, van 
Baalen et al. 2000) performed in vivo pressure measurements within aneurysmal 
thrombus during aneurysmectomy and showed the difference between the mean
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arterial pressure and the mean pressure within the thrombus were not related to the 
thickness of the thrombus at the level of the pressure measurement.
It has been demonstrated by other authors that ILT can significantly alter the wall 
stress distribution in an AAA. Martino et al (Di Martino and Vorp 2003) investigated 
the effect of ILT thickness on the wall stress distribution using finite element analysis. 
The stress distribution was computed for 3-D, asymmetric AAA models with ILT of 
different constitutive parameters and uniform applied systolic pressure (120mmHg). 
The presence of ILT, regardless of its mechanical properties redistributed the wall 
stress. Altering the mechanical properties of the ILT had a moderate effect on the 
distribution and peak stress. In all cases the maximum stress distribution occurred on 
the posterior wall. The load was sustained almost completely by the aortic wall, rather 
than the ILT. There was no significant difference between the stress distribution for 
homogeneous and inhomogeneous ILT.
These ILT studies indicate that ILT may significantly alter the stress distribution at 
the aortic wall. These results may support the clinical observations which indicate that 
the presence of ILT is associated with increased rupture risk. The shape and size of 
the aneurysm has also been shown to affect the flow patterns and wall stress. Because 
blood flow patterns are dependant on the artery size, shape and elasticity, analysis of 
the distal Doppler waveform could possibly provide information on the size, shape 
and possibly even the extent of thrombus within an AAA.
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1.8.3 Detection of AAA Flow Disturbances In Vivo
The primary aims of this research project were to determine whether AAA causes 
disturbance to the normal aortic flow, whether the disturbances are propagated distally 
and if they can be detected using Doppler ultrasound. The distal distance at which it 
may be possible to detect the any flow disturbances set up within an AAA will depend 
on the strength of the disturbance and the impedance to flow in the iliac and femoral 
vessels. The most proximal vessel distal to the aorta which can be most readily 
assessed using Doppler ultrasound is the common femoral artery (CFA).
This work came about because Dr Neil Pugh who has over 20 years vascular 
experience in vascular ultrasound noted during routine clinical assessments for 
peripheral vascular disease that when certain changes were observed in the CFA 
waveform an AAA was often present on examination of the aorta. An example of the 
modifications to the normal CFA waveform measured using colour flow duplex 
imaging from a patient with an AAA are shown in Figure 1.14. The CFA waveform in 
the presence of an AAA shows high levels of spectral broadening, typical of disturbed 
or turbulent flow in the deceleration phase of the systolic peak. These changes seem 
to be consistent with the intermittent turbulent bursts observed in the flow within an 
AAA model during the deceleration phase of the flow cycle in the study by Yip and 
Yu (2003) shown in Figure 1.15. This suggests that AAA may alter the distal flow 
pattern. Therefore it may be feasible to detect the presence of AAA by analysis of the 
CFA Doppler waveform.
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b)
Figure 1.14: Modification o f CFA waveform in the presence o f AAA.a) CFA waveform from patient 
with normal calibre aorta, b) CFA waveform from patient with 4.6cm AAA.
Figure 1.15: Phase variation o f stream wise velocity measured where turbulent bursts appeared during 
deceleration phase in AAA model (Yip and Yu 2003)
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The results of an early study by Humphries et al (Humphries, Hames et al. 1982) 
which aimed to detect arterial dilatation (arteria magna) from continuous wave 
Doppler waveforms of the lower limb palpation sites supports these observations. The 
study was based on Doppler shift signals obtained simultaneously from the common 
femoral, popliteal, posterior tibial and dorsalis pedis arteries in 54 patients with 
angiographic, B-mode or surgical confirmation of arterial dilatation. The Doppler 
shift signals from each artery were displayed in the form of a spectrogram and the 
maximum frequency envelope (MFE) was calculated. The results showed that indices 
such as PI or the Laplace damping factor (5) calculated from the MFE were unable to 
adequately indicate arterial dilatation. There were however characteristic and 
distinctive Doppler shift waveform patterns produced by general dilatation and AAA. 
In patients with AAA and no occlusive arterial disease, the waveform at the common 
femoral artery had a characteristic flattening or ‘knee’ on the first forward flow 
component as illustrated in Figure 1.16, which manifested as a dissociation of the first 
and second (forward and reverse) components at the posterior tibial artery.
Figure 1.16: Characteristic flattening or ‘knee’ on the first forward flow component o f CFA waveform 
in patient with AAA (Humphries, Hames et al. 1982).
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The CFA waveform from a patient with a normal calibre aorta and SFA occlusion 
also showed a flattening but this was at a higher level on the downward slope than 
was seen with AAA or dilatation as illustrated in Figure 1.17. The CFA waveforms 
from patients with dilatation and or tortuosity also had a characteristic signature of a 
skewed first component (systolic peak) followed by a reverse flow component 
extending over the remainder of the cardiac cycle as illustrated in Figure 1.18.
Figure 1.17: Flattening o f first forward flow component o f CFA waveform with SFA occlusion
(Humphries, Hames et al. 1982).
Figure 1.18: Reverse component o f CFA waveform extending over the rest o f the cardiac cycle with 
proximal dilatation and tortuosity (Humphries, Hames et al. 1982).
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A qualitative assessment of dilatation was made based on the recognition of 3 
waveform signatures: 1) waveforms with an flattening or ‘knee’ in the first flow 
component, 2) waveforms with a skewed first component and a reverse component 
extending over the remainder of the cardiac cycle, and 3) waveforms with a reverse 
frequency peak within the time period of the first forward component. When these 
classification criteria were applied by visual inspection of the CFA waveforms, 
success rates for predicting generalised dilatation, AAA and AAA with dilatation 
were 76%, 41% and 36% respectively. In the case of AAA with associated occlusive 
arterial disease the sensitivity was only 7%. The sensitivities in the detection of 
generalised dilatation, AAA and AAA with dilatation were increased to 85%, 56% 
and 50% when the classification was based on the waveforms collected from all the 
measurement sites: common femoral, popliteal, posterior tibial and dorsalis pedis 
arteries. The sensitivity to AAA with associated occlusive disease was unchanged.
This study indicates that there are changes to the distal Doppler waveforms in the 
presence of arterial dilatation and/or AAA. Pattern recognition of the Doppler 
waveforms was successful in diagnosing general arterial dilatation but was less 
sensitive to the diagnosis of AAA, and was particularly poor in cases with associated 
occlusive disease.
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1.9 Discussion and Conclusions
Studies have shown that screening for Abdominal Aortic Aneurysm (AAA) using 
conventional ultrasound techniques is cost effective. While screening is desirable, 
conventional ultrasound scanning is generally hospital based and requires a specialist 
operator to perform the investigation and interpret the results. Theoretically the 
presence of an AAA should change the aortic flow pattern and these changes should 
influence the characteristics of Doppler waveform in distal arteries. The AAA 
modelling studies indicate that disturbed and possibly turbulent flows occur within 
AAAs and that these disturbances may be transported distally. In theory, it may be 
possible to detect the flow disturbances in the large arteries of the lower limb using 
Doppler ultrasound. The observation of spectral broadening in the deceleration phase 
of the flow cycle in the CFA waveform during routine clinical examination seems to 
be consistent with the disturbed flows observed in the modelling studies. This is also 
supported by the observations by Humphries who demonstrated that characteristic and 
distinctive Doppler waveform signatures at the lower limb palpation sites were 
produced by general dilatation and AAA. These studies and observations suggest it 
may be feasible to detect the presence of AAA by analysis of the CFA waveform.
The studies by Peattie et al and Yip and Yu indicate that the flows set up within an 
AAA model are dependant upon the AAA size and shape. Yip and Yu also indicated 
that these flow patterns can significantly affect wall stress and its distribution and may 
contribute to the development and rupture of AAAs. Turbulent fluid stress may 
promote the build up of ILT on the aneurysm wall. Studies also show that ILT 
possibly redistributes the stress at the aortic wall. At present elective AAA repair is
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based on the maximum diameter of the aneurysm. However, AAAs with the same 
diameter may have different mechanical properties which could effect the growth and 
likelihood of rupture. Because the flow patterns in the AAA models were dependant 
on the physical aspects of the aneurysm models, analysis of the CFA waveforms 
could also possibly provide data on the size of the aneurysm, and even the presence of 
ILT. This data is useful to clinicians due to the associated implications for 
management and treatment options. Because turbulent flows appear to increase wall 
stress, if turbulent flows can be detected in the distal waveform in this research, this 
may be an aid for the prediction of rupture risk in future studies.
The main aim of this research project was to develop an alternative method for AAA 
detection by analysis of the CFA waveform. This involved a formal investigation to 
determine if and how AAA changes the characteristic CFA waveform, followed by 
the development of an objective, automated analysis technique to detect the changes 
and determine whether or not an AAA is present. The second aim was to determine 
whether the technique could also be used to provide information to the clinician on 
aspects such as the size and presence of thrombus in the AAA.
The interpretation of Doppler waveforms requires a high level of skill and training but 
still remains subjective. The analysis is complicated further by changes to the 
waveform due to occlusive arterial disease. In Humphries early study, prediction of 
AAA by classification of the CFA waveform was relatively low (<50%) and very 
poor for AAA with associated occlusive arterial disease. The waveform changes were 
completely removed by the presence of occlusive arterial disease proximal to the 
measurement site. It was therefore necessary to investigate the combined effects of
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occlusive arterial disease and AAA on the distal waveform. In some cases the changes 
to the distal waveforms may be subtle and may not be obvious on visual examination 
of the waveforms. More complex and objective analysis may be necessary to detect 
characteristic alterations. It was decided that it may be viable to use MATLAB 
software based analysis of the CFA waveforms to determine objectively whether or 
not an AAA is present. An overview of the general methods and equipment used to 
conduct the research study is given in Chapter 2.
CFA Doppler waveforms are routinely measured by GPs and outpatient nurses using a 
simple hand held ‘Pocket Doppler system’. If it proves possible to objectively detect 
AAA from CFA the waveform. It may be possible in future work to develop a hand­
held screening tool for AAA which could provide a quick and more cost effective 
method for screening in GP surgeries, outpatient clinics and home visits to indicate 
the need for a full ultrasound examination.
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Chapter 2: Equipment and General Methods
This chapter is an overview of the general methods and equipment used to conduct the 
research study. The data was collected using two main ultrasound modalities: 
ultrasound imaging to assess the arteries for aneurysmal and atherosclerotic disease 
and Doppler ultrasound to assess and measure the blood flow. The first section of this 
chapter gives an overview of the study design. The second section describes the 
arterial imaging equipment and methods. The third section describes the equipment 
and methods used for Doppler waveform measurement and the fourth section 
describes the general signal processing methods. A summary of the collected data is 
given in the fifth section.
2.1 Study Design
Doppler waveforms were measured from the CFA in 70 patients with AAA (‘cases’) 
and 70 patients without AAA (‘normals’). For each patient, a B-mode ultrasound 
scan of the aorta was performed to confirm and measure the AAA for the ‘cases’ or 
rule out the presence of AAA for the ‘normals’. Because the Doppler waveform in an 
artery is changed in the presence of atherosclerotic or further aneurysmal disease, a 
bilateral scan of the iliac and lower limb arteries was performed on all subjects to rule 
out or determine the extent of atherosclerotic or further aneurysmal disease. Both the 
scans were performed following the standard clinical protocols described in sections
2.2.2 and 2.2.3. All subjects were over 50 years of age. This age criterion was set to 
obtain a similar age range in the aneurysm and non-aneurysm groups. This was 
necessary because the elasticity of arteries within the body naturally decreases with
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age, causing minor alterations to the Doppler waveforms (Nichols and O'Rourke 
2005).
The data from the AAA and no AAA patient groups were divided into two main 
categories: the first category comprised the patients with no significant atherosclerotic 
disease of the iliac or femoro-poplitael arteries and the second category comprised the 
patients with 1 or more significant stenotic or occlusive atherosclerotic lesions within 
the iliac, femoral or popliteal arteries. The data from the patients in these two main 
categories were dealt with separately, naturally dividing the study into 2 main 
sections. The research process for each section involved 2 main stages. The first stage 
was the identification of features which may be characteristic of AAA by visual 
inspection of the CFA waveforms in each group. In the second stage, the waveforms 
were processed using MATLAB software to analyse the waveforms and extract a set 
of meaningful parameters to best represent the visual features. A computer program 
was then established using MATLAB software to perform the analysis objectively 
and to classify the waveforms in terms of AAA according to the parameters 
representing the characteristic features. The ability of the classification technique to 
correctly diagnose AAA from the CFA waveform was determined. The first and 
second research stages for the patients with no significant iliac or femoro-poplitael 
arterial disease are described in Chapters 3 and 4 of this thesis respectively. The first 
and second research stages for the patients with significant iliac or femoro-poplitael 
arterial disease are described in Chapters 5 and 6 of this thesis. In the final stage of the 
research discussed in chapter 7, the relationship between the characteristic waveform 
features and the physical characteristics of AAAs were investigated. A discussion of 
the main results and conclusions is given in Chapter 8.
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2.2 Arterial Imaging Methods
The B-mode ultrasound scans of the aorta to confirm or exclude AAA and the 
bilateral Doppler ultrasound scans of the lower limb arteries to rule out or determine 
the extent of atherosclerotic or further aneurysmal disease were performed on all 
patients using a Toshiba Xario ultrasound system. An overview of this system and the 
protocols followed for each part of the scan are detailed below.
2.2.1 Toshiba Xario System
The Toshiba Xario system (Toshiba Medical Systems, Crawley, UK) is one of two 
Toshiba systems routinely used for clinical assessment of vascular disease in the 
Doppler Ultrasound Department at UHW. It is a sophisticated colour flow duplex 
system, optimised for the assessment of peripheral vascular disease and has a range of 
transducers available for different vascular imaging applications. For this study the 
lower limb arteries were assessed using the PLT-604AT linear probe employing tissue 
harmonic imaging at 6.6MHz and pulsed wave Doppler at 4MHz fundamental 
frequency. The aorta and iliac arteries were assessed using the PVT-375BT 
curvilinear probe employing tissue harmonic imaging at 4.0MHz and pulsed wave 
Doppler at 1.8MHz fundamental frequency.
2.2.2 AAA Scan Protocol
In scanning the aorta, the patient lay supine on the scanning couch with the lower 
abdomen exposed. The scan was performed using the curvilinear probe and the
63
‘Abdominal Vascular’ pre-set. The distal aorta was imaged by placing the ultrasound 
transducer on the lower abdomen with contact gel. The aorta was imaged in 
longitudinal and transverse planes and the maximum diameter of the aorta was 
measured in each plane. If the diameter of the distal aorta exceeded 3cm it was 
classed as aneurysmal. If ILT was present within an AAA the diameter of the residual 
lumen was measured in longitudinal and transverse planes. All images were stored 
onto the scanner memory. Examples of the transverse and longitudinal measurements 
of an AAA and residual lumen diameter for an AAA with ILT are given in Figure 2.1.
Figure 2.1: Maximum AAA and residual lumen diameters in a) transverse plane and b) longitudinal
plane
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2.2.3 Lower Limb Arterial Scan Protocol
In scanning the lower limb arteries, the patient lay supine on the scanning couch with 
the legs and lower abdomen exposed. The iliac arteries were imaged using the 
curvilinear probe and Abdominal Vascular pre-set. The blood flow in the common 
iliac arteries (CIAs) and external iliac arteries (EIAs) were assessed bilaterally using 
colour flow Doppler and triplex functions. The CFAs, SFAs and popliteal arteries 
were assessed bilaterally using the linear probe and lower limb arterial scan pre-set. 
The CFA, SFA and popliteal arteries were imaged in longitudinal plane using B- 
mode, colour flow and triplex to determine patency and extent of disease. Disease 
severity was assessed using triplex mode to the measure ratio of the peak systolic 
velocity (PSV) from the Doppler waveform just proximal to and through the stenosis. 
The disease severity was classified using the following standard criteria given in 
Table 2.1.
PSV ratio % Stenosis
<2 Not haemodynamically significant
2 50% (moderate)
>3 >70% (tight)
No colour flow Complete Occlusion
Table 2.1: PSV ratios for stenosis classification
A complete occlusion was confirmed by reducing the colour scale and/or using Power 
Doppler. The presence of collateral vessels and the level of reconstitution were 
recorded.
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2.3 Waveform Measurement Methods
2.3.1 Waveform Measurement Equipment
The Toshiba Xario system permits pulsed wave Doppler measurements in duplex or 
triplex mode. The Doppler shift data is displayed as an on-screen spectrogram and is 
also output audibly via an in-built speaker. Because the system was designed for 
routine clinical assessment of blood flow, it did not permit the Doppler shift signals to 
be output in a format which could be analysed by an external computer. Therefore a 
software package called DopStudio (Skidmore Medical, Bristol, UK) was used to 
record the Doppler shift signals from the Toshiba Xario system onto a laptop PC. 
DopStudio samples an audio Doppler shift signal input from an external Doppler 
system via a USB sound card. The incoming Doppler shift signal is sampled at 48kHz 
and the sampled frequency data is displayed in the form of a spectrogram. The 
DopStudio software was modified by the manufacturer for this research project to 
convert the Doppler frequency shift data into CSV file format to facilitate analysis in 
MATLAB software. In order to output the Toshiba Xario audio Doppler signal a 
Toshiba engineer activated the headphone sockets on the system and attached wires 
for connection into the laptop soundcard. The composite waveform measurement 
system is referred to in this thesis as the Xario-DopStudio system.
2.3.2 Measurement Protocol
The CFA Doppler waveforms recorded using the Xario-DopStudio system were 
obtained using the Xario triplex function to visualise the CFA to enable the Doppler
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gate at to be placed at mid-CFA level to avoid flow disturbances which can occur 
around the bifurcation. The gate was positioned at the vessel centre and the gate width 
was increased to encompass -75% of the patent lumen. The Doppler angle cursor was 
aligned with the flow and the probe angle was adjusted if necessary to maintain a 
Doppler angle of <60°. The ‘update’ function was used to increase the Doppler PRF 
scale to remove signal aliasing in the on-screen DopStudio spectrogram The 
DopStudio spectrogram timescale was set to 5s. The Doppler gains on the Toshiba 
Xario system and the DopStudio system were altered to minimise background noise 
and optimise the waveform signal observed in the DopStudio spectrogram. The 
DopStudio spectrograms were saved in CSV file format in the laptop computer 
memory. The on-screen displays of the spectrograms on DopStudio and the Toshiba 
Xario systems were also saved in the respective system memories.
2.3.3 Comparison of Toshiba Xario and DopStudio Waveforms
A short study was performed to examine the quality of the waveforms recorded using 
the Xario-DopStudio system. CFA waveforms from 5 AAA and 5 ‘normal’ patients 
measured using the Toshiba Xario system and the Xario-DopStudio system were 
visually compared.
The Toshiba Xario waveforms were reproduced well by the DopStudio system. All 
the main features were preserved. The only main difference between the waveforms 
were that the Xario-Dopstudio system signals were more prone to background noise 
but the noise was not excessive. The Xario-Dopstudio system had a higher level high 
pass ‘wall thump’ filter resulting in a signal-free band either side of the zero axis.
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However, all other waveform features were well preserved by the system. It was 
decided that the Xario-Dopstudio waveforms were of sufficient quality for the data 
collection. An example of a CFA waveform measured using the Toshiba Xario system 
and the corresponding waveform displayed by DopStudio are shown in Figure 2.2.
b)
Figure 2.2: a) CFA Waveform measured with the Toshiba Xario System, b) corresponding waveform
displayed by the DopStudio system.
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2.4 Input Data
The CFA Doppler shift signals recorded using the Xario-DopStudio system and saved 
in CSV file format were transferred to a desktop PC for analysis. All signal 
processing for this study was performed using MATLAB software (The Math Works 
Inc, Natick, MA, USA). The CSV files were read into MATLAB and stored as a 
matrix. The DopStudio data was output as a 256 by 500 matrix, with 500 columns 
representing the time base and 256 rows containing the Doppler shift frequency 
amplitudes of the spectrogram. The magnitude (power) of the Doppler shift signal is 
stored as an integer in each matrix element. The CFA spectrograms were reproduced 
using the ‘imagesc’ plotting function in the MATLAB software. Figure 2.3 shows the 
reproduction of the CFA waveform shown in Figure 2.2 using the MATLAB 
‘imagesc’ function.
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Figure 2.3: Xario-DopStudio CFA waveform reproduced in MATLAB
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2.5 Data Summary
The 70 patients with AAA and 70 patients without AAA were divided into 4 main 
groups. The first group contained patients with AAA and no significant iliac or 
femoro-popliteal atherosclerotic disease. The second group contained patients without 
AAA and no significant iliac or femoro-popliteal atherosclerotic disease. The third 
group contained patients with AAA and with significant atherosclerotic disease of the 
iliac and/or femoro-popliteal arteries. The fourth group contained patients without 
AAA but with significant atherosclerotic disease of the iliac and/or femoro-popliteal 
arteries. A summary of the patient data in each group is given in Table 2.2. More 
detailed summaries of the patient data for each group are given in Appendices 1 to 4.
The first patient group with AAA and no significant atherosclerotic arterial disease of 
the iliac or femoro-popliteal arteries comprised 46 patients of mean age 72.6yrs
j|(
(range 40 -88yrs), mean AAA diameter 4.3cm (range 3.0-6.4cm). 7 out of the 46 
patients had aneurysmal disease of the iliac arteries in addition to an AAA and 2 
patients had aneurysmal disease of the popliteal arteries in addition to an AAA. 
Because any changes to the CFA waveform with AAA may be influenced by the 
presence of additional aneurysmal disease this AAA group was divided into two 
sections: the first containing the 37 patients with an AAA and the second containing 
the 9 patients with an AAA and additional aneurysmal disease. The second patient 
group without AAA and no significant atherosclerotic arterial disease of the iliac or 
femoro-popliteal arteries comprised 41 patients of mean age 68.4yrs (range 50-92yrs), 
mean abdominal aorta diameter 1.6cm (range 1.1-2.3cm).
* A 40 year old male presented with a 5.2cm AAA and was included in the study. All other patients 
were aged over 50 years.
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In the first section of the research the waveforms from the first and second patient 
groups were studied and compared (as discussed in Chapter 3). A MatLab based 
computer program was then written to differentiate between the two groups (as 
discussed in Chapter 4). At the beginning of the study, 30 AAA patients (with no 
additional aneurysmal disease) and 30 patients without AAA were selected at random 
from the first and second patient groups respectively. These were used as ‘study’ 
groups to determine the differences between the AAA and normal CFA waveforms 
and to set up the AAA detection method. The remaining 7 AAA patients and 11 out of 
the 41 patients without AAA in the first and second groups were separated from the 
data sets. These were used as blind sets of test data which were used at the end of the 
study to test the success of the chosen AAA detection method and reduce bias. The 
remaining 9 patients with an AAA and additional aneurysmal disease were used a 
second blind test set at the end of the study.
The third patient group with AAA and significant atherosclerotic disease of the iliac 
and/or femoro-popliteal arteries comprised 24 patients of mean age 75.7yrs (range 55- 
91yrs) and mean AAA diameter 4.9cm (range 3.0-6.3cm). 1 out of these 24 patients 
had iliac aneurysms in addition to AAA. 6 out of these 24 AAA patients had 
significant proximal (iliac) disease. The forth patient group without AAA but with 
significant atherosclerotic disease of the iliac and/or femoro-popliteal arteries 
comprised 29 patients of mean age 72.6yrs (range 50-96yrs) and mean abdominal 
aorta diameter 1.7cm (range 1.1-2.6cm). 7 of these 29 patients had significant 
proximal (iliac) disease. Because proximal and distal disease have different affects on 
the blood flow in the CFA, the patients with and without AAA in the significant
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atherosclerotic disease groups were sub-divided into those with distal (femoro- 
popliteal) disease and those with proximal (aorto-iliac) disease.
In the second section of the research the waveforms from the third and forth patient 
groups were studied and compared (as discussed in Chapter 5). The MatLab based 
computer program was then used to differentiate between the two groups (as 
discussed in Chapter 6). At the beginning of the study, 15 AAA patients with 
significant distal disease and 18 patients without AAA with significant distal disease 
were selected at random from the third and forth and second patient groups 
respectively. These were used as ‘study’ groups to set up the AAA detection method. 
The remaining 3 out of the 18 AAA patients and 4 out of the 22 patients without AAA 
in the third and forth groups with significant distal disease were separated from the 
data sets. These were used as blind sets of test data which were used at the end of the 
study to test the success of the chosen AAA detection method and reduce bias.
Studies show that the prevalence of AAA is up to 7.6% in men and 1.3% in women 
(Scott, Wilson et al. 1995; Scott, Bridgewater et al. 2002) and the prevalence of 
atherosclerotic disease affecting the lower limb arteries is around 12% (Fowkes, 
Housley et al. 1991; Ostchega, Paulose-Ram et al. 2007). The relative sizes of the 
groups with and without AAA, and with and without significant aorto-iliac and or 
femoro-popliteal atherosclerotic disease in this study are not representative of the 
proportions in the general population. This was because it was necessary for the there 
to be enough patients in each category to facilitate analysis of reasonable sample 
sizes.
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Occlusive Disease 
Category
AAA
Category
Total
Number
of
Patients
Group Number of Patients
Mean Age 
(yrs)
Range
(yrs)
Mean Abdominal 
Aorta Diameter 
(cm)
Range (cm)
No Significant Aorto- 
iliac or Femoro- 
Popliteal 
Atherosclerotic 
Disease
AAA 46
Study Group 30 70.8 40-85 4.6 3.2-5.8
Test group 7 76.1 61-83 3.9 3.1-5.2
Additional
Aneurysmal
Disease
9 75.7 68-88 4.3 3.0-5.7
No AAA 41 Study Group 30 67.5 52-92 1.6 1.1-2.2Test group 11 70.9 50-83 1.8 1.4-2.3
Significant Aorto- 
iliac or Femoro- 
Popliteal 
Atherosclerotic 
Disease
AAA 24
Distal
Disease
Study
Group 15 73.9 55-85 4.6 3.0-6.0
Test
Group 3 85 76-91 5.1 4.8-5.6
Proximal
Disease
Study
Group 6 75.3 73-79 5.0 3.6-6.3
No AAA 29
Distal
Disease
Study
Group 18 74.2 50-96 1.6 1.3-2.2
Test
Group 4 70.3 63-75 1.6 1.3-2.0
Proximal
Disease
Study
Group 7 69.7 51-87 1.8 1.2-2.6
Table 2.2: Patient data and group summaries
Chapter 3: Visual Analysis of CFA Waveforms from AAA and Normal Patients 
with No Significant Atherosclerotic Disease 
3.1 Introduction and Aim
Routine visual examination of CFA waveforms during routine clinical studies 
indicated that when certain changes were observed in the CFA Doppler waveform, an 
AAA was often present on examination of the distal aorta. Following the review of 
the literature in Chapter 1, these changes seemed to be consistent with certain features 
of flow within AAA models and also with waveform changes observed in vivo by 
Humphries et al. A preliminary study, described in this chapter, was performed to 
investigate these observations more formally in patients with no significant aorto-iliac 
or femoro-popliteal atherosclerotic disease. The aim was to determine the type of 
changes to the CFA Doppler waveform that may be associated to AAA, and to 
determine the feasibility of detecting AAA by visual identification of CFA waveform 
features.
3.2 Method
The patient cohort comprised the 30 AAA patients and 30 normal patients in the study 
groups with no significant femoro-popliteal atherosclerotic disease (summarised in 
Table A 1.1, Appendix 1 and Table A2.1, Appendix 2). For each patient the CSV data 
files for the left and right CFA waveforms measured using the Xario-DopStudio 
system were reproduced as spectrograms in MATLAB using the ‘imagesc’ plotting 
function in the ‘vga’ colour scale.
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The waveforms within the spectrograms were visually inspected to identify features 
within the waveform cycles which differed from ‘ideal’ CFA waveform cycles as 
shown in Figure 3.1. These ‘ideal’ waveform cycles are triphasic with uniform 
upstroke and down-stroke and minimal spectral broadening.
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Figure 3.1: Normal ‘ideal’ CFA waveform cycles
3.3 Feature Identification
On visual inspection of the CFA waveforms 5 features were noted, predominantly in 
the AAA group, as being different from an ‘ideal’ CFA waveform: 1) spectral 
broadening on the systolic down-stroke, 2) the appearance of ‘spikes’ on the systolic 
down-stroke, 3) an irregular reverse flow pattern, 4) simultaneous forward and reverse 
flow during systole and 5) elongation of the waveform during the cardiac cycle.
Examples of the first feature, that of increased spectral broadening in the deceleration 
phase of the systolic peak in waveform cycles from AAA and normal patients, are 
shown in Figures 3.2 and 3.3 respectively. In the presence of atherosclerotic arterial
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disease, spectral broadening increases but is generally exhibited as an in-fill under the 
curve of the systolic peak. None of the patients in these study groups had significant 
atherosclerotic arterial disease. In the normal patient waveforms, the spectral 
broadening is generally exhibited as an infill under the peak, whereas in the AAA 
waveforms the increase in spectral broadening is mainly in the systolic down-stroke 
region.
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Figure 3.2 a and b: Examples o f spectral broadening on the systolic down-stroke in AAA  waveform
cycles
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Figure 3.3 a and b: Examples o f spectral broadening on the systolic down-stroke in normal waveform
cycles
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The spectral broadening observed in many of the AAA waveforms had a spiked 
appearance extending both above and below the downward slope of the systolic peak. 
In some cases the ‘spikes’ also extended down into the reverse flow region. Examples 
of this feature of spikes in the spectral broadening on the systolic down-stroke in 
waveform cycles from AAA and normal patients are given in Figures 3.4 and 3.5 
respectively. In general, the spikes were more prominent in the AAA patient 
waveforms.
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Figure 3.4 a and b: Examples o f spikes on the systolic down-stroke in AAA waveform cycles
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Figure 3.5 a and b: Examples o f spikes on the systolic down-stroke in normal waveform cycles
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Examples of the third feature of an irregular reverse flow pattern observed in some of 
the waveform cycles from AAA patients are shown in Figure 3.6. There were two 
types of irregularity noted in the reverse flow. The first, shown in Figure 3.6a 
illustrates an elongation of the reverse flow component with an irregular profile and 
distinct spikes. The second, shown in Figure 3.6b illustrates an ‘exaggerated’ reverse 
flow component, with increased amplitude and a slightly square, irregular profile. 
Examples of these irregular reverse flow patterns observed in waveform cycles from 
normal patients are given in Figure 3.7.
Figure 3.6 a and b: Examples of irregular reverse flow patterns in AAA waveform cycles
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Figure 3.7 a and b: Examples o f irregular reverse flow patterns in normal waveform cycles
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An example of waveform cycles from an AAA patient displaying the fourth feature of
simultaneous forward and reverse flow under the systolic peak is given in Figure 3.8. 
In the ‘ideal’ CFA waveform cycle the reverse flow component occurs after the 
systolic peak as a result of pressure reflection and elastic recoil of the artery wall. In 
this feature low power reverse flow can be seen under the systolic peak before the 
onset of the ‘true’ reverse flow component. This can possibly be attributed to flow 
disturbances occurring during the systolic flow phase. An example of this feature seen 
in waveform cycles from a normal patient is given in Figure 3.9.
Figure 3.8: Examples o f simultaneous forward and reverse flow in AAA waveform cycles
Figure 3.9: Examples o f simultaneous forward and reverse flow in normal waveform cycles
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The fifth feature noted in the waveforms was a subtle elongation of the waveform 
cycle length within the beat cycle. An example of waveform elongation in waveform 
cycles from AAA and normal patients are given in Figures 3.10 and 3.11 respectively. 
Typically, with this feature the waveform cycle appeared to be ‘spread out’ with an 
additional reverse flow phase extending over the rest of the cardiac cycle.
3.4 AAA Detection Using CFA Visual Feature Analysis
In order to determine the feasibility of detecting AAA using visual feature analysis, 
the waveforms from the 30 AAA and 30 normal patients were scored according to the 
presence of the 5 features. It is interesting to note that in both patient groups, the CFA 
waveforms from the right and left legs in the same patient did not necessarily exhibit
Figure 3.10: Example of waveform elongation in AAA waveform cycles
4 ^
Figure 3.11: Example o f waveform elongation in normal waveform cycles
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the same features. This may possibly be due to slight differences between the paths of 
the iliac arteries on the left and right side. Different levels of tortuosity and minor 
calcification between the two sides may also possibly explain the differences. 
Therefore the left and right CFA waveforms for each patient were individually scored 
according to the 5 features. If a feature was present in one or more cycles within the 
waveform, a score of 1 was awarded for that feature. Only 3 AAA patients and 2 
normal patients exhibited the same combination of features in the waveforms from the 
left and right legs.
3.4.1 Waveform Feature Results
Figure 3.12 shows the number of CFA waveforms out of the 60 AAA and 60 normal 
waveforms with each feature present.
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Figure 3.12: Number o f CFA waveforms from AAA and normal patients in the no significant arterial 
disease study groups with each feature present visually
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3.4.2 Waveform Feature Results: Discussion
All 5 features provided good differentiation between AAA and normal waveforms. 
The two most prominent features in the AAA group were spectral broadening and 
irregular reverse flow, but there was no single feature which was characteristic to all 
AAA waveforms. Therefore for each waveform the scores for all 5 factors were 
combined in order to improve the differentiation between the two groups.
3.4.3 Individual Patient Scores
Because the left and right CFA waveforms for a patient often contained different 
features the total factor score for an individual patient was based on the summation of 
the total scores of the left and right leg CFA waveforms.
3.4.4 Individual Patient Score Results
The total scores for the 30 AAA and 30 normal patients are plotted in Figures 3.13a 
and 3.13b.
The total patient scores for the 30 AAA and 30 normal patients were then used to set a 
threshold level to best distinguish between the AAA and normal groups. Figure 3.14 
shows the number of AAA and normal patients with a total patient score of >1, >2 
and >3.
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Figure 3.13a: Total Patient Scores for the 30 AAA patients in the study group with no significant
atherosclerotic disease
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Figure 3.13b: Total Patient Scores for the 30 normal patients in the study group with no significant
atherosclerotic disease
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Figure 3.14: Number of AAA and normal patients in the study groups with no significant arterial
disease with total score >1, >2 and >3
3.4.5 Individual Patient Score Results: Discussion
From Figures 3.13a and 3.13b the mean factor score per patient in the AAA group 
was 4.4 with a maximum score of 9 factors and a minimum score of 0 factors. The 
mean total factor score per patient in the normal group was 1.1 with a maximum score 
of 5 factors and a minimum score 0 factors. Figure 3.14 shows the number of AAA 
and normal patients with a total patient score of >1, >2 and >3. A threshold score 
level of >1 for a positive AAA, achieved an overall sensitivity of 93.3% (28 out of 30 
AAA patients correctly identified) with a specificity of 47% (14 out of 30 normal
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patients correctly identified) for AAA detection. The threshold score level of >2 for a 
positive AAA also provided a sensitivity of 93.3% with an improved specificity of 
70% (21 out of 30 normal patients correctly identified) for AAA detection. The 
threshold score level of >3 for a positive AAA reduced the overall sensitivity to 
76.7% (23 out of 30 AAA patients correctly identified) with an increase in specificity 
to 76.7% (23 out of 30 normal patients correctly identified) for AAA detection. 
Therefore a threshold of >2 on the total patient score achieved the best level of 
differentiation between the AAA and normal patients.
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3.5 Discussion
In this preliminary study of 30 patients with AAA and 30 patients without AAA with 
both groups having no significant femoro-popliteal arterial disease, there were 5 
features noted on visual inspection of the CFA waveforms which differed from an 
‘ideal’ CFA waveform, and that were more predominant in the AAA patient group: 1) 
1) spectral broadening on the systolic down-stroke, 2) the appearance of spikes on the 
systolic down-stroke, 3) an irregular reverse flow pattern, 4) simultaneous forward 
and reverse flow during systole and 5) elongation of the waveform during the cardiac 
cycle.
To our knowledge, the effect of AAA on the CFA waveform has not been widely 
studied with only one previously reported study, that by Humphries et al. As far as we 
are aware there is no accepted explanation or suggestion as to why the 5 features 
observed in this study occur. The modelling studies discussed in Chapter 1 provide 
an insight into the flows occurring within aneurysms but do not examine the effects 
on the distal flow in the iliac or femoral arteries. Therefore, one can only hypothesise 
as to why these flow changes in the CFA exist. From the results of these modelling 
studies which suggest that flow disturbances with vortices and turbulence are set up 
within aneurysms, it is hypothesised that these flow disturbances may be transported 
distally and may manifest in the CFA waveform as the features described above.
The feature of spectral broadening may be explained by the increased range of 
Doppler frequencies resulting from the different orientations and magnitudes of
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velocity vectors of flow disturbances originating within the AAA remaining within 
the bulk flow in the CFA.
The features of spikes, irregular reverse flow and simultaneous forward and reverse 
flow may possibly be explained by considering the range of Doppler shift frequencies 
detected from a vortex recirculating within a Doppler ultrasound beam as illustrated in 
Figure 3.15.
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Figure 3.15: Doppler frequencies detected at a point in time from a recirculating vortex moving with
the bulk flow within a Doppler beam
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By considering the Doppler shift frequencies detected at a point in time from points 
A, B, C and D on the vortex in this diagram during the forward flow phase, it can be 
seen that the Doppler shift from the vortex flow at point A is maximum because the 
velocity vector is parallel to the ultrasound beam, directed towards the transducer 
producing a maximum, positive Doppler frequency shift. At point C the velocity 
vector is parallel to the Doppler beam but opposed to the transducer, producing a 
maximum negative Doppler frequency shift. At points B and D the velocity vectors of 
the vortex flow are perpendicular to the beam direction resulting in zero Doppler shift. 
If the Doppler frequencies corresponding to the velocity vectors of the vortex motion 
are displayed on a spectrogram, at a single point in time there will be a continuum of 
frequencies ranging from the maximum negative frequency up to the maximum 
positive frequency. The magnitude of the maximum positive and negative Doppler 
shifts detected from the vortex motion are the same, however when these are 
superimposed on the normal flow profile, the range of frequencies are off set in the 
positive direction due to the translation of the vortex within the bulk flow towards the 
transducer.
The modelling studies suggest that vortices and flow disturbances are set up within an 
aneurysm during flow deceleration. The appearance of spikes on the systolic down- 
stroke of the CFA waveform may therefore correspond to the motion of vortices and 
flow disturbances set up within the bulk flow during flow deceleration in the systolic 
flow phase. The feature of simultaneous forward and reverse flow during the systolic 
flow phase may also possibly be explained by the motion of vortices within the bulk 
flow: the bulk flow direction is forwards but there will also be velocity vectors in the 
reverse flow direction detected from the circulating flow regions. The irregularities in
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the reverse flow profile may also possibly be explained in a similar manner as 
described above for the forward flow phase.
If the flow disturbances set up within AAAs are transported within the bulk flow into 
the femoral vessels, this may well explain the increased spectral broadening and 
spikes in both the forward and reverse flow phases. The feature of elongation is less 
easily explained. The reverse flow phase results form elastic recoil of the artery wall, 
therefore elongation of the reverse flow phase may be in some way related to the 
elastic recoil properties of the AAA wall and the corresponding development of flow. 
However, further research is necessary, possibly using numerical fluid dynamics 
modelling with finite element analysis techniques to simulate the development, decay 
and transportation of AAA flow disturbances through the iliac and femoral vessels to 
fully understand the haemodynamics and explain the features observed in this study.
By scoring the CFA waveforms according to the presence of these 5 features and 
setting a threshold of >2 on the sum of the left and right CFA waveform scores for 
each patient, it was possible to predict AAA in patients with no significant femoro- 
popliteal arterial disease with a sensitivity of 93.3% and a specificity of 70%. These 
results suggest it is feasible to detect AAA by analysis of the CFA waveform.
Visual inspection of CFA waveforms is subjective, especially because the waveform 
changes can be subtle. Arterial Doppler waveforms are affected by several different 
factors and although each artery in the body has a ‘signature’ waveform, even in the 
absence of any aneurysmal or atherosclerotic disease the waveform characteristics 
vary from person to person depending on several inherent factors; for example,
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cardiac output, vessel size and tortuosity. Because visual examination is so subjective 
there will be a certain level of bias in determining whether waveform changes are 
present or not. In the absence of any significant occlusive arterial disease, 28 out of 
the 30 waveforms do show distinct waveform changes which may possibly be 
attributed to flow disturbances from an AAA. Therefore, a much more objective 
analysis method is necessary to reduce bias. An approach would be to extract the 
features more objectively using MATLAB software based analysis.
Visual inspection of arterial waveforms is not only subjective, but is also largely 
limited to the interpretation of waveform shapes. There may also be changes to 
aspects of the waveforms not obvious even to a trained eye. The Doppler spectrogram 
is a 2-D representation of a 3-D data set with the time versus frequency-shift on the x- 
y axis and the power of each frequency component at a point in time proportional to 
the brightness of each pixel within the spectrogram. Other features such as the 
distribution of frequency components and corresponding intensities may also differ 
between AAA and normal patients. It may be possible to identify such features by 
implementing more sophisticated analysis using MATLAB software.
It is accepted that the sensitivity and specificity sensitivity of 93.3% and a specificity 
of 70% achieved with these visual inspections are biased because the results are from 
on a single trained observer analysing non-blinded data subjectively. However, the 
main aim of the work in this chapter was to identify waveform features. The 
sensitivity and specificity were only calculated to determine whether it was worth 
pursuing more detailed, objective MatLab based analysis. In conclusion, it may be 
feasible to objectively identify features characteristic to AAA and objectively
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diagnose AAA from CFA waveforms using MATLAB software. The following 
chapter describes the next stage of the research in which a MATLAB program was 
designed and tested to try and improve on the results achieved in the visual analysis 
for AAA detection by objective analysis of the CFA waveforms based on the 5 
features identified in this preliminary study. Bias was reduced by the objective nature 
of the MatLab analysis and by subjecting the program to blind data sets to verify the 
results.
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Chapter 4: AAA Detection by Objective Analysis of CFA Waveforms in Patients 
with No Significant Atherosclerotic Disease
4.1 Introduction and Aim
Visual analysis of CFA waveforms from patients with and without AAA with no 
significant iliac or femoro-popliteal atherosclerotic disease in Chapter 3 identified five 
features: 1) spectral broadening on the systolic down-stroke, 2) the appearance of 
‘spikes’ on the systolic down-stroke, 3) an irregular reverse flow pattern, 4) 
simultaneous forward and reverse flow during systole and 5) elongation of the 
waveform during the cardiac cycle which were different from the features of an 
‘ideal’ waveform and which were more prominent in waveforms from patients with 
an AAA than from normal patients. Based on visual identification of these features it 
was possible to detect AAA in the 30 AAA patients compared with the 30 normal 
patients in the no significant atherosclerotic disease study groups with a sensitivity of 
93.3% and a specificity of 70%. Visual analysis of Doppler waveforms is subjective 
and requires a high level of training. Therefore the aim of the work in this chapter 
was to develop a method to automatically and objectively analyse the CFA 
waveforms to detect AAA based on the 5 the features noted in the visual analysis. The 
following sections describe the method by which a MATLAB based program capable 
of detecting AAA from CFA waveforms in patients with no significant femoro- 
popliteal atherosclerotic disease was written and tested.
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4.2 Method Overview
The CFA waveforms from the 30 AAA and 30 normal patients in the study groups 
with no significant iliac or femoro-popliteal atherosclerotic disease, that were visually 
analysed in Chapter 3 were used to set up a MATLAB based AAA detection program. 
In the first stage of the work, described in section 4.3, initial data processing was 
performed using MATLAB code to manipulate and interrogate the CFA waveform 
data. The aim was to extract parameters from which the five waveform features noted 
in the visual inspections in Chapter 3 could be described. In the second stage, 
discussed in section 4.4, these parameters were used to calculate a number of indices 
to provide measures for each of the 5 features. In the third stage, described in section 
4.5, a range of threshold levels were tested on each of the indices to determine the 
index levels which provided the best discrimination between AAA and normal 
waveforms in the no significant atherosclerotic arterial disease study groups. In 
section 4.6, the indices were used to set up a MATLAB based AAA detection 
program. The selected indices were tested in a range of different combinations, with a 
number of different threshold levels and weighting factors applied, to select the 
permutation providing the best sensitivity and specificity for AAA detection in the 30 
AAA and 30 normal study group patients. In section 4.7, the performance of the 
detection program was tested by its response to the waveform data from the AAA and 
normal patients with no significant atherosclerotic arterial disease that were placed 
into the test groups at the start of the study. In section 4.8, the performance of the 
program in response to the CFA waveforms measured from the group of patients with 
AAA and additional aneurysmal disease of the iliac or popliteal arteries was assessed. 
The AAA detection program performance and results are discussed in section 4.9.
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4.3 Initial Data Processing
The CSV files containing the CFA waveform data were loaded into the MATLAB 
software and stored as 256 by 500 matrices. Initial data processing was performed on 
the waveform data with two main aims: 1) to reduce noise in the data and 2) to 
identify reference points within individual waveform (cardiac) cycles. Both these aims 
were achieved with programming based on the calculation of a parameter called the 
maximum frequency envelope.
4.3.1 Extraction of the Maximum Frequency Envelope
The maximum frequency envelope (MFE) is commonly used in the processing of 
Doppler ultrasound signals. It is integral to several well documented analysis methods 
for the calculation of diagnostic indices such as the Pulsatility Index. It is also 
valuable for the identification of regions of interest within the signal, for example 
individual cardiac cycles. The MFE is derived from the amplitude of the Doppler 
frequency spectrum. For this study the MFEs were extracted using the 95 percentile 
method. In this method the amplitudes of the pixels in each column of the data matrix 
(corresponding to a point in time on the spectrogram) were summed, and the 
maximum frequency point was calculated as the pixel that corresponded to 95% of the 
summed frequency amplitudes at this point in time. The 95% level was chosen in 
order to eliminate spurious noise in the spectrogram lying outside the true arterial 
signal. The method does not distinguish between positive and negative frequency 
shifts and therefore the MFEs were calculated separately for the forward and reverse 
flow components of each waveform. An example of an MFE generated for the
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forward flow components of a normal CFA waveform using this method is shown in 
Figure 4.1. The MFE can be affected by noise in the signal. Therefore the MFE was 
subjected to a 6th order Butterworth low-pass filter to remove the unwanted high 
frequency noise components. The resulting MFE was cleaner as shown in Figure 4.2.
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Figure 4.1: Unfiltered MFE
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Figure 4.2: Butterworth filtered MFE
4.3.2 Identification of Individual Waveform Cycles
Blood flow patterns usually contain specific repeating features corresponding to the 
phases of the cardiac cycle. The filtered MFEs were used to locate and extract fixed 
reference points within the spectrogram for example the start and end of each cardiac 
(waveform) cycle. Once individual waveform cycles were isolated, it was possible to 
extract specific regions of interest within or between each pulse.
The cardiac cycle begins with the systolic upstroke. The start of the systolic upstroke 
in a Doppler waveform is known as the ‘pulse foot’. Locating the pulse foot can be 
complicated due to different physiological and pathological effects. For example in a 
normal, healthy person the CFA waveform is triphasic and the pulse foot can be easily 
determined as the point at which the waveform crosses the zero line. However there 
may be no zero crossing in cases where there is vaso-dilation or significant disease 
causing very damped flow. Irregular heartbeats in conditions such as atrial fibrillation 
(AF) also introduce uncertainties. However, although difficult to locate, the pulse-foot 
of a new cardiac cycle is reasonably well preserved under most conditions. A method 
for extracting the pulse-foot is the 1st derivative method. This method firstly involves 
identification of the systolic peaks within the MFE from which the pulse foot of the 
systolic peak can then be located.
4.3.2.1 Identification of the Systolic Peak
The systolic peaks were located by identifying all points on the systolic upstroke with 
amplitude >40% of the maximum amplitude in the filtered MFE and then counting
96
‘up’ this envelope matrix vector until the peak was reached. A threshold of 20 points 
was set between peak locations to prevent the increased amplitudes of spikes or 
shoulders in the systolic down-stroke being incorrectly assigned as a systolic peak.
To locate the pulse foot at the start of the systolic peak, the differentials between 
successive points ‘down’ the filtered MFE on the systolic upstroke were calculated 
and then interrogated to locate the pulse foot, which was defined as the first point of 
inflection of the differential values (where the differential value changed from 
negative to positive). This was repeated for all peaks located in the signal, except for 
peaks occurring within the first 20 points of the envelope in order to exclude 
incomplete peaks.
To locate the foot of the deceleration phase (down-stroke) of the systolic peak, the 
differentials of 60 subsequent, adjacent points along the filtered MFE from the peak 
along the down-stroke were calculated. The differential values were then interrogated 
to locate the end pulse foot, which was defined as first the point of inflection below a 
level of 50% of the envelope value at the systolic peak. The 50% threshold level was 
set to prevent ‘spikes’ or deflections in the systolic down-stroke being incorrectly 
identified as a pulse foot. The pulse foot of the deceleration phase was not calculated 
for the last peak in the spectrogram in case the peak was incomplete. Examples of the 
peak and pulse foot locations identified on the MFE using this method are shown in 
Figure 4.3.
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Figure 4.3: MFE with black, yellow and red lines indicating the peak, pulse foot of the upstroke and 
deceleration phase foot locations of the systolic peak respectively
4.3.3 Noise Reduction
During the measurements of the CFA waveforms, the gains on the Xario and 
DopStudio systems were adjusted to visually optimise the signal to noise ratio in each 
of the spectrograms. However, in some cases the background noise level remained 
high, for example in the case of low lying or calcified vessels. The 95 percentile 
method for MFE generation produced satisfactory MFEs, representative of the CFA 
waveform profile for spectrograms with low levels of background noise, but produced 
unsatisfactory results when waveforms with higher levels of background noise were 
subjected as shown in Figure 4.4. It was therefore necessary to reduce the unwanted 
background noise in the data to enable analysis of the true CFA signal.
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Figure 4.4: Unsatisfactory MFE (indicated by red line) for spectrogram containing a high level o f
background noise
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4.3.3.1 Thresholding
A thresholding technique known as ‘grass cutting’ was implemented to remove the 
unwanted low power background noise from the spectrogram. In this technique a 
threshold was set as a percentage of the maximum power amplitude in the signal and 
all pixels in the spectrogram matrix with an amplitude below this level were set to 
zero. Initially the threshold level was set to 10% of the maximum signal amplitude. 
This threshold level produced good results in general for cases of low background 
noise and more satisfactory MFEs were obtained as shown in Figure 4.5a. However, 
the 10% threshold still produced unsatisfactory results when signals with higher levels 
of background noise were subjected as shown in Figure 4.5b.
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Figure 4.5a: MFE (indicated by red line) for a spectrogram containing a low level o f background noise
with 10% filter threshold applied
100 
50 
0
0 50 100 150 200 250 300 350 400 450 500
Figure 4.5b: MFE (indicated by red line) for a spectrogram containing a high level o f background noise
with 10% filter threshold applied
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A range of threshold levels were tested with the aim of determining an optimum 
threshold level. Higher threshold levels produced good results for noisy signals, for 
example Figure 4.6a shows the resulting MFE achieved with a 20% filter threshold 
applied to the spectrogram that was shown in Figure 4.4. However, it can be seen in 
Figure 4.6b that when the 20% filter threshold was applied on the same spectrogram 
as shown in Figure 4.5a, a crude MFE was produced but too much spectral data was 
removed from the true arterial signal.
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Figure 4.6a: MFE (indicated by red line) for a spectrogram containing a high level o f background noise
with 20% filter threshold applied
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Figure 4.6b: MFE (indicated by red line) for a spectrogram containing a low level o f background noise
with 20% filter threshold applied
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f4.3.3.2 Automatic Thresholding
An automatic thresholding technique was implemented in the MATLAB code to 
optimise the threshold level for filtering for each spectrogram individually, depending 
upon the level of low power noise present in the spectrogram background. This 
involved sampling the background noise from specific regions within the background 
outside the true arterial signal. The pulse foot markers indicating the start and end of 
each systolic peak were used to demarcate regions lying in between individual 
waveform cycles. This enabled the background noise to be sampled from the 
background regions lying in between each systolic peak, and ensured the higher 
amplitudes from the true arterial signal were not selected. The threshold for ‘grass 
cutting’ was then set depending upon the noise levels present within the sampled 
regions.
In this technique, the maximum power amplitude within each vertical column of the 
forward flow spectrogram matrix was determined and the mean value was calculated. 
The initial threshold level for ‘grass cutting’ was set to 55% of this mean level. This 
threshold was high enough to remove the background noise from spectrograms 
containing a high level of background noise, but still enabled reasonable MFEs to be 
produced from spectrograms containing low levels of background noise. The 
locations of the systolic peaks and the pulse foot at the start and end of each systolic 
peak were determined from the filtered MFE for each complete waveform cycle in the 
spectrogram, as described above. The location of the pulse foot at the start of the last 
incomplete pulse was also calculated. The pulse foot locations were used to select 
regions within the background in between each pulse, away from the true arterial
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signal. The height and vertical positions of the sample regions were set as a 
percentage of the systolic peak height. It was ensured that the vertical position of 
sample regions lay above the second forward flow phases. Examples of the sampled 
background regions are indicated in mid-blue on the spectrogram shown in Figure 4.7.
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Figure 4.7: Forward flow CFA spectrogram with sampled regions indicated in mid-blue.
The maximum power levels within each of the sampled regions were calculated and 
the threshold level for ‘grass cutting’ was set to 120% of the maximum level. All 
pixels within the spectrogram matrix with an amplitude below this threshold level 
were set to zero. This method optimised the removal of background noise from the 
spectrograms, whilst maintaining a sufficient level of data in the CFA waveforms to 
permit further analysis.
irtfn ! i - 'b.  /* |  i <n*f , J
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To ensure the method operated correctly for all the 60 AAA and 60 normal 
waveforms, the process was performed on each waveform individually to ensure the 
initial peak and pulse foot locations and the sample regions were correctly placed. 
After the automatic thresholding technique had been implemented, the forward flow 
maximum frequency envelope and peak and feet locations were recalculated and 
superimposed onto the CFA waveforms in the filtered spectrogram to ensure they 
were also positioned correctly.
4.3.4 Power Level Normalisation
The power (pixel amplitude) levels within the spectrogram were dependent upon the 
gain settings used in the waveform measurement. Therefore the power levels were 
normalised by dividing the power level contained in each pixel of the spectrogram 
matrix by the maximum power level within the spectrogram.
4.4 Calculation of Waveform Parameters
Once automatic thresholding had been applied to the spectrogram and the power 
levels had been normalised, the matrix was manipulated in order to calculate a 
number of parameters from which the features noted in the visual inspections could be 
described. The maximum frequency envelopes were calculated to examine the 
contours of the waveforms, with the aim of capturing the spikes on the systolic down 
stroke. The minimum frequency envelopes were calculated with the aim of providing 
a measure to describe the level of spectral broadening. The power levels within the 
spectrum were used to calculate a ‘Power Envelope’ to describe the variation of the
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power levels within the waveform cycles. The location markers for the systolic, 
reverse and 2nd forward flow phases were calculated and used to examine the 
parameters within the different flow phases of the waveform cycles.
4.4.1 Maximum Frequency Envelope Calculation
The MFEs for the forward and reverse flow components were calculated separately 
using the 95% MFE method. The positions of the forward and reverse flow MFEs for 
each of the 60 AAA and 60 normal waveforms were checked by plotting and 
superimposing the forward and reverse flow MFEs onto the MATLAB spectrogram. 
The forward and reverse flow MFEs were then normalised by dividing the amplitude 
of each point in the envelope by the maximum amplitude of the forward flow MFE.
4.4.2 Minimum Frequency Envelope Calculation
A technique similar to the maximum frequency envelope calculation was employed to 
calculate an envelope to follow the ‘inner’ profile of the forward flow waveform 
component. This ‘minimum frequency envelope’ was derived from the amplitude of 
the Doppler frequency spectrum by calculating the point of the 95% power level 
working down from the Maximum Frequency envelope. The amplitudes of the pixels 
in each column of the data matrix (corresponding to a point in time on the 
spectrogram) were summed from the level of the maximum frequency envelope down 
to the baseline (middle row of the spectrogram matrix). The minimum frequency point 
was calculated as the pixel that corresponded to 95% of the summed frequency 
amplitudes down from the MFE at this point in time. The positions of the minimum
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frequency envelopes were checked for each waveform by plotting and superimposing 
the minimum frequency envelope onto the forward flow MATLAB spectrogram. The 
minimum frequency envelopes were then normalised by dividing the amplitude of 
each point along the envelope by the maximum amplitude of the un-normalised 
forward flow maximum frequency envelope.
4.4.3 Bandwidth Envelope Calculation
To provide a measure of the level of spectral broadening in the forward flow, a 
‘bandwidth envelope’ was calculated by subtracting the value of minimum frequency 
envelope from the value of the maximum frequency envelope at each point in time. 
An example of the bandwidth envelope is shown in Figure 4.8. The white line 
indicates the maximum frequency envelope, the yellow line indicates the minimum 
frequency envelope and the red line indicates the bandwidth envelope. The bandwidth 
envelopes were also normalised with respect to the maximum amplitude of the 
forward flow MFE.
Figure 4.8: Example o f forward flow spectrogram with maximum frequency envelope, (white line), 
minimum frequency envelope (yellow line), and bandwidth envelope (red line) superimposed.
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4.4.4 Power Envelope Calculation
The normalised power levels of the frequencies occurring at each point in time were 
summed to produce parameter called the ‘total power envelope’. Separate total power 
envelopes were calculated for the forward and reverse flow components by summing 
the power levels of the pixels in each column from the baseline (middle row in the 
spectrogram) up to the top row of the spectrogram matrix, and from the baseline down 
to the bottom row of the spectrogram matrix respectively. Two more power envelopes 
were calculated by summing the power levels in each matrix column from the 
baseline up to the level of the Butterworth filtered MFEs in the forward and reverse 
directions. An example of a total power envelope for the forward flow component is 
plotted in Figure 4.9. The large peaks represent the power within the systolic peak 
regions and the smaller peaks represent the power within the second forward flow 
phases.
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Figure 4.9: Example o f  Total Power Envelope.
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4.4.5 Systolic Peak Markers
The positive Butterworth filtered MFEs were interrogated using the method described 
in Section 4.3.2.1 to calculate the locations of the start of the systolic flow phase, the 
systolic peak and the end of the systolic flow phase. To check the locations of the 
calculated markers the MFEs were plotted with the peak markers superimposed. The 
systolic peak markers were also used to calculate the length of the systolic peak, the 
length of the systolic upstroke region and the length of the systolic down-stroke 
region for each waveform cycle. The ‘beat lengths’ between each of the waveform 
cycles were calculated as the difference between the pulse foot locations of 
subsequent systolic peaks.
4.4.6 Reverse Flow and Second Forward Flow Phase Markers
The shape of the reverse flow phases were often more complex than the systolic peaks 
and therefore application of the differential method to the reverse MFE did not 
adequately locate the pulse foot locations for the reverse flow in more than half of the 
waveforms. Instead, to locate the start and end of the reverse flow phases, sections of 
the reverse flow MFE lying in the region from 5 points (columns) to the left of the 
systolic peak marker to 40 points to the right of the systolic down-stroke pulse foot 
marker were interrogated. The amplitudes of these reverse flow sections were 
examined and the marker indicating the beginning of the reverse flow phase was 
placed at the point where the amplitude of the reverse flow MFE exceeded 25% of the 
maximum reverse flow amplitude. The end of the reverse flow phase was calculated 
by counting backwards along the reverse flow MFE from the pulse foot at the start of
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the subsequent systolic peak until the height of the revere flow MFE exceeded 10% of 
the maximum reverse height within the cycle.
The markers for the end of the second forward flow phases were located in a similar 
manner by counting backwards from the subsequent systolic pulse foot along the 
forward flow MFE. The location marker was positioned at the point at which the 
height of the MFE exceeded 30% of the maximum height of the MFE region lying 
between the end of the systolic peak of the waveform cycle and the pulse foot of the 
subsequent systolic peak.
The locations of the markers for the reverse flow and second forward flow phases 
were checked for each waveform by superimposing the location markers onto the 
spectrogram as shown in Figure 4.10.
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Figure 4.10: Markers indicating the calculated start and end o f the reverse flow phase (yellow and red 
lines respectively) and the end o f the 2nd positive flow phase (white line).
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4.5 Identification of Measures to Describe CFA Waveform Features
The maximum frequency envelopes, bandwidth envelopes, power envelopes and the 
flow phase markers were used to calculate a number of different indices to provide 
measures of aspects of the 5 features noted visually: Spectral broadening on the 
systolic down-stroke, the appearance of spikes on the systolic down-stroke, an 
irregular reverse flow pattern, simultaneous forward and reverse flow, and elongation 
of the waveform during the cardiac cycle. Each of the indices were calculated for 
each individual waveform cycle in the spectrogram, except for the first and last 
waveform cycles which were excluded to ensure all cycles were complete. The mean 
index value per waveform cycle was then calculated.
Each index was calculated and plotted for the left and right CFA waveforms for the 30 
AAA and 30 normal patients in the no significant femoro-popliteal atherosclerotic 
disease groups. The plots were visually inspected to determine whether the index 
provided any discrimination between the AAA and normal waveforms. For the 
indices which showed a level of discrimination, a number of threshold levels were 
tested on the plots to determine the optimum level to best separate the AAA and 
normal waveforms.
Each index provided a measure for one of the visual features, and in effect, the 
threshold levels were used to determine objectively whether or not the feature was 
present in a waveform.
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4.5.1 Spectral Broadening Indices
A number of different indices to describe the first feature noted in the visual analysis 
of increased spectral broadening on the systolic down-stroke, illustrated in Figure 4.11 
were generated by examining the bandwidth and power envelope distributions in the 
systolic peak regions. The location markers were used to identify the systolic peak, 
systolic upstroke, and systolic down-stroke regions for each complete waveform cycle 
within the spectrogram.
Narrow Bandwidth
Increased Bandwidth
a) b)
Figure 4.11: Illustration o f systolic peaks showing a) normal systolic down-stroke bandwidth and b) 
increased systolic down-stroke bandwidth with AAA
The bandwidth envelopes were interrogated to determine the maximum bandwidth 
levels within the systolic peak, systolic upstroke and systolic down-stroke regions for 
each complete waveform cycle and the mean values per cycle were calculated. The 
difference and the ratio between the maximum bandwidth level on the systolic down- 
stroke and the maximum bandwidth level on the systolic upstroke were also 
calculated.
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The bandwidth envelopes for the systolic peak and the systolic upstroke and down- 
stroke regions (identified using the flow phase markers) were integrated for each 
complete waveform cycle by the application of Simpson’s rule. The lengths of each of 
the systolic peaks, systolic upstroke and systolic down-stroke regions were calculated 
from the phase location markers. The mean bandwidth level in each region was 
calculated by dividing the bandwidth integral by the length of the corresponding 
region. The mean bandwidths for the systolic peak, the systolic upstroke and systolic 
down-stroke regions were calculated for each complete waveform cycle and the mean 
values per cycle were calculated. The difference and the ratio between the mean 
bandwidth over the systolic down-stroke region and the mean bandwidth over the 
systolic upstroke region were also calculated.
Indices were also calculated from the power envelopes. The total power levels 
contained within the systolic peak, the systolic upstroke and systolic down-stroke 
regions were calculated by applying Simpson’s rule to integrate the power envelope 
within these regions. The difference and the ratio between the total power level in the 
systolic down-stroke and the total power level in the systolic upstroke regions were 
also calculated. Another index was calculated by dividing the total power within the 
systolic down-stroke by the bandwidth integral of the systolic down-stroke.
The above indices were calculated for each individual, complete waveform cycle 
within each spectrogram and the mean values per cycle were calculated. The indices 
were plotted for the left and right CFA waveforms from the 30 AAA and 30 normal 
patients. An explanation of the format of the index plots is given in Appendix 5. The 
plots were visually examined to determine which of the indices provided
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discrimination between the two patient groups. A narrow bandwidth indicates how 
‘laminar’ the blood flow is. In theory in the presence of an AAA the flow may be 
more disturbed and therefore in general the bandwidth may be wider. Two of the 
above indices to provide measures to describe the level of spectral broadening: the 
maximum systolic down-stroke bandwidth and the maximum upstroke bandwidth, 
showed a level of discrimination between the AAA and normal waveforms.
The maximum systolic down-stroke bandwidth index is plotted for the right and left 
CFA waveforms from the 30 AAA and 30 normal patients in Figure 4.12.
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Figure 4.12: Maximum Down-stroke Bandwidth Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients without significant
atherosclerotic arterial disease
In general, the AAA waveform cycles have a higher maximum bandwidth level on the 
systolic down-stroke compared to normal waveform cycles. A range of threshold 
levels were tested to determine the optimum level to best discriminate between the 
AAA and normal waveforms. The thresholds tested and the results for each threshold 
are given in Table 4.1.
Threshold Level
Number of AAA 
waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
0.70 42 40
0.72 39 30
0.74 35 24
0.76 33 16
0.78 24 12
0.80 16 11
Table 4.1: Discrimination levels for the range o f threshold levels tested for the Maximum Down-stroke
Bandwidth Index.
The best threshold level to separate the AAA and normal waveforms by this index 
was around 0.76 as over half (55%) of the AAA waveforms are above the threshold 
level and around a quarter (26.6%) of the normal waveforms are above the threshold.
The Maximum Upstroke Bandwidth index is plotted for the left and right CFA 
waveforms from the 30 AAA and 30 normal patients in Figure 4.13.
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Figure 4.13: Maximum Upstroke Bandwidth Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients without significant
atherosclerotic arterial disease
In general, the AAA waveforms have a higher maximum bandwidth level on the 
systolic upstroke compared to normal waveforms. The upstroke bandwidth is 
generally lower than the down-stroke bandwidth; this is expected due to the alignment 
of the flow vectors due to the forward acceleration of the bulk flow during systole. 
Again, a range of threshold levels were tested to determine the optimum index level to 
discriminate between the AAA and normal waveforms. The results are given in Table 
4.2. For this index the threshold level which provided the best separation between the 
AAA and normal waveforms was around 0.68 for which half the AAA waveforms 
and a third of the normal waveforms were above the threshold.
Threshold Level
Number of AAA 
waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
0.60 46 37
0.62 42 32
0.64 42 29
0.66 39 27
0.68 30 20
0.70 24 19
Table 4.2: Discrimination levels for the range o f threshold levels tested for the Maximum Upstroke
Bandwidth Index.
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4.5.2 Systolic Down-Stroke ‘Spikes’ Index
To second feature noted in the visual analysis was the presence of ‘spikes’ on the 
down-stroke of the systolic peak, illustrated in Figure 4.14.
a) Systolic Down-Stroke 
Region
Spike
b) Systolic Down-Stroke 
Region
Figure 4.14: Illustration o f  systolic peaks showing a) normal systolic down-stroke and b) systolic
down-stroke with spike
In order to automatically detect this feature MATLAB code was written to identify 
discontinuities on the down-stroke. This was achieved by examination of the 
differentials between subsequent points of the MFE in the systolic down-stroke 
region. The method ‘counted’ along the MFE of the systolic down-stroke region until 
the amplitude of the subsequent point was greater than the last. A ‘spike’ was 
identified if the deflection continued for >2 further subsequent points along the MFE. 
This criterion was set to try and discount irregularities in the profile occurring due to 
noise. The process terminated at the pulse foot at the end of the systolic peak. The
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number of ‘spikes’ in the systolic down-stroke region of every complete waveform 
cycle in the spectrogram were calculated and then the mean number of spikes per 
waveform cycle was calculated.
The results for the right and left CFA waveforms from the 30 AAA and 30 normal 
patients for are plotted in Figures 4.15a and 4.15b respectively. On visual inspection 
of the AAA waveforms the spikes were not always present on every single systolic 
peak. It was decided by visual inspection of the plots that that a threshold of >0.5 
discriminated best between the AAA and normal waveforms.
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Figure 4.15a: Systolic Spike Index plotted for the left and right CFA waveforms for the 30 patients with AAA without significant atherosclerotic arterial disease
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Figure 4.15b: Systolic Spike Index plotted for the left and right CFA waveforms for the 30 patients without AAA and without significant atherosclerotic arterial disease
The number of AAA and normal waveforms with a systolic spike index above the 
threshold level of >0.5 are given in Table 4.3. This index and threshold level provided 
a very good level of discrimination between the AAA and normal waveforms, with 25 
out of the 60 AAA waveforms and only 2 out of the 60 normal waveforms having a 
spike index >0.5.
AAA Normal
Number of CFA 
waveforms with Systolic 
Spike Index >0.5
25 2
Table 4.3: Number o f CFA waveforms with Systolic Spike Index >0.5
4.5.3 Irregular Reverse Flow Indices
The third feature noted in the visual analysis of the CFA waveforms was an irregular 
reverse flow phase. There were two different types of irregularity noted in the visual 
waveform inspection, illustrated in Figure 4.16: 1) an elongation of the reverse flow 
with an irregular profile and distinct spikes, and 2) an ‘exaggerated’ reverse flow 
component, with increased amplitude and an irregular, slightly square profile.
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Figure 4.16: Ilustration o f a) normal reverse flow patten, b i) reverse flow component with increased 
amplitude and an irregular, square profile, and b ii) elongation o f the reverse flow component with
irregular profile
A method similar to that used to identify the spikes on the systolic down-stroke was 
applied to the reverse flow Butterworth filtered maximum frequency envelope to 
detect fluctuations in the profile of the reverse flow phase. The criteria for the length 
of the deflection in the differentials was increased to >3 and a second criteria was set 
so that the height of the deflection had to exceed 30% of the maximum reverse flow 
height to be counted as a ‘fluctuation’. A number of different regions in the reverse 
flow were tested. The best results were achieved for the reverse flow region lying 
under the systolic down-stroke from the systolic peak to the pulse foot of the systolic 
down-stroke plus half the systolic peak length. This region incorporated the 
irregularities in the reverse flow arising from the simultaneous forward and reverse
flow in the systolic down-stroke as well as those occurring in the true reverse flow 
phase. As for the systolic spikes, the number of ‘fluctuations’ were counted in the 
reverse flow region of every complete waveform cycle in the spectrogram and the 
mean number of fluctuations per waveform cycle was calculated.
The number of fluctuations for the right and left CFA waveforms from the 30 AAA 
and 30 normal patients are plotted in Figures 4.17a and 4.17b respectively. A number 
of threshold levels were tested and the threshold of >2 fluctuations provided the best 
separation between the AAA and normal waveforms. The number of AAA and 
normal waveforms with a reverse flow fluctuation index above the threshold level of 
>2 are given in Table 4.4. Again, this index and threshold level provided a very good 
level of discrimination between the AAA and normal waveforms, with 27 out of 60 
AAA waveforms and only 8 out of the 60 normal waveforms above the threshold.
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Figure 4.17a: Reverse Flow Fluctuation Index plotted for the left and right CFA waveforms for the 30 patients with AAA without significant atherosclerotic
arterial disease
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Figure 4 .17b: Reverse Flow Fluctuation Index plotted for the left and right CFA waveforms for the 30 patients without AAA without significant atherosclerotic
arterial disease
AAA Normal
Number of CFA 
waveforms with Reverse 
Flow Fluctuation Index >2
27 8
Table 4.4: Number o f CFA waveforms with Reverse Flow Fluctuation Index >2
To investigate the observed features of elongation and increased amplitude of the 
reverse flow phase a measure called the ‘reverse power density’ was derived. The 
reverse power density was calculated as the integral of the normalised power envelope 
divided by the integral of the normalised maximum frequency envelope. It was 
thought that the reverse power density may be reduced in waveforms with an 
exaggerated reverse flow component because the ‘area’ occupied by the reverse flow 
phase is increased. The mean power density was calculated for a number of different 
regions of the reverse flow component for each waveform cycle. As for the reverse 
flow fluctuation index, the best results were achieved for the region lying between the 
systolic peak location marker to the down-stroke pulse foot plus the half systolic peak 
length.
The Reverse Power Density Index is plotted for the left and right CFA waveforms for 
the 30 AAA and 30 normal patients in Figure 4.18. It can be seen that there were 
several AAA waveforms which had a lower reverse power density in comparison to 
the majority. Again, a range of threshold levels were tested to determine the optimum 
level to discriminate between the AAA and normal waveforms. The results are given 
in Table 4.5. The threshold level of <4.2 provided the best separation between the 
AAA and normal waveforms with 18 out of the 60 (30%) AAA waveforms and only 5 
out of the 60 (8.3%) normal waveforms lying below the threshold level.
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Figure 4.18: Reverse Power Density Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients without significant
atherosclerotic arterial disease
Threshold Level
Number of AAA 
waveforms with index 
below threshold
Number of normal 
waveforms with index 
below threshold
3.0 8 1
3.4 13 2
3.8 15 3
4.2 18 5
4.6 23 7
5.0 26 9
Table 4.5: Discrimination levels for range o f threshold levels tested for the Reverse Power Density
ratio index.
To define the feature of increased amplitude in the reverse flow phase, the ratio of the 
maximum reverse flow height to the systolic peak height was calculated from the 
forward and reverse flow MFEs for each complete waveform cycle. The Reverse to 
Systolic to Height Ratio Index is plotted for the left and right CFA waveforms from 
the 30 AAA and 30 normal patients in Figure 4.19. There are several AAA 
waveforms which are ‘outliers’ on the graph that have an increased height ratio due to 
the increased relative height of the reverse flow component. A range of threshold 
levels were tested to determine the optimum level to discriminate between the AAA 
and normal waveforms. The results are given in Table 4.6. All the threshold levels 
tested provide reasonable separation between the AAA and normal waveforms. The 
threshold level of 0.52 eliminated all the normal waveforms with 7 outliers from the 
AAA group remaining above the threshold.
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Figure 4.19: Reverse to Systolic Height Ratio Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients without significant
atherosclerotic arterial disease
Threshold Level
Number of AAA 
waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
0.44 21 7
0.46 11 3
0.48 10 3
0.50 8 2
0.52 7 0
Table 4.6: Discrimination levels for the range o f threshold levels tested for the Reverse to Systolic
Height Ratio Index.
4.5.4 Simultaneous Forward and Reverse Flow Indices
The fourth feature noted in the visual analysis was the presence of simultaneous 
forward and reverse flow during the systolic flow phase is illustrated in Figure 4.20.
Figure 4.20: Illustration o f a) normal waveform with minimal overlap o f forward and reverse flow, and 
b) waveform with simultaneous forward and reverse flow
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Several indices were generated to provide a measure of the overlap in the forward and 
reverse flow phases under the systolic peak. The first index was generated to measure 
the time-delay between the systolic peak and the on-set of reverse flow. This was 
calculated by subtracting the position of the marker indicating the start of the reverse 
flow phase from the systolic peak marker position. The time-delay for each complete 
waveform cycle was normalised by dividing by the beat length. The time-delay index 
is plotted for the left and right CFA waveforms for the 30 AAA and 30 normal 
patients in Figure 4.21. There are several waveforms from AAA patients with a 
shorter time-delay between the systolic peak and the on-set of reverse flow. In 7 AAA 
waveforms the index value was negative indicating that a significant level of reverse 
flow occurred before the systolic peak was reached in the forward flow phase. The 
results for the threshold levels that were tested on this index to determine the best 
level to discriminate the between the AAA and normal waveforms are given in Table 
4.7. The threshold level of <0.04 provides reasonable separation between the groups.
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Figure 4.21: Systolic to Reverse Flow Time-Delay Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients without
significant atherosclerotic arterial disease
Threshold Level
Number of AAA 
waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
0.12 44 40
0.10 35 32
0.08 30 21
0.06 26 15
0.04 18 8
0.02 12 6
Table 4.7: Discrimination levels for the range o f threshold levels tested for the Systolic to Reverse
Flow Time-Delay Index
Alternative measures to describe the simultaneous forward and reverse flow feature 
were calculated from the power levels within the reverse flow occurring under the 
systolic peaks. The total power levels within the reverse flow under each systolic peak 
were calculated by integrating the power envelope (by the application on Simpson’s 
rule) for the reverse flow regions lying under the systolic peaks. In general, the power 
levels under the systolic upstroke were very low, to an order of 10 lower than under 
the systolic down-stroke. Therefore the power integrals under the upstroke and down- 
stroke regions were calculated separately to produce two different indices: 1) The 
Integral of the Reverse Power Under the Systolic Upstroke Index and 2) The Integral 
of the Reverse Power Under the Systolic Down-Stroke Index.
The Integral of the Reverse Power Under the Systolic Upstroke Index is plotted in 
Figure 4.22. It can be seen that although the power levels under the systolic upstroke 
were very low, there are several CFA waveforms from AAA patients which have a 
much higher level of reverse flow under the systolic upstroke than the normal 
waveforms.
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Figure 4.22: Integral o f Reverse Power Under Systolic Upstroke Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal patients
without significant atherosclerotic arterial disease
The presence of reverse flow power under the systolic upstroke may possibly be 
explained by flow disturbances and vortices in the forward flow set up by an AAA. 
The overall direction of the bulk flow is forwards, but the vortices and flow 
disturbances have vectors in the reverse direction as the circulating vortices are 
carried forwards by the bulk flow. Therefore there will be a small amount of flow 
passing through the ultrasound beam with vectors in the reverse flow direction.
A range of threshold levels were tested on this index to determine the optimum level 
to discriminate between the AAA and normal waveforms. The results are given in 
Table 4.8. The threshold level of 0.025 provided a good level of separation with 25 
out of the 60 (41.7%) AAA waveforms and only 7 out of the 60 (11.7%) normal 
waveforms above the threshold.
Threshold Level Number of AAA 
waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
0.025 25 7
0.05 18 6
0.10 14 5
0.15 9 4
0.20 7 2
Table 4.8: Discrimination levels for the range o f  threshold levels tested for the Integral Reverse Power
Under Systolic Upstroke index
The integral of the Reverse Power Under the Systolic Down-Stroke Index is plotted in 
Figure 4.23.
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Figure 4.23: Integral o f Reverse Power Under Systolic Down-Stroke Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal
patients without significant atherosclerotic arterial disease
There are several ‘outliers’, predominantly from the AAA group with an increased 
power level under the systolic down-stroke. This may be related to the early on-set of 
reverse flow as seen in some AAA waveforms due to flow disturbances during the 
systolic down-stroke. The results for the range of threshold levels tested to determine 
the best level to discriminate between the AAA and normal waveforms are given in 
Table 4.9. The threshold level of 1.5 best separates the ‘outliers’ from the rest of the 
waveforms.
Threshold Level Number of AAA waveforms with index 
above threshold
Number of normal 
waveforms with index 
above threshold
1.0 21 29
1.1 17 18
1.2 15 14
1.3 13 9
1.4 12 6
1.5 10 5
Table 4.9: Discrimination levels for the range o f  threshold levels tested for the Integral Reverse Power
Under Systolic Down-Stroke index.
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4.5.5 Elongation Indices
The 5th feature of waveform elongation is illustrated in Figure 4.24. To provide a 
measure for this feature the peak and pulse foot markers for the different phases of 
flow in each complete waveform cycle were used to calculate a number of different 
mean indices: Beat length, reverse flow length, waveform length, ratio of the 
waveform length to the beat length, ratio of the systolic peak length to the beat length, 
ratio of the reverse flow length to the beat length, ratio of the systolic peak length to 
the waveform length, ratio of the systolic peak length to the reverse flow length and 
the ratio of the reverse flow length to the waveform length.
Wavefrom Length Increased Waveform Length
Figure 4.24: Illustration o f a) normal wavelength and b) increased waveform length
The plots of all these indices for the left and right CFA waveforms from the 30 AAA 
and 30 normal patients were visually inspected. The index that provided the best 
separation between the AAA and normal groups was the Ratio of the Systolic Peak 
Length to the Reverse Flow Length Index which is plotted in Figure 4.25.
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Figure 4.25: Mean Ratio of the Systolic Peak Length to the Reverse Flow Length Index plotted for the left and right CFA waveforms from the 30 AAA and 30 normal
patients without significant atherosclerotic arterial disease
There were several waveforms, predominantly in the AAA patient group with a lower 
ratio than the majority, indicating an increase in the reverse flow length in comparison 
to the systolic peak length. This was due to an elongation of the reverse flow phase or
tVi •the presence of a 4 flow phase. Several threshold levels were tested on this index to 
determine the level to best discriminate between the AAA and normal waveforms. 
The results are given in Table 4.10. The threshold level providing the best separation 
is around 1.2 or 1.3. The level of 1.3 is possibly better as it included more of the AAA 
waveforms.
Threshold Level
Number of AAA 
waveforms with index 
below threshold
Number of normal 
waveforms with index 
above threshold
1.6 38 29
1.5 35 26
1.4 28 24
1.3 27 18
1.2 21 10
1.1 14 5
1.0 8 2
Table 4.10: Discrimination levels for the range o f threshold levels tested for the Ratio o f the Systolic
Peak Length to the Reverse Flow Length Index
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4.6 AAA Detection Pro2ram: Combination of Indices to Discriminate between
AAA and Normal Patients
A summary of the 10 indices that were chosen to represent each of the 5 visual 
features is given in Table 4.11. The number of CFA waveforms included by the 
threshold levels that were set by visual inspection of the index plots are summarised 
in Figure 4.26.
Visual Feature MATLAB Index
Increased Spectral Broadening 
on Systolic Peak
Maximum Systolic Down-Stroke 
Bandwidth Index
Maximum Systolic Upstroke 
Bandwidth Index
Spikes in systolic Down-Stroke 
Profile Systolic Spike Index
Irregular Reverse Flow Pattern
Reverse Flow Fluctuation Index
Reverse Power Density Index
Reverse to Systolic Height Ratio 
Index
Simultaneous Forward and 
Reverse Flow
Systolic to Reverse Flow Time 
Delay Index
Integral Reverse Power under 
Systolic Upstroke Index
Integral Reverse Power Under 
Systolic Down-Stroke Index
Elongation of Waveform Ratio of the Systolic Peak length to the Reverse Flow Length Index
Table 4.11: Summary o f  the indices representing each o f  the 5 visual features.
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Figure 4.26: Number o f CFA waveforms from the 30 AAA and 30 normal patients with no significant atherosclerotic arterial disease with an index value for each of the
10 Indices included by the corresponding threshold level
In the visual analysis of the waveforms in Chapter 3, there was no single feature 
present in all the AAA waveforms and individually, the features did not provide 
adequate discrimination between the AAA and normal waveforms. However, by 
scoring the waveforms based on a combination of all 5 features a sensitivity of 93.3% 
and a specificity of 70% were achieved for AAA detection. Similarly, as illustrated in 
Figure 4.26, individually, these 10 indices with the threshold levels chosen visually, 
do not adequately discriminate between the AAA and normal waveforms with 
adequate sensitivity and specificity for AAA detection. Therefore a MATLAB 
program was written to combine these indices, with a range of different threshold 
levels and weighting factors applied, to determine the optimum combination to 
discriminate between the AAA and normal patients without significant atherosclerotic 
arterial disease.
For three of the visual features: Increased spectral broadening on the systolic peak, an 
irregular reverse flow pattern and simultaneous forward and reverse flow there was 
more than one index for each feature that provided good differentiation between the 
AAA and normal waveforms. The best performance for AAA detection was not 
necessarily provided by a combination of all the 10 indices. It was necessary to 
determine which of the indices in combination provided the best separation between 
the AAA and normal patients. The more indices that were included, the more specific 
the AAA detection program would be to the data within the study group. Because the 
overall aim was to be able to apply the AAA detection program to a general 
population, possibly for screening, it was necessary to determine the best combination 
for AAA detection with a minimum number of indices. Therefore, the program was 
designed to not only to test different combinations of threshold levels and weighting
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factors, but also different combinations with different numbers of the indices 
included.
The method by which the MATLAB based program operated was similar to the 
process used to detect AAA by visual analysis of the CFA waveforms in Chapter 3. 
For each patient in the AAA and normal study groups, the indices representing each 
of the visual features were calculated individually for the right and left CFA 
waveforms. Each waveform was then allocated a score for each of the indices 
depending upon where the calculated index value lay in relation to the threshold level 
set for the index. The total scores for the ten indices for each waveform were summed. 
For each patient the total waveform scores for the left and right leg were then summed 
to give a total patient score. Once the total patient scores had been calculated for all 
the 30 AAA and normal patients, the total scores were subjected to threshold levels to 
determine the threshold level to best distinguish between the AAA and normal 
patients.
A summary of how the MATLAB program combined the different indices, threshold 
levels and weighting factors is given in Figure 4.27. The threshold levels (T1-T10) 
and weighting factors (W1-W10) for each of the 10 individual indices were entered 
manually at the start of the program. The ranges of the threshold levels that were 
tested were taken from the values given in Tables 4.1-4.10. The weighting factors 
were set to 1,2,  or 0. A weight of 2 increased the importance of the index in the 
combination, and a weight of 0 in effect, removed the index from the combination. 
The left and right CFA waveform data files for each of the 30 AAA and 30 normal 
patients were loaded automatically and in sequence into the program. The initial data
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processing was performed on each waveform file to reduce noise, extract the 
maximum frequency envelopes for the forward and reverse flow components, 
calculate the positions of the forward and reverse flow phase markers, and calculate 
the minimum frequency envelopes, bandwidth envelopes and power envelopes. The 
10 indices were then calculated individually for each waveform and compared to the 
set threshold levels. For the Maximum Systolic Down-Stroke Bandwidth Index, 
Maximum Systolic upstroke Bandwidth Index, Systolic Spike Index, Reverse Flow 
Fluctuation Index, Reverse to Systolic Height Ratio Index, Integral Reverse Power 
Under Systolic Upstroke index, Integral Reverse Power Under Systolic Down-Stroke 
Index and Ratio of the Systolic Peak Length to the Reverse flow Length Index a score 
of 1 was awarded if the waveform index level lay above the threshold or 0 if it lay 
below. For the Reverse Power Density Index and Systolic to Reverse Flow Time- 
Delay Index, a score of 1 was awarded if the waveform index lay below the threshold 
or 0 if it lay above. In effect, the threshold levels were used to determine whether the 
visual feature represented by the index was present in the waveform or not. For each 
individual waveform, the score for each index was then multiplied by the 
corresponding weighting factor that was entered at the start of the program. The 
weighted scores for the 10 indices were summed to give a total score for each 
individual waveform. The waveform scores for the left and right leg of each patient 
were then summed to give a total patient score. To determine the best threshold level 
to place on the patient score to provide the best sensitivity and specificity to AAA 
detection, the total score for each patient and the number of patients in each group 
with total scores above threshold levels of >1, >2 and >3 were output at the end of the 
program.
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Figure 4.27: Summary o f  how the MATLAB program combines the indices, threshold levels and
weighting factors
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A large number of different combinations and permutations of the 10 indices, 
threshold levels and weighting factors were systematically tested. The best level of 
separation between the patients in the AAA and normal study groups without 
significant atherosclerotic disease was achieved by the combination of 6 indices to 
represent the 5 visual features with the corresponding threshold levels and weighting 
factors given in Table 4.12. The remaining 4 indices: Maximum Systolic Upstroke 
Bandwidth Index, Reverse Flow Fluctuation Index, Ratio of the Systolic Peak Length 
to the Reverse Flow Length Index and Systolic to Reverse Flow Time-Delay Index 
did not improve on the sensitivity and specificity for AAA detection when included in 
the combination and were therefore disregarded. All indices apart from the systolic 
spikes index were not weighted. The Systolic Spike Index was weighted by a factor of 
2, because visually (and objectively), the feature of spikes on the systolic down-stroke 
was a very dominant feature in the AAA waveforms.
147
Visual Feature Index Threshold Level Weighting Factor
Increased
Spectral
Broadening
Maximum Systolic 
Down-Stroke 
Bandwidth Index
>0.76 1
Spikes on Systolic 
Down-stroke Systolic Spike Index >0.5 2
Irregular Reverse 
Flow Pattern / 
Waveform 
Elongation
Reverse Power 
Density Index <4.2 1
Irregular Reverse 
Flow Pattern
Reverse to Systolic 
Height Ratio Index >0.52 1
Simultaneous 
Forward and 
Reverse Flow
Integral Reverse 
Power under 
Systolic Upstroke 
Index
>0.025 1
Integral Reverse 
Power under 
Systolic Down- 
Stroke Index
>1.5 1
Table 4.12: Indices with corresponding threshold levels and weighting factors providing the best 
discrimination between the AAA and normal study group patients without significant atherosclerotic
arterial disease.
4.7 AAA Detection Program Results
4.7.1 AAA Detection Program Study Groups’ Results
The total scores that were output by the program for each individual patient in the 
AAA and normal patient study groups for this combination are plotted in Figures 
4.28a and 4.28b respectively.
The number of patients in each group with a total score of >1, >2 and >3 are plotted in 
Figure 4.29.
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Figure 4.28a: Total Patient Scores for the 30 AAA patients in the no significant atherosclerotic disease
study group
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Figure 4.28b: Total Patient Scores for the 30 normal patients in the no significant atherosclerotic
disease study group
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Figure 4.29: Number of AAA and normal patients in the no significant atherosclerotic disease study 
groups with a Total Patient Score o f >1, >2 and >3.
4.7.1.1 AAA Detection Program Study Groups’ Results: Discussion
It can be seen from Figures 4.28a and 4.28b there is a significant difference between 
the mean scores within the AAA and normal groups. The mean score per patient in 
the AAA group was 4.8 with maximum score of 11 and minimum score of 2. The 
mean score per patient in the normal group was 1.2 with a maximum score of 5 and 
minimum score of 0.
Figure 4.29 shows that the threshold providing the best levels of sensitivity and 
specificity for AAA detection is a total patient score of >2. 30 out of the 30 AAA 
patients had a total patient score >2 and 25 out of the 30 AAA patients had a total 
patient score >3. For the normal patient group, 22 patients out of 30 had a total patient 
score >1, 8 out of 30 had a total patient score >2 and 4 out of 30 had a total patient
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score >3. Therefore, the threshold of >1 provided a sensitivity of 100% with a 
specificity of 26.7%, the threshold of >2 provided a sensitivity of 100% with a much 
improved specificity of 73.3%, and the threshold level of threshold of >3 provided a 
reduced sensitivity of 83.3% with an increased specificity of 86.6% for AAA 
detection in the no significant atherosclerotic disease groups. Therefore the threshold 
placed on the total patient score for a positive identification of an AAA by the AAA 
detection program was a score of >2.
4.7.2 Response of AAA Detection Program to Blind Test Groups
The AAA detection program provided very good differentiation between the 30 AAA 
and 30 normal patients in the study groups used to the select the combination of the 
indices, threshold levels and weighting factors used in the program. In order to test the 
ability of the program to diagnose AAA from a blind data set, the previously unseen 
waveforms from the test groups containing 7 AAA and 11 normal patients without 
significant atherosclerotic disease (separated from the cohort at the start of the study, 
summarised in Table A1.2, Appendix 1 and Table A2.2, Appendix 2) were subjected 
to the AAA detection program.
The 6 indices: 1) Maximum Systolic Down-Stroke Bandwidth Index, 2) Systolic 
Spike Index, 3) Reverse Power Density Index, 4) Reverse to Systolic Height Ratio 
Index, 5) Integral Reverse Power under Systolic Upstroke index, and 6) Integral 
Reverse Power Under Systolic Down-Stroke Index are plotted for the left and right 
CFA waveforms for the 7 AAA and 11 normal test group patients in Figures 4.30a to 
4.3Og. The dotted lines indicate the threshold levels set by the program.
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Figure 4.30a: Maximum Systolic Down-Stroke Bandwidth Index plotted for the left and right CFA waveforms for the 7 AAA and 11 normal
patients in the no significant atherosclerotic disease test groups.
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Figure 4.30b: Systolic Spike Index plotted for the left and right CFA waveforms for the 7 AAA patients in the no significant atherosclerotic
disease test group.
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Figure 4.30c: Systolic Spike Index plotted for the left and right CFA waveforms for the 11 normal patients in the no significant
atherosclerotic disease test group.
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Figure 4.3Od: Reverse Power Density Index plotted for the left and right CFA waveforms for the 7 AAA and 11 normal patients in the no
significant atherosclerotic disease test groups.
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Figure 4.30e: Reverse to Systolic Height Ratio Index plotted for the left and right CFA waveforms for the 7 AAA and 11 normal patients in
the no significant atherosclerotic disease test groups.
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Figure 4.30f: Integral of Reverse Power Under the Systolic Upstroke Index plotted for the left and right CFA waveforms for the 7 AAA and 11 normal
patients in the no significant atherosclerotic disease test groups.
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Figure 4.30g: Integral of Reverse Power Under the Systolic Down-Stroke Index plotted for the left and right CFA waveforms for the 7 AAA and 11 normal
patients in the no significant atherosclerotic disease test groups.
For the Maximum Systolic Down-Stroke Bandwidth Index, 3 out of the 14 AAA 
waveforms and 4 out of the 22 normal waveforms lay above the threshold level of 
0.76. For the Systolic Spike Index, 4 out of the 14 AAA waveforms and 1 out of the 
22 normal waveforms lay on or above the threshold level of 0.5. For the Reverse 
Power Density Index, 1 out of the 14 AAA waveforms and 4 out of the 22 normal 
waveforms lay below the threshold level of 4.2. For the Reverse to Systolic Height 
Ratio Index, 2 out of the 14 AAA waveforms and none of the normal waveforms lay 
above the threshold level of 5.2. For the Integral Reverse Power Under Systolic 
Upstroke Index 10 out of the 14 AAA waveforms and 6 of the 22 normal waveforms 
lay above the threshold level of 0.025. For the Integral Reverse Power Under Systolic 
Down-Stroke Index 2 out of the 14 AAA waveforms and 1 of the 22 normal 
waveforms lay above the threshold level of 1.5.
4.7.2.1 AAA Detection Program Blind Test Groups’ Results
The individual scores for each of the 7 AAA and 11 normal patients are plotted in 
Figures 4.31a and 4.31b. The number of AAA and normal test group patients with 
total patient scores of >1, >2 and >3 are plotted in Figure 4.31c.
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Figure 4.31a: Total Patient Scores for the 7 AAA test group patients with no significant atherosclerotic
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Figure 4.31b: Total Patient Scores for the 11 normal test group patients with no significant
atherosclerotic disease
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Figure 4.3 lc: Number o f AAA (n=7) and normal (n=l 1) patients in the no significant atherosclerotic 
disease test groups with total patient scores o f >1, >2 and >3
4.7.2.2 AAA Detection Program Blind Test Groups’ Results: Discussion
It can be seen from Figures 4.31a and 4.31b that there is a significant difference 
between the mean patient scores in the AAA and normal test group. The mean score 
per patient in the AAA test group was 3.7 with a maximum score of 5 and minimum 
score of 2. The mean score per patient in the normal test group was 1.6 with a 
maximum score of 5 and minimum score of 0.
In Figure 4.31c the threshold score of >2 for a positive AAA diagnosis the AAA 
detection program correctly ‘identified’ 100% (7 out of 7) of the AAA test patients as 
having an AAA, and 63.6% ( 7 out of 11) of the normal test patients as not having an 
AAA. The 100% sensitivity to AAA in the test group is excellent and the specificity
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level of 63.6% is acceptable given the limited size of the test sets. These results 
indicate that the objective analysis of CFA waveforms using the AAA detection 
program has potential as an alternative method for AAA detection.
4.8 AAA Detection Program Performance for Patients with AAA and Additional 
Aneurysmal Disease
There were 9 patients within the AAA group with no significant atherosclerotic 
arterial disease that had aneurysmal disease of the iliac arteries or popliteal arteries in 
addition to an AAA. These 9 patients were not included in the study group used to 
design the MATLAB AAA detection program so that the effect of AAA alone could 
be investigated. The waveforms from these 9 patients were in effect a second ‘blind’ 
test set and were also subjected to the AAA detection program to test its response.
A summary of the AAA and additional aneurysm locations and diameters is given in 
Table A 1.3, Appendix 1. It is worth noting that patients number 1 and 6 within this 
group had additional aneurysms of the popliteal artery and patient 3 had additional 
aneurysmal disease of the right CIA but the left CIA was normal calibre. All other 
patients within this group had bilateral iliac aneurysms in addition to an AAA.
The 6 indices calculated by the program are plotted for the left and right CFA 
waveforms for the 9 patients in the additional aneurysm group in Figures 4.32a to 
4.32f. The threshold levels set by the AAA detection program for each of the indices 
are indicated by the dotted line on each graph.
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Figure 4.32a: Maximum Systolic Down-Stroke Bandwidth Index plotted for the left and right CFA waveforms for the 9 AAA patients with
additional aneurysmal disease but no significant atherosclerotic disease.
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Figure 4.32b: Systolic Spike Index plotted for the left and right CFA waveforms for the 9 AAA patients with additional aneurysmal disease
but no significant atherosclerotic disease.
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Figure 4.32c: Reverse Power Density Index plotted for the left and right CFA waveforms for the 9 AAA patients with additional aneurysmal
disease but no significant atherosclerotic disease.
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Figure 4.32d: Reverse to Systolic Height Ratio Index plotted for the left and right CFA waveforms for the 9 AAA patients with additional aneurysmal
disease but no significant atherosclerotic disease.
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Figure 4.32e: Integral o f Reverse Power Under the Systolic Upstroke Index plotted for the left and right CFA waveforms for the 9 AAA patients
with additional aneurysmal disease but no significant atherosclerotic disease.
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Figure 4.32f: Integral of Reverse Power Under the Systolic Down-Stroke Index plotted for the left and right CFA waveforms for the 9 AAA
patients with additional aneurysmal disease but no significant atherosclerotic disease.
Out of the 18 waveforms from patients with AAA and additional aneurysmal disease, 
11 exceeded the threshold of 0.76 for the Maximum Systolic Down-Stroke Bandwidth 
Index, 4 exceeded the threshold of 0.5 for the Systolic Spike Index, 13 lay below the 
threshold of 4.2 for the Reverse Power Density Index, 6 exceeded the threshold for 
the reverse to Systolic Height Ratio Index of 5.2, 9 exceeded the threshold of 0.025 
for the Integral Reverse Power Under Systolic Upstroke Index and 3 exceeded the 
threshold of 1.5 for the Integral Reverse Power Under Systolic Down-Stroke index.
4.8.1 AAA Detection Program Additional Aneurysm Group Results
The total scores for these 9 patients with AAA and additional aneurysmal disease but 
no significant atherosclerotic disease are plotted in Figure 4.33. The number of 
patients with AAA and additional aneurysmal disease but no significant 
atherosclerotic disease with a total patient score o f >1, >2 and >3 are plotted in Figure 
4.34.
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Figure 4.33: Total Patient Scores for the 9 AAA patients in with additional aneurysmal disease but no
significant atherosclerotic disease.
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Figure 4.34: Number o f AAA patients with additional aneurysmal disease but no significant 
atherosclerotic disease with total patient scores o f  >1, >2 and >3.
4.8.2 AAA Detection Program Additional Aneurysm Group Results: Discussion
It can be seen from Figure 4.33 that the mean score per patient in this patient group 
was 5.3 with a maximum score of 8 and minimum score of 2. The mean score per 
patient in this group is higher than for the study set o f 30 patients (mean score 4.8) 
and test set of 7 patients (mean score 3.7) with AAA and no significant atherosclerotic 
or additional aneurysmal disease. This can possibly be expected due to additional 
flow disturbances which may be set up within the additional aneurysms. The total 
scores are lowest for patients number 3 and 6. The score may be lower for patient 
number 3 because only the right CIA is aneurysmal and the left CIA is normal calibre. 
Theoretically, because popliteal aneurysms are distal to the CFA, they may not affect 
the CFA waveform to the same extent as a proximal iliac aneurysm. The score for 
patients numbers 1 and 6 with AAA and popliteal aneurysms were 7 and 2 
respectively. The score may possibly be higher for patient 1 because the AAA for this
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patient was 5.7cm compared to 3.5cm for patient 6 . The effect of AAA size on the 
patient scores is investigated in Chapter 7.
In Figure 4.34 all 9 of the patients had a patient score >2, and 7 had a score >3. 
Therefore for the threshold patient score of >2 set by the program provided a 
sensitivity of 100% for AAA detection for the 9 patients with AAA and additional 
aneurysmal disease of the iliac or popliteal arteries. These results are again very 
encouraging.
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4.9 Discussion
At the beginning of this chapter, MATLAB code was written to calculate parameters 
from which indices to describe the visual features noted in the CFA waveforms in 
Chapter 3 could be derived. There were 6 indices chosen to represent the 5 features: 
1) The Maximum Systolic Down-Stroke Bandwidth Index to measure the feature of 
increased spectral broadening on the systolic down-stroke, 2) The Systolic Spike 
Index to measure the presence of spikes on the systolic down-stroke, 3) The Reverse 
to Systolic Height Ratio Index to measure the feature of an irregular reverse flow 
pattern, 4) The Reverse Power Density Index to provide a measure of both the feature 
of irregular reverse flow and the feature of waveform elongation, and 5) The Integral 
Reverse Power Under the Systolic Upstroke Index and the Integral Reverse Power 
Under the Systolic Down-Stroke Index to measure the feature of simultaneous 
forward and reverse flow. These 6 indices, along with the corresponding threshold 
levels and weighting factors given in Table 4.12, and with a threshold of >2 applied to 
the total patient score achieved a very good level of discrimination between AAA and 
normal patients without significant atherosclerotic disease. The 100% sensitivity and 
73.3% specificity achieved by the AAA detection program for the 30 AAA and 30 
normal patients in the study groups with no significant atherosclerotic arterial disease 
improved on the results achieved for these patients in the visual analysis of the 
waveforms of 93.3% sensitivity 70% specificity. The response of the AAA detection 
program to the blind test groups containing 7 AAA and 11 normal patients was 
encouraging given the limited sizes of the test groups. The sensitivity of 100% and 
specificity of 63.6% were in line with the levels achieved from the 30 AAA and 30 
normal patients in the study groups used to select the indices, thresholds and
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weighting factors in the program. The programs response of 100% sensitivity to the 
group of 9 AAA patients with additional aneurysmal disease which also acted as a 
second blind test group was also very promising.
The overall response of the AAA detection program for the 46 patients with AAA and 
no significant atherosclerotic arterial disease (the study group, plus the test group, 
plus the additional aneurysmal group patients) and 41 patients without AAA and no 
significant atherosclerotic disease (the study group plus the test group patients) was a 
sensitivity of 100% for AAA detection (46 out of 46 correctly identified as having 
AAA), and a specificity of 70.7% (29 out of 41 normal patients correctly identified as 
not having AAA). If these results are projected onto to the general population with no 
significant aorto-iliac or femoro-popliteal atherosclerotic arterial disease, assuming 
the prevalence of lower limb PAD is around 12%, this gives a sensitivity of around 
100% and a specificity of around 70% for approximately 88% of the general 
population. These levels indicate that this type of objective analysis of the CFA 
waveform has the possible potential for use as an alternative method to B-mode 
ultrasound for AAA detection.
The screening studies for AAA discussed in Chapter 1 indicate that a single B-mode 
scan would be performed on all males of 65 years old. PAD is a progressive disease 
and the studies indicate that the prevalence of PAD is around 7% for those aged 60-69 
years old, and increases to around 23% for those aged over 80 years old (Fowkes, 
Housley et al. 1991; Ostchega, Paulose-Ram et al. 2007). Therefore if the 
performance of this AAA detection program is projected onto the potential screened 
population, assuming 93% of the screened population would not have significant
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atherosclerotic arterial disease, the AAA detection program would provide a 
sensitivity of around 100% and specificity of around 70% for approximately 93% of 
the screened population.
In order to determine the feasibility of using these CFA analysis methods to detect 
AAA in the remaining 7% of the screened population with significant atherosclerotic 
disease, the visual feature analysis of the CFA waveforms was applied to the patient 
groups with significant atherosclerotic disease of the aorto-iliac or femoro-popliteal 
arteries. The objective MATLAB based AAA detection technique was then applied to 
these significant atherosclerotic disease groups. The applications of the visual and 
objective feature analysis of the CFA waveforms to the significant atherosclerotic 
disease groups are discussed in Chapters 5 and 6 respectively.
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Chapter 5: Visual Inspection of CFA Waveforms from AAA and No AAA
Patients with Significant Atherosclerotic Disease
5,1 Introduction and Aims
In Chapter 3, visual examination of CFA waveforms from 30 patients with AAA and 
30 patients without AAA with no significant aorto-iliac or femoro-popliteal 
atherosclerotic arterial disease identified 5 features that differed from an ‘ideal’ CFA 
waveform that were more prominent in the group of AAA patients: 1) spectral 
broadening on the systolic down-stroke, 2 ) the appearance of spikes on the systolic 
down-stroke, 3) an irregular reverse flow pattern, 4) simultaneous forward and reverse 
flow during systole and 5) elongation of the waveform during the cardiac cycle. Based 
on the visual identification of these features it was possible to detect AAA in these 
patients with a sensitivity of 93.3% and a specificity of 70%. In this chapter, 
waveforms from the patients with and without AAA but with significant 
atherosclerotic disease of the iliac and/or femoro-popliteal arteries were visually 
assessed to determine whether these 5 features and whether any additional features 
were present. The results were used to determine whether the visual waveform 
analysis method could also be used to detect AAA in patients with significant 
atherosclerotic disease of the aorto-iliac and/or femoro-popliteal arteries.
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5.2 Method
The cohort for the first part of this study comprised the study groups containing the 15 
AAA and 18 no AAA patients with significant atherosclerotic femoro-popliteal 
(distal) arterial disease (summarised in Table A3.1, Appendix 3 and Table A4.1, 
Appendix 4). The cohort for the second part of this study comprised the study groups 
containing the 6 AAA and 7 no AAA patients with significant iliac (proximal) disease 
(summarised in Table A3.3, Appendix 3 and A4.3, Appendix 4). The patients in the 
significant distal disease groups had at least one significant (>50%) stenosis or 
occlusion of the femoro-popliteal arteries. 3 patients in each group had unilateral 
disease. These were patients number 2, 10 and 11 in the AAA group and patients 
numbers 5,11 and 18 in the no AAA group, all of whom had significant disease in the 
left leg and diffuse disease but no significant femoro-popliteal focal lesions in the 
right leg. The remaining patients had significant distal disease bilaterally. All patients 
in the significant proximal disease groups had at least one significant stenosis (>50%) 
or occlusion of the iliac arteries. 2 patients in the AAA group and 3 patients in the no 
AAA group had bilateral proximal disease. Patients number 2, 3, and 5 in the AAA 
group had significant proximal disease on the left side only. Patient number 6 had an 
occlusion of the left CFA and therefore a CFA waveform was not measured, and in 
addition to an AAA the right CIA was also aneurysmal. Patient numbers 2 and 4 had 
no significant distal disease bilaterally. Patients number 1, 3, 4 and 6 had bilateral 
distal disease in addition to significant proximal disease. In the no AAA patient 
group, patients number 1, 4 and 6 had significant proximal disease on the left side 
only and patient number 3 had significant proximal disease on the right side only. In 
addition to significant proximal disease, patients number 2, 4, and 5 had bilateral
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significant distal disease. Patients number 1, 3, 6 and 7 had no significant distal 
disease.
The distal and proximal disease groups were analysed separately. As in Chapter 3, the 
CSV data files for the left and right CFA waveforms for each patient were reproduced 
as spectrograms in MATLAB using the ‘imagesc’ plotting function in the ‘vga’ colour 
scale. The waveform cycles within the CFA spectrograms were visually inspected for 
the 5 features: 1) spectral broadening on the systolic down stroke, 2) the appearance 
of spikes on the systolic down-stroke, 3) an irregular reverse flow pattern, 4) 
simultaneous forward and reverse flow during systole and 5) elongation of the 
waveform during the cardiac cycle, and also to determine whether any additional 
features were present in the waveforms.
5.3 Results
5.3.1 Visual Inspection of CFA Waveforms from Patients with Significant Femoro- 
Ponliteal Disease
5.3.1.1 Feature Results
As would be expected, the majority of the CFA waveforms in both the AAA and no 
AAA significant distal disease groups were ‘higher impedance’ due to the presence of 
the atherosclerotic disease. Just over half the waveforms in both groups were bi- 
phasic rather than triphasic. There were features in the waveforms characteristic of 
distal disease such as a reduced reverse flow component or a shoulder on the systolic
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down-stroke, but there were no additional features displayed in the waveforms that 
were more prominent in the AAA group that were different from the 5 features noted 
in Chapter 3. Therefore the waveforms were individually scored according to the 
presence of these 5 features with a score of 1 awarded if the feature was present in 
one or more cycles within the waveform. Figure 5.1 shows the number of CFA 
waveforms from the AAA and no AAA patient groups with significant femoro- 
popliteal (distal) disease with each feature present. Again, as for the no significant 
atherosclerotic disease groups, in general the combination of features present in the 
left and right CFA waveforms for the same patient were not always the same.
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Figure 5.1: Number o f CFA waveforms out o f the 30 AAA and 36 no AAA CFA waveforms in the 
significant distal arterial disease study groups with each feature present visually
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5.3.1.2 Description of Features
The feature of spectral broadening was present in 28 out of the 30 AAA waveforms 
and 24 out of the 36 no AAA waveforms. This is a much higher proportion in both the 
AAA and no AAA groups than for the waveforms in the no significant atherosclerotic 
disease groups in Chapter 3 (for which 37 out of the 60 AAA waveforms and 14 out 
of the 60 normal waveforms displayed increased spectral broadening). Examples of 
the waveform cycles from AAA and no AAA patients with significant distal disease 
displaying increased spectral broadening are shown in Figure 5.2 and Figure 5.3 
respectively. In some cases, the pattern of spectral broadening in the waveforms in 
patients with distal disease was different to that observed in the waveforms from 
patients with no significant arterial disease. The level of spectral broadening appeared 
to be increased and in some waveforms, the profile appeared to have a ‘shoulder’ on 
the profile of the systolic down-stroke which is characteristic to distal disease.
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Figures 5.2a-d: Examples o f spectral broadening on the systolic down-stroke in AAA patients with 
significant femoro-popliteal atherosclerotic arterial disease
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Figures 5.3a-d: Examples o f spectral broadening on the systolic down-stroke in no AAA patients with 
significant femoro-popliteal atherosclerotic arterial disease
The feature of a spiked profile in the spectral broadening in the downward slope of 
the systolic peak was present in 14 out of 30 AAA waveforms and 8 out of the 36 no 
AAA waveforms. Examples of waveform cycles from AAA and no AAA patients 
displaying the feature of spikes on the systolic down-stroke are shown in Figures 5.4 
and 5.5 respectively.
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Figures 5.4a-d: Examples o f spikes on the systolic down-stroke in AAA patients with significant 
femoro-popliteal atherosclerotic arterial disease
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Figures 5.5a-d: Examples o f spikes on the systolic down-stroke in no AAA patients with significant 
femoro-popliteal atherosclerotic arterial disease
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In general, the spikes in the no AAA waveforms were more subtle than in the AAA 
waveforms. The proportions of waveforms displaying spikes within both the AAA 
and no AAA distal disease groups were higher than for the groups with no significant 
atherosclerotic arterial disease in Chapter 3 (for the AAA group with no significant 
atherosclerotic disease 23 out of the 60 waveforms displayed spikes, for the normal 
patient group only 3 out of the 60 displayed spikes). The increase in the number of 
waveforms with spikes present, especially in the no AAA group may possibly be 
attributed to increased reflection of pressure due to the increase in distal impedance 
caused by the distal disease.
In general, due to the atherosclerotic disease, the reverse flow phases within the 
waveforms were reduced in both the AAA and no AAA groups, possibly due to the 
increased impedance to flow. This resulted in a ‘stumped’ appearance to the reverse 
flow phase as illustrated in Figures 5.3a and 5.3b. The feature of an irregular reverse 
flow pattern was present in 8 of the 30 AAA waveforms, this is a much lower 
proportion than in the AAA group with no significant disease in which half of the 
AAA waveforms displayed this feature. This may possibly be due to the reduction of 
the reverse flow component due to the increased impedance. As in Chapter 3, there 
were two types of irregularity noted in the reverse flow within the AAA patient group. 
The first, shown in Figure 5.6a illustrates an elongation of the reverse flow with an 
irregular profile with distinct spikes, the second, shown in Figure 5.6b illustrates an 
‘exaggerated’ reverse flow component with increased amplitude and distinct spikes.
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Figure 5.6 a and b: Examples o f irregular reverse flow patterns for AAA patients with significant 
femoro-popliteal atherosclerotic arterial disease
The irregular reverse flow pattern was present in 3 out of the 36 no AAA waveforms 
which is a similar proportion to that in the no AAA no significant atherosclerotic 
disease group. The irregularities were less distinct in these no AAA waveforms than 
in the AAA waveforms. An example of waveform cycles from a no AAA patient 
displaying irregular reverse flow is given in Figure 5.7.
Figure 5.7: Example o f irregular reverse flow pattern for no AAA patient with significant femoro-
popliteal atherosclerotic arterial disease
The feature of simultaneous forward and reverse flow was present in 13 out of the 30 
AAA waveforms and 4 out of the 36 no AAA waveforms. Examples of simultaneous 
forward and reverse flow in waveform cycles from AAA patients are given in Figure 
5.8. In comparison to the no significant atherosclerotic disease group in which 21 out 
of the 60 waveforms displayed this feature, the proportion of AAA waveforms with 
the feature in this disease group is slightly higher. The proportion of no AAA 
waveforms displaying this feature is also increased as only 1 out of the 60 waveforms 
in the no significant atherosclerotic disease group displayed simultaneous forward and 
reverse flow.
In this feature, low power reverse flow can be seen under the systolic peak, before the 
onset of the ‘true’ reverse flow component. This can possibly be attributed to flow 
disturbances occurring during the systolic flow phase. In Chapter 3, for patients with 
no significant atherosclerotic arterial disease, the flow disturbances could possibly be 
attributed to the presence of AAA. However the presence of atherosclerotic disease 
also disturbs the flow and this could explain why this feature is more prevalent in both 
the AAA and no AAA distal disease groups than in the no significant disease groups. 
Examples of this feature displayed in waveform cycles from a patient without AAA is 
given in Figure 5.9. Again, this feature was generally more pronounced in the AAA 
waveforms.
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Figure 5.8 a-b: Examples o f simultaneous forward and reverse flow in AAA waveforms with 
significant femoro-popliteal atherosclerotic arterial disease
Figure 5.9: Example o f simultaneous forward and reverse flow in a no AAA waveform with significant
femoro-popliteal atherosclerotic arterial disease
The feature of waveform elongation was present in only 4 out of the 30 AAA 
waveforms and was not present in any of the no AAA waveforms. An example of the 
elongation in AAA waveform cycles is given in Figure 5.10. There may be several 
reasons why waveform elongation is less prevalent in the significant atherosclerotic 
disease patients: the effect of minor atherosclerotic disease of the proximal arteries
reducing the amplitude of the flow at the CFA, the influence of distal impedance, and 
the removal of low amplitude reverse flow by the high pass ‘wall thump’ filter 
inherent in the system.
h---------------------------- H*
Figure 5.10: Example o f Elongation in AAA waveform with significant femoro-popliteal
atherosclerotic arterial disease
It can be seen in Figure 5.1, that the separation between the AAA and no AAA 
waveforms provided by identification of the 5 visual features is poorer than the 
separation provided by these features for the AAA and no AAA patients without 
significant atherosclerotic disease in Figure 3.12 (Chapter 3). The additional changes 
to the CFA waveforms caused by the presence of significant femoro-popliteal 
atherosclerotic disease, make it much more difficult to discriminate between CFA 
waveforms from patients with and without AAA by visual feature analysis. Each 
individual feature does show a level of discrimination, but there is no single feature 
that is characteristic to AAA. In the following section, the scores for the five 
waveform features were combined to determine whether AAA could be identified 
more successfully by detection based on the combination of the 5 visual features.
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5.3.1.3 AAA Detection in Patients with Significant Femoro-Popliteal Atherosclerotic 
Disease Using CFA Visual Feature Analysis
The same method that was applied to the patients in the no significant atherosclerotic 
disease groups in Chapter 3 was used to determine whether visual analysis of the CFA 
waveforms, based on a combination of the five visual features, could correctly detect 
AAA in the patients in the significant femoro-popliteal atherosclerotic disease groups. 
As for the no significant disease groups, the visual features present in the left and 
right CFA waveforms for each patient were not necessarily the same. This may be due 
to the different paths of the left and right iliac arteries, combined with differences in 
the pattern of proximal and distal atherosclerotic disease between the two sides. 
Therefore for each patient, the total scores for the waveforms from the left and right 
legs were summed to give a total patient score.
The total scores for the 15 AAA and 18 no AAA patients are plotted in Figures 5.1 la  
and 5.11b. The mean factor score per patient in the AAA group was 4.5 with a 
maximum score of 8 factors and a minimum score of 2 factors. The mean total factor 
score per patient in the no AAA group was 2.2 with a maximum score of 6 factors 
minimum score 0 factors. In comparison with the results obtained from the no 
significant disease groups, the mean score for the AAA group is similar but the mean 
score in the no AAA group is increased. This may be expected due to the increase in 
flow disturbances caused by the atherosclerotic disease, making it more difficult to 
differentiate between the two groups.
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Figure 5.1 la: Total Patient Scores for the 15 AAA patients with significant femoro-popliteal
atherosclerotic disease.
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Figure 5.11b: Total Patient Scores for the 18 no AAA patients with significant femoro-popliteal
atherosclerotic disease.
Following the method described in Chapter 3, the total patient scores were used to set 
a threshold level to best distinguish between the AAA and no AAA groups. Figure 
5.12 shows the number of AAA and no AAA patients with significant atherosclerotic
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disease of the femoro-popliteal arteries with >1, >2 and >3 features present. A 
threshold score level of >1 features per patient for a positive AAA, achieved an 
overall sensitivity of 100%, but a very low specificity of 16.6% for AAA detection. A 
threshold score level of >2 features per patient for a positive AAA, also achieved a 
sensitivity of 100%, with a low, but slightly improved specificity of 27.7% for AAA 
detection. A threshold score level of >3 features per patient for a positive AAA, 
reduced the overall sensitivity to 6 6 .6% with an increase in specificity to 61.1% for 
AAA detection. Therefore, as for the no significant disease patient groups the best 
threshold for AAA detection was a patient score of >2 as this provided 100% 
sensitivity with the higher level of specificity. The additional changes to the CFA 
waveforms caused by the significant femoro-popliteal atherosclerotic disease made it 
much more difficult to discriminate between patients with and without AAA by visual 
analysis of the CFA waveforms and therefore the specificity is low.
>1 >2
Total Score
>3
■ AAA with 
significamnt distal 
atherosclerotic 
disease
■ No AAA with 
significant distal 
atherosclerotic 
disease
Figure 5.12: Number o f  AAA (n=15) and no AAA (n=18) patients in the study groups with significant 
femoeo-popliteal atherosclerotic disease with total score >1, >2 and >3
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5.3.2 Visual Inspection of CFA Waveforms from Patients with Significant Proximal 
Atherosclerotic Disease
5.3.2.1 Feature Identification
Proximal disease was present for 8 out of the 11 AAA waveforms and 10 out of the 
14 no AAA waveforms from the 6 AAA and 7 no AAA patients in the significant 
proximal disease study groups. On visual inspection, all the CFA waveforms from the 
limbs with significant iliac disease were damped. 7 out of the 8 waveforms from 
patients with AAA, and 9 out of the 10 waveforms from patients without AAA were 
‘mono-phasic’. Examples of these mono-phasic waveform cycles are given in Figure 
5.13. It can be seen that there was no real differences between the profiles of the AAA 
and no AAA mono-phasic waveforms.
b)
Figure 5.13: Damped ‘mono-phasic’ CFA waveform with significant proximal disease and a) AAA
and b) No AAA.
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All the waveforms in both groups with proximal disease displayed the feature of 
spectral broadening. 2 out of the 8 AAA waveforms and 3 out of the 10 no AAA 
waveforms had the appearance of spikes on the down-stroke of the peak of the 
waveform cycle as illustrated in Figure 5.14. However, it is probably not possible for 
flow disturbances set up within an AAA to be transmitted through a tight iliac artery 
stenosis or through collateral arteries in the case of an iliac occlusion. Therefore, these 
features are more likely to be due to flow disturbances set up by proximal stenotic, 
local or distal disease rather than by an AAA.
Figure 5.14: Spikes on peak down-stroke o f damped waveform cycles for patients with significant 
proximal disease and a) AAA and b) No AAA
The feature of irregular reverse flow, as illustrated in Figure 5.15, was only present in 
2 out of the 8 AAA waveforms and was not exhibited in any of the 10 no AAA 
waveforms. The feature of simultaneous forward and reverse flow was present in 3 of 
the AAA waveforms and only 1 of the no AAA waveforms. This feature is illustrated 
for waveform cycles from AAA and no AAA patients in Figure 5.16 and is also 
illustrated in the waveform cycles from the AAA patient in Figure 5.15. None of the 
CFA waveforms in the proximal disease groups exhibited the feature of elongation.
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Figure 5.15: Irregular reverse flow pattern in AAA waveform cycle with significant proximal disease.
b)
Figure 5.16: Simultaneous forward and reverse flow in a) AAA and b) no AAA waveform cycles with
significant proximal disease.
It was not possible to determine whether the features observed in the AAA waveforms 
with proximal disease resulted from flow disturbances set up within the AAA, or 
whether they were caused by the presence of atherosclerotic disease. In the case of an 
occlusion of the iliac artery, the features in the CFA waveform are unlikely to be due 
to an AAA because the blood flow below the level of reconstitution is reliant upon 
collateral circulation. In the case of an iliac stenosis, the waveform changes are also 
more likely to be related to the flow disturbances associated with a stenosis rather 
than an AAA.
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5.3.2.2 AAA Detection in Patients with Significant Proximal Atherosclerotic Disease 
Using CFA Visual Feature Analysis
In order to determine the feasibility of detecting AAA by visual feature analysis of 
CFA waveforms for patients in the proximal atherosclerotic disease groups, the right 
and left CFA waveforms each patient (including the 3 waveforms in the AAA group 
and 4 waveforms in the no AAA group without proximal disease) were scored 
according to the presence of the 4 visual features discussed in the previous section. 
Figure 5.17 shows the number of CFA waveforms from the AAA and no AAA 
patients in the significant proximal atherosclerotic disease groups with each feature 
present. It can be seen that none of the features provide a good level of discrimination 
between the AAA and no AAA patients in these groups.
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Figure 5.17: Number o f  CFA waveforms out o f  11 AAA and 14 no AAA CFA waveforms in the 
significant proximal atherosclerotic disease groups with each feature present visually
193
Again, the total scores for the CFA waveforms from the left and right legs were 
summed to give a total factor score per patient to try and improve the discrimination. 
The total scores for the 6 AAA and 7 no AAA patients are plotted in Figures 5.18a 
and 5.18b. The mean factor score per patient in the AAA group was 3.5 with a 
maximum score of 4 factors and a minimum score of 2 factors. The mean total factor 
score per patient in the no AAA group was 2.6 with a maximum score of 4 factors and 
a minimum score of 2 factors.
The mean score for this proximal disease AAA group is lower than the mean scores 
for the no significant disease and significant distal disease AAA groups. This may be 
because the features in the waveforms related to AAA flow disturbances are not 
transmitted through an iliac stenosis or collateral vessels. The mean score in the no 
AAA proximal disease group is slightly increased and this is most likely to be due to 
the increased spectral broadening and other features related to the flow disturbances 
caused by atherosclerotic disease.
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Figure 5.18a: Total Patient Scores for the 6 AAA patients with significant proximal atherosclerotic
disease.
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Figure 5.18b: Total Patient Scores for the 7 no AAA patients with significant proximal atherosclerotic
disease.
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Again, the threshold levels of >1, >2 and >3 were applied to the total patient score. 
The results are plotted in Figure 5.19. The threshold score levels of >1 and >2 features 
per patient for a positive AAA, achieved an overall sensitivity of 100% but with no 
specificity for AAA detection. A threshold score level of >3 features per patient for a 
positive AAA, improved the specificity to 57.1% but the sensitivity decreased to 
83.3%. Therefore this technique did not provide adequate discrimination between 
AAA and no AAA patients to be able to detect AAA in patients with significant 
disease of the iliac arteries. This is most likely to be because the flow disturbances 
that may be set up by an AAA are probably not transmitted past significant iliac 
disease, and flow disturbances set up as a result of the atherosclerotic disease in both 
the AAA and no AAA groups make it almost impossible to discriminate between 
AAA and no AAA patients with significant proximal disease by visual analysis of the 
CFA waveform.
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Figure 5.19: Number o f AAA (n=6) and no AAA (n=7) patients with significant proximal 
atherosclerotic disease with >1, >2 and >3 features present.
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5,4 Discussion
Visual analysis of the CFA waveforms from patients in the study groups with 
significant atherosclerotic disease of the femoro-popliteal arteries has shown that the 
5 features noted visually in patients with AAA, but no significant aorto-iliac or 
femoro-popliteal atherosclerotic disease, are also present in the waveforms from 
patients with significant femoro-popliteal disease. For the patients studied in Chapter 
3 with no significant atherosclerotic disease, it was possible to attribute the changes 
noted in the waveforms from patients with AAA to the flow disturbances set up 
within the AAA. However, in patients with atherosclerotic disease of the lower limb 
arteries, flow disturbances are also set up by the presence of atheromatous plaques 
and occlusions. All patients in the significant distal disease groups had at least one 
significant stenosis or occlusion of the femoro-popliteal arteries. In addition, the 
majority of patients also had extensive, diffuse calcification on the arterial walls 
throughout the iliac and femoro-popliteal arteries that may also disturb the blood 
flow. Therefore, in patients with AAA and significant atherosclerotic disease of the 
femoro-popliteal arteries, it was not possible to attribute the waveform changes solely 
to the AAA. Many of the waveforms from patients without AAA with significant 
distal disease also displayed similar changes. Therefore visual analysis of the CFA 
waveforms based on the 5 features of spectral broadening on the systolic down stroke, 
the appearance of spikes on the systolic down stroke, an irregular reverse flow 
pattern, simultaneous forward and reverse flow during systole and elongation of the 
waveform during the cardiac cycle, provided sensitivity to AAA of 100% but with a 
low specificity of 27.7% due to additional flow disturbances set up by atherosclerotic 
lesions.
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Visual analysis of CFA waveforms from AAA and no AAA patients with significant 
iliac artery disease showed that the 5 features displayed in the no significant arterial 
disease and significant distal disease groups were almost completely removed. The 
features that were present in the waveforms were more likely to be set up by the 
atherosclerotic arterial disease rather than AAA. It was therefore not possible to 
adequately discriminate between the AAA and no AAA patients with significant 
disease of the iliac arteries by visual feature analysis of the CFA waveform.
The additional changes to the CFA waveforms set up in the presence of significant 
iliac or femoro-popliteal atherosclerotic disease made it much more difficult to 
discriminate between patients with and without AAA by visual analysis of the CFA 
waveforms. Because visual analysis is subjective, it was aimed in Chapter 6 of this 
thesis to improve on the specificity by performing more objective analysis on these 
data sets using the MATLAB based AAA detection program designed in Chapter 4.
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Chapter 6: Objective Analysis of CFA Waveforms from AAA and No AAA
Patients with Significant Atherosclerotic Disease using MATLAB Software
6,1 Introduction and Aim
In Chapter 4, the MATLAB based program to detect AAA by analysis of CFA 
waveform features produced excellent results for patients with no significant 
atherosclerotic iliac or femoro-popliteal disease. The aim of the work in this chapter 
was to apply this method to objectively analyse the CFA waveforms from patients 
with significant iliac or femoro-popliteal atherosclerotic arterial disease, based on the 
features noted in visual inspection of the waveforms in Chapter 5, to try and improve 
on the results achieved for AAA detection by the visual analysis method.
In the first stage of the work, described in section 6.2 of this chapter, the CFA 
waveform files from the patients with and without AAA in the study groups with 
significant femoro-popliteal atherosclerotic disease were subjected to the AAA 
detection program that was designed and tested for patients without significant 
atherosclerotic disease in Chapter 4. Based on the outcome, in section 6.3, the 
selection of indices and threshold levels implemented by the detection program were 
adjusted to try to improve the performance of the program for these patients. In 
section 6.4, the performance of the modified detection program for the AAA and no 
AAA patient study groups with significant femoro-popliteal arterial disease is 
discussed. In section 6.5, the performance of the modified detection program was 
tested by its response to the blind test sets of waveform data from the AAA and no 
AAA patients with significant femoro-popliteal atherosclerotic disease that were
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separated into the test groups. In section 6.6, the CFA waveforms from patients with 
and without AAA with significant iliac disease were subjected to the program. A 
discussion of the results and performance of the AAA detection program are given in 
section 6.7.
6.2 Performance of the AAA Detection Program for Patients with Significant 
Femoro-Popliteal Atherosclerotic Disease
In order to test the performance of the AAA detection program for patients with 
significant femoro-popliteal atherosclerotic disease, the CSV CFA waveform files 
from the 15 AAA and 18 no AAA patients in the study groups with significant 
femoro-popliteal disease were subjected to the program.
6.2.1 Preliminary Tests
Before the waveforms were subjected to the AAA detection program, the initial data 
processing implemented by the program (described in section 4.3) was performed on 
each waveform file individually to ensure the program functioned correctly for each 
waveform. The sample regions for the automatic thresholding for background noise 
reduction were plotted to check their position. The maximum, minimum and 
bandwidth envelopes were plotted and visually inspected. The location markers to 
indicate the systolic peak and pulse foot, and the start and end of the reverse flow 
phases were plotted and superimposed on the spectrogram to check their position.
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The initial data processing operated correctly for all of the waveform files in the AAA 
and no AAA significant femoro-popliteal disease study groups.
6.2.2 Initial AAA Detection Program Performance Results
The left and right CFA waveforms from the 15 AAA and 18 no AAA patients were 
entered automatically into the AAA detection program in sequence. The individual 
scores that were calculated by the program for these patients are plotted in Figures 
6.1a and 6.1b respectively. The mean score per patient in the AAA group was 5.1 
with a maximum score of 10 and a minimum score of 3 factors. The mean score per 
patient in the no AAA group was 4.8 with a maximum score of 9 and minimum score 
of 0. These results were compared to those obtained for the no significant 
atherosclerotic disease study groups in Chapter 4 (Section 4.6). The mean score of 5.1 
in the AAA distal disease group is slightly higher than the mean score of 4.8 in the 
AAA with no significant disease group. The mean score in the no AAA distal disease 
group of 4.8 is significantly higher than the mean score of 1.2 in the normal group.
Figure 6.2 shows the number of AAA and no AAA patients with >1, >2 and >3 
features present.
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Figure 6.1a: Total Patient Scores for the 15 AAA patients with significant femoro-popliteal
atherosclerotic disease.
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Figure 6.1b: Total Patient Scores for the 18 No AAA patients with significant femoro-popliteal
atherosclerotic disease.
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Figure 6.2: Number o f  AAA (n=15) and no AAA (n=18) patients with significant femoro-popliteal 
atherosclerotic disease with >1, >2 and >3 features present.
6.2.3 Initial Program Results: Discussion
The increase in the patient scores was expected from the results of the visual analysis 
of the distal disease group waveforms in Chapter 5, and may possibly be explained by 
additional flow disturbances set up by the atherosclerotic disease.
The discrimination between the AAA and no AAA patients with significant femoro- 
popliteal disease that was achieved by the program using the threshold level of >2 on 
the patient scores between the AAA and no AAA distal disease groups was much 
poorer than was achieved for the no significant disease group.
The threshold score levels of >1 and >2 achieved a sensitivity of 100% with but with 
very low specificities of 5.6% and 11.1% respectively. The threshold score level of
204
>3 maintained the sensitivity of 100% and specificity increased to 33.3% for AAA 
detection. Although the discrimination level is low, the threshold level of >3 did 
improve on the specificity of 27.7% achieved in the visual inspection for the group in 
Chapter 5. However, the presence of significant atherosclerotic disease made it much 
more difficult to separate the two groups by both visual and MATLAB based 
identification of waveform features.
6.3 Optimisation of the AAA Detection Program for Patients with Significant 
Femoro-Popliteal Atherosclerotic Disease
In order to try to improve the discrimination between the AAA and no AAA patients 
in the significant femoro-popliteal atherosclerotic disease groups, the levels for each 
of the 6 indices calculated by the AAA detection program (1) Maximum Systolic 
Down-Stroke Bandwidth Index, 2) Systolic Spike Index, 3) Reverse Power Density 
Index, 4) Reverse to Systolic Height Ratio Index, 5) Integral Reverse Power Under 
Systolic Upstroke Index, 6) Integral Reverse Power Under Systolic Down-Stroke 
Index) for the left and right CFA waveforms from the 15 AAA and 18 no AAA 
patients in the significant Femoro-Popliteal disease groups were plotted and visually 
inspected. The aims were: 1) to determine whether the indices were suitable for the 
waveforms in these groups; and 2) to determine whether the threshold levels for the 
indices set by the original program provided adequate discrimination between the 
groups, or whether the level could be improved by adjusting the threshold levels.
A new MATLAB program referred to as the ‘disease group AAA detection program’ 
was set up to test different combinations of the indices, threshold levels and weighting
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factors with the aim of improving on the performance of the original program for the 
significant distal disease patients. This new program operated in the same way as the 
original AAA detection program as described in Figure 4.22 (Chapter 4, Section 4.6).
6.3.1 Maximum Systolic Down-Stroke Bandwidth Index in the Distal Disease Groups
The Maximum Systolic Down-Stroke Bandwidth Index levels for the left and right 
CFA waveforms for the 15 AAA and 18 no AAA patients in the significant distal 
disease study groups are plotted in Figure 6.3a. The threshold level set by the original 
AAA detection program is indicated by the dotted black line.
The range of levels for this index within these two study groups is similar to the range 
in the no significant disease study groups plotted in Figure 4.12 (Chapter 4). The 
index level for 43.3% of AAA (13 out of 30) waveforms and 27% of no AAA (10 out 
of 36) waveforms in the distal disease groups lay above the threshold of 0.76. This 
discrimination level is not as good as it was for the no significant disease groups for 
which 55% of AAA (33 out of 60) waveforms and 26.7% of normal (16 out of 60) 
waveforms lay above the threshold.
On visual inspection of Figure 6.3a the threshold is reasonably well placed. However, 
to increase the discrimination between the AAA and no AAA distal disease groups a 
number of different, increased, threshold levels were tested in the disease group AAA 
detection program index combinations. The best level of discrimination was provided 
with a threshold level of 0.80 as indicated by the dotted green line.
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Figure 6.3a: Maximum Systolic Down-Stroke Bandwidth Index plotted for the left and right CFA waveforms for the 15 AAA and 18 no AAA patients in the
significant femoro-popliteal atherosclerotic disease study groups.
6.3.2 Systolic Spike Index in the Distal Disease Groups
The Systolic Spike Index levels for the left and right CFA waveforms from the 15 
AAA and 18 no AAA patients in the significant distal disease study groups are plotted 
in Figures 6.3b and 6.3c. This index provided excellent discrimination between AAA 
and normal patients with no significant disease with 41.7% (25 out of 60) AAA and 
only 3.3% (2 out of 60) normal waveforms above the threshold of >0.5. 
Unfortunately, the discrimination by this index threshold for the distal disease group 
was much poorer with 56.6% (17 out of 30) of AAA and 41.7% (15 out of 36) of no 
AAA waveforms above the threshold. On visual inspection of graphs 6.3b and 6.3c, 
altering the threshold level does not greatly improve the discrimination. The problem 
was that the increase in the distal impedance resulting from the presence of significant 
distal disease can cause a fluctuation or ‘shoulder’ on the systolic down-stroke which 
may manifest as a ‘spike’. A number of different conditions for the classification of a 
spike by the program including the spike height, length and position were tested to try 
to differentiate between the ‘spikes’ present on AAA and no AAA waveforms. The 
problem was that the spike profiles in both groups do have a very similar appearance 
as illustrated in Figures 5.4 and 5.5 in Chapter 5. Therefore it was not possible to 
improve on the discrimination level achieved by the original conditions and threshold. 
A number of different threshold levels were tested in the disease group AAA 
detection program combinations but it was not possible to improve on the 
discrimination levels provided by the original levels. Therefore the calculation 
method, threshold level and weighting factor for the systolic spike index in the disease 
group AAA detection program were not adjusted.
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Figure 6.3b: Systolic Spike Index plotted for the left and right CFA waveforms for the 15 AAA patients in the significant femoro-popliteal atherosclerotic
disease study group.
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Figure 6.3c: Systolic Spike Index plotted for the left and right CFA waveforms for the 18 no AAA patients in the significant femoro-popliteal atherosclerotic
disease study group.
6.3.3 Reverse Power Density Index in the Distal Disease Groups
The Reverse Power Density Index provided a good level of discrimination for the no 
significant atherosclerotic disease groups in Chapter 4. In general, for these patients, 
the index was lower for the AAA waveforms than for normal waveforms. This was 
possibly explained by an elongation of the reverse flow component. The index levels 
for 30% (18 out of 60) of AAA and only 8.3% (5 out of 60) of normal waveforms in 
the no significant atherosclerotic disease study groups were below the threshold of 
4.2. This index is plotted for the left and right CFA waveforms for the 15 AAA and 
18 no AAA patients in the significant distal atherosclerotic disease groups in Figure 
6.3d. On visual inspection it is much more difficult to separate the waveforms in the 
AAA and no AAA significant distal disease groups using this index. The majority of 
the waveforms in both the AAA and no AAA distal disease study groups have a low 
power density. However, there are also several waveforms in each group with a 
relatively high power density in the reverse flow. In the visual inspection of the 
significant distal disease waveforms in Chapter 5, many waveforms had a reduced 
reverse flow component with a ‘stumped’ appearance. This ‘compression’ of the 
reverse flow region may explain the increased power density for some of the distal 
disease waveforms. The conflicting features in the reverse flow components for 
different AAA and no AAA waveforms made it difficult to discriminate between the 
AAA and no AAA patients with significant distal disease using this index. In some 
cases the power density was low due to ‘elongation’ of the reverse flow phase and in 
other cases the power density was increased due to ‘compression’ of the reverse flow 
phase. Therefore this index calculation was removed from the disease AAA detection 
program.
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Figure 6.3d Reverse Power Density Index plotted for the left and right CFA waveforms for the 15 AAA and 18 no AAA patients in the significant femoro-
popliteal atherosclerotic disease study groups.
6.3.4 Reverse to Systolic Height Ratio Index in the Distal Disease Groups
The levels of the Reverse to Systolic Height Ratio Index are plotted for the left and 
right CFA waveforms from the 15 AAA and 18 no AAA patients in the significant 
distal disease study groups in Figure 6.3e. In the no significant atherosclerotic disease 
groups the height ratio was increased in some AAA patients due to the presence of 
spikes in the reverse flow profile. However, in the distal disease group there were 
waveforms in both groups which had an increased height ratio, but also several which 
had a decreased height ratio compared to the majority. The general decrease in reverse 
flow height could possibly be explained by the reduction of the reverse flow 
component due to the increased impedance caused by the atherosclerotic disease. On 
inspection of Figure 6.3e, there are more AAA waveforms with a height ratio index 
above the bulk of the group than below. In general the index is slightly lower in both 
the distal disease groups than in the no significant disease groups. Therefore the 
original threshold of >5.2 was possibly slightly too high, and the threshold level was 
reduced. After testing a number of different, reduced, threshold levels in the disease 
group AAA detection program, a new threshold of >4.2 (as indicated by the dotted 
green line on the graph) was set. The index levels for 7 out of the 30 AAA waveforms 
and 4 out of the 36 no AAA waveforms in the significant distal disease study groups 
were above this new threshold level.
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Figure 6.3e Reverse to Systolic Height Ratio Index plotted for the left and right CFA waveforms for the 15 AAA and 18 no AAA patients in the significant
femoro-popliteal atherosclerotic disease study groups.
6.3.5 Integral of Reverse Power Under Systolic Upstroke Index in the Distal Disease
Groups
The levels of the Integral of the Reverse Power Under the Systolic Upstroke Index for 
the left and right CFA waveforms from the 15 AAA and 18 no AAA patients in the 
distal disease study groups are plotted in Figure 6.3f. This index provided a good 
level of discrimination in the no significant disease groups with 41.7% of AAA (25 
out of 60) and only 11.7% of normal (7 out of 60) waveforms having index levels 
above the threshold of 0.025. In the distal disease groups the index level for 33.3% of 
AAA (10 out of 30) and 44% of no AAA (16 out of 36) waveforms were above the 
threshold. Therefore this threshold level did not produce any real discrimination 
between the two patient groups.
In the no significant disease groups the presence of reverse flow under the systolic 
peak was attributed to the presence of flow disturbances in the bulk forward flow 
during the systolic upstroke phase. For the AAA waveforms the disturbances were in­
part attributed to flow disturbances set up within the AAA. The significant increase in 
the presence of reverse flow under the systolic upstroke in the waveforms from 
patients without AAA with significant distal atherosclerotic disease may be attributed 
to flow disturbances set up by the presence of the atherosclerotic disease.
On visual inspection of Figure 6.3f, the discrimination between the AAA and no AAA 
groups may be improved by increasing the threshold level. The index was included in 
the index combinations in the AAA disease detection program and a number of 
increased threshold levels were tested.
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The threshold level was increased to 0.1 (as indicated by the dotted green line on the 
graph. The index levels for 23.3% (7 out of 30) of AAA waveforms and 16.7% (6 out 
of 36) of the no AAA waveforms in the significant distal disease study groups were 
above this new threshold level.
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Figure 6.3f: Integral o f the Reverse Power Under the Systolic Upstroke Index plotted for the left and right CFA waveforms for the 15 AAA and 18 normal
patients in the significant femoro-popliteal atherosclerotic disease study groups.
6.3.6 Integral of Reverse Power Under Systolic Down-Stroke Index in the Distal
Disease Groups
The levels of the Integral of the Reverse Power Under the Systolic Down-Stroke 
Index for the left and right CFA waveforms from the 15 AAA and 18 no AAA 
patients in the distal disease study groups are plotted in Figure 6.3g. This index 
provided a good level of discrimination in the no significant disease groups with 
16.7% of AAA (10 out of 60) and 8.3% of normal (5 out of 60) waveforms having 
index levels above the threshold of 1.5. However, this threshold did not provide any 
real discrimination between the AAA and no AAA distal disease groups study groups 
with index levels for 10% of AAA (3 out of 30) and 8.3% % of no AAA (3 out of 36) 
waveforms above the threshold.
The feature of reverse flow occurring under the systolic down-stroke possibly results 
from flow disturbances occurring during the deceleration of the bulk forward flow. 
The feature of simultanous forward and reverse flow was quite prominent in the 
visual inspections of the waveforms in Chapter 5. Therefore this index was included 
in the disease AAA detection program. In order to try and improve the discrimination 
level, a number of reduced threshold levels were tested in the program. The best 
discrimination level was achieved with a reduced threshold level of 1.25 as indicated 
by the dotted green line.
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Figure 6.3g: Integral of the Reverse Power Under the Systolic Down-Stroke Index plotted for the left and right CFA waveforms for the 15 AAA and 18 normal
patients in the significant femoro-popliteal atherosclerotic disease study groups.
6.4 Disease AAA Detection Program
The indices, threshold levels and the weighting factors that provided the best 
performance for AAA detection in the significant femoro-popliteal (distal) disease 
study groups are summarised in Table 6.1.
Index ThresholdLevel
Weighting
Factor
Maximum Systolic Down- 
Stroke Bandwidth Index >0.80 1
Systolic Spike Index >0.5 2
Reverse to Systolic Height 
Ratio Index >0.42 1
Integral Reverse Power 
under Systolic Upstroke 
Index
>0.1 1
Integral Reverse Power 
under Systolic down 
stroke Index
>1.25 1
Table 6.1: Indices with corresponding threshold levels and weighting factors giving the best 
discrimination between AAA and No AAA patients in the significant distal disease study groups
6.4.1 Disease AAA Detection Program Study Groups’ Results
The individual scores output by the new disease AAA detection program 
implementing the above combination of indices for the 15 AAA and 18 no AAA 
patients with significant femoro-popliteal occlusive disease are plotted in Figures 6.4a 
and 6.4b respectively.
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Figure 6.4a: Total Patient Scores for the 15 AAA patients with significant femoro-popliteal
atherosclerotic disease.
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Figure 6.4b: Total Patient Scores for the 18 no AAA patients with significant femoro-popliteal
atherosclerotic disease.
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Figure 6.5 shows the number of AAA and no AAA significant distal disease patients 
with total scores >1, >2 and >3 calculated by the new disease AAA detection 
program.
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significant 
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Figure 6.5: Number o f AAA (n=15) and no AAA (n=18) patients with significant femoro-popliteal 
atherosclerotic disease with >1, >2 and >3 features present.
6.4.2 Disease AAA Detection Program Study groups’ Results: Discussion
The mean score per patient in the AAA group was 4.1 with a maximum score of 8 and 
a minimum score of 2 factors. The mean score per patient in the no AAA group was 
2.9 with a maximum score of 8 and a minimum score of 0. In comparison of these 
results to the results obtained from the original AAA detection program for the distal
2 2 2
disease study groups, the mean scores in each group are lower. The mean score in the 
AAA group is reduced by 1.0 and the mean score in the no AAA group is reduced by 
1.9. The difference between the mean scores of the two groups is increased from 0.3 
to 1.9. However, this is still lower than the difference of 3.6 between the means of the 
AAA and normal patient groups with no significant atherosclerotic disease.
The threshold score level of >1 provided a sensitivity of 100% with but with a low 
specificity of 22.2%. The threshold score level of >2 provided a sensitivity of 100% 
with an improved specificity of 33.3%. The threshold score level of >3 reduced the 
sensitivity to 80% with a specificity of 38.9%. Therefore, the threshold level of >2 on 
the patient score again provided the best result. The specificity of 33.3% is equivalent 
to that achieved by the original A A A  detection program with an increased threshold 
of >3 on the patient score. This is a slight improvement on the specificity attained 
form the visual analysis of the distal disease group waveforms in Chapter 5 of 27.7%. 
The indices and threshold levels selected for the disease A A A  detection program are 
probably more applicable to the distal disease groups than those in the original AAA 
detection program.
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6.5 Response of Disease AAA Detection Program to Blind Test Groups
The performance of the new disease AAA detection program was tested by subjecting 
the waveforms from the 3 AAA and 4 no AAA patients with significant distal disease 
in the blind test groups that were separated at the start of the study (summarised in 
Table A3.2, Appendix 3 and A4.2, Appendix 4). The 5 indices are plotted for the left 
and right CFA waveforms for the AAA and no AAA test group patients in Figures 
6.6a to 6.6f. The dotted lines indicate the threshold levels set by the disease AAA 
detection program.
For the Maximum Systolic Down-Stroke Bandwidth Index, 1 waveform in each group 
had an index level above the threshold of 0.80. For the Systolic Spike Index, 3 
waveforms in each group had an index level above the threshold of 0.5. For the 
Reverse to Systolic Height Ratio Index, 1 of the AAA waveforms and none of the no 
AAA waveforms lay above the threshold level of 4.2. For the Integral Reverse Power 
Under Systolic Upstroke Index 1 AAA waveform and 2 no AAA waveforms had an 
Index level above the threshold of 0.10. For the Integral Reverse Power Under 
Systolic Down-Stroke Index none of the AAA waveforms and 3 of the no AAA 
waveforms had an index level above the threshold of 1.25.
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Figure 6.6a: Maximum Systolic Down-Stroke Bandwidth Index plotted for the left and right CFA waveforms from the 3 AAA and 4 normal patients in the distal
disease test groups.
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Figure 6.6b: Systolic Spike Index plotted for the left and right CFA waveforms from the 3 AAA patients in the distal disease test group.
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Figure 6.6c: Systolic Spike Index plotted for the left and right CFA waveforms from the 4 normal patients in the distal disease test group.
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disease test groups.
In
te
rg
al
 o
f 
Re
ve
rs
e 
Po
we
r 
Un
de
r 
Sy
st
ol
ic 
Up
st
ro
ke
 
In
de
x
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
+
+
+
+
+
+
+
+
+
+
AAA with significant 
+  femoro-popliteal
atherosclerotic disease
No AAA with significant 
+  femoro-popliteal
atherosclerotic disease
Patient (Left and Right CFA Waveform)
Figure 6.6e Integral of Reverse Power Under Systolic Upstroke Index plotted for the left and right CFA waveforms from the 3 AAA and 4 normal patients in the
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6.5.1 Blind Test Groups’ Results
The individual scores for each of the 3 AAA and 4 no AAA test group patients output 
by the disease AAA detection program are plotted in Figures 6.7a and 6.7b. The mean 
score per patient in the AAA test group was 2.7 with a maximum score o f 3 and a 
minimum score of 2. The mean score per patient in the no AAA test group was 3.3 
with a maximum score of 5 and a minimum score of 1.
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Figure 6.7a: Total Patient Scores for the 3 AAA distal disease test group patients
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Figure 6.7b: Total Patient Scores for the 4 no AAA distal disease test group patients
231
The number of test patients with total patient scores of >1, >2 and >3 are plotted in 
Figure 6.8.
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Test Group
>1 >2 >3
Total Score
Figure 6.8: Number o f AAA (n=3) and no AAA (n=4) patients in the distal disease test groups with
total patient scores o f >1, >2 and >3
6.5.2 Blind Test Groups’ Results: Discussion
For the threshold on the patient score of >2 for a positive AAA diagnosis the AAA 
detection program correctly ‘identified’ 100% (3 out of 3) of the test AAA patients as 
having an AAA and correctly ‘identified’ 75% ( 3 out of 4) of the no AAA test 
patients as not having an AAA. It is promising that all of the AAA patients and one of 
the no AAA patients were correctly diagnosed, but it was not really possible with 
such limited patient numbers in the test groups to measure the performance of the 
program.
------ 1 !" ■ P
232
6.6 AAA Detection Program for Patients with Significant Iliac Atherosclerotic 
Disease
The visual analysis of the CFA waveforms in Chapter 5 showed that the 5 features 
present in the no significant atherosclerotic disease and significant femoro-popliteal 
atherosclerotic disease groups were almost completely removed by the presence of 
significant atherosclerotic iliac (proximal) disease. Visual identification of these 
features for the 6 AAA and 7 no AAA patients with significant proximal disease did 
not provide any separation between the AAA and no AAA patients for a sensitivity of 
100%. In order to test the performance of the AAA detection program for patients 
with significant proximal atherosclerotic disease the CFA waveforms from the 6 AAA 
and 7 no AAA patients in the study groups were subjected to the disease AAA 
detection program.
Unfortunately, the AAA and disease AAA detection programs did not run for the 
waveforms with proximal disease because the pulse foot at the end of the systolic 
peak could not be located with the criteria set by the program. This was due to the 
fact that the waveforms were very damped. However, because the features which 
seemed to be characteristic to AAA were almost completely removed from the CFA 
waveforms in the presence of significant proximal disease in the visual inspections, it 
was decided to let the program ‘break’ if the pulse foot of the systolic down-stroke 
could not be located. If this system was implemented as a screening tool, this would 
indicate the need for further investigation of the patient. Further investigation of the 
disease state of the aorto-iliac and femoro-popliteal arteries would be necessary 
regardless of whether the patient had an AAA.
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From experience in the Doppler Ultrasound department at UHW, approximately 25% 
of patients with significant lower limb arterial disease have significant proximal 
disease. Studies indicate the prevalence of significant lower limb PAD in the general 
population is around 12%. From the estimate of 25% for the prevalence of significant 
proximal disease, this would only involve around 3% of the general population. 
Therefore, because the proportion of the population with significant aorto-iliac 
disease is very low, the inability of the disease detection program to function for these 
patients may not be critical to the overall performance of the program as a screening 
tool.
6.7 Discussion
In this chapter, two different MATLAB programs were tested on patients with and 
without AAA with significant femoro-popliteal atherosclerotic disease. The aim was 
to determine whether AAA could be detected in these patients by automatic, objective 
analysis of the CFA waveforms. The additional changes to the CFA waveforms set up 
in the presence of significant femoro-popliteal atherosclerotic disease made it much 
more difficult to discriminate between patients with and without AAA, even with an 
objective analysis method. The original AAA detection program, with a threshold of 
>2 placed on the total patient score, provided a sensitivity of 100% and a specificity 
of only 11.1 % for AAA detection. The specificity was increased to 33.3% with an 
increased threshold of >3 placed on the total patient score. Inspection of the plots of 
the 6 indices showed that the reverse power density index was unsuitable and that the 
discrimination between the groups by the five remaining indices could be improved 
by adjustment of the set threshold levels.
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The new ‘disease AAA detection program’ combined the 5 indices: 1) Maximum 
Systolic Down-Stroke Bandwidth Index, 2) Systolic Spike Index, 3) Reverse to 
Systolic Height Ratio Index, 4) Integral Reverse Power Under Systolic Upstroke 
Index and 5) Integral Reverse Power Under Systolic Down-Stroke Index with 
adjusted threshold levels. This program achieved a sensitivity of 100% and a 
specificity of 33.3% for AAA detection in patients with significant femoro-popliteal 
atherosclerotic disease. This improved on the specificity of 11.1% achieved by the 
original AAA detection program, and marginally improved on the specificity level of 
27.7% achieved in the visual inspection of the waveforms in Chapter 5. The indices 
and threshold levels implemented by the disease AAA detection program were also 
more applicable to the waveforms in the distal disease patient groups.
If the AAA detection programs were to be implemented as a method for screening for 
AAA, it may be possible to combine the use of the 2 programs with a technique such 
as an ABPI measurement to assess whether the patient has significant PAD. If the 
ABPI measurement was normal, the original program could be implemented to 
analyse the CFA waveforms. If the ABPI measurement indicated significant disease, 
the Disease AAA program described in this chapter could be implemented.
The relatively poor specificity achieved for patients with significant atherosclerotic 
disease may not be critical to the overall performance of the combined screening 
method. If these results are projected onto the general population with no significant 
aorto-iliac or femoro-popliteal occlusive arterial disease, this gives a sensitivity of 
100% and specificity of around 73% for 88% of the general population, assuming the 
prevalence of lower limb PAD is around 12%.
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The screening studies for AAA indicate that a single scan would be performed on all 
males of 65 years old. PAD is a progressive disease, and studies indicate that the 
prevalence of PAD is around 7% for those aged 60-69 years old and around 23% for 
those aged over 80 years old (Fowkes, Housley et al. 1991; Ostchega, Paulose-Ram et 
al. 2007). Therefore, if  this AAA detection technique was applied as an AAA 
screening technique in 65 year olds, it would provide a sensitivity of around 100% 
and specificity of around 70% for 93% of the screened population. In the remaining 
7% of the screened population with significant atherosclerotic arterial disease, around 
25% (1.75% of the screened population) would have significant proximal disease and 
would automatically require further investigation of the aorto-iliac and femoro- 
popliteal arteries. For the remaining 5.25% of the screened population with significant 
femoro-poplital disease, the disease AAA detection program would provide a 
sensitivity of around 100% with a specificity of around 33%. If the original AAA 
detection program was used for the population with no significant disease and the 
disease AAA detection program was used for the population with significant 
atherosclerotic disease, combining the outcomes for the no significant disease, distal 
and proximal disease groups gives an overall sensitivity of around 100% and an 
overall specificity of around 70% to AAA detection in the screened population.
If the outcomes for the original AAA detection program (with a threshold on the total 
patient score of >2) are projected onto the screened population, the sensitivity to AAA 
would be very high (around 100%). The specificity for the 93% of the screened 
population without significant atherosclerotic disease would be around 73%. The 
specificity for the small proportion (-7%) of the population with significant
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atherosclerotic disease would only be around 11%. Hence, the overall specificity for 
the screened population would be around 68%.
Further work would be necessary to determine the feasibility of implementing the two 
AAA detection programs in conjunction with a simple method for arterial disease 
detection such as an ABPI measurement. Although the combined method may provide 
a slightly better specificity to AAA in the screened population than the original AAA 
detection program. For a practical view point, the implementation of the single 
program would be much simpler and because such a small percentage (-7%) of the 
screened population would have significant PAD, the reduction of around 2% in 
specificity may not be critical to the overall performance of the device in a screening 
programme.
The sensitivity and specificity levels provided by both the combined and single AAA 
detection programs are adequate for a tool to screen for AAA and indicate that 
objective analysis of CFA waveform features is a promising, alternative technique to 
conventional ultrasound for AAA detection.
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Chapter 7: Characterisation of AAA In Patients with No Significant 
Atherosclerotic Arterial Disease
7.1 Introduction and Aim
The AAA modelling studies reviewed in Chapter 1 indicated that disturbed and 
possibly turbulent flows occur within AAAs, and that these disturbances may be 
translated distally. The primary aim of this research was to develop a method to detect 
AAA by analysis of the CFA waveform. The MATLAB based AAA detection 
program described in Chapter 4 was capable of detecting AAA with 100% sensitivity 
and around 70% specificity for patients without significant iliac or femoro-popliteal 
atherosclerotic arterial disease. The modelling studies also indicated that the flow 
disturbances set up within AAA models are dependant upon the AAA size and shape. 
The aim of the work described in this chapter was to determine whether, in addition to 
detecting AAA, the information provided by the AAA detection program could also 
be used to provide information on the physical characteristics of the AAA such as the 
AAA size and the presence of ILT. This information is useful to the clinician when 
determining the optimum management path and treatment options.
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7.2 Method
The cohort for this section of work was the group of 37 patients with AAA but no 
significant atherosclerotic arterial disease (30 patients in the study group, plus the 7 
patients in the test group).
In the first section of the work, the AAA size and presence of intra-luminal thrombus 
were plotted against the total scores for each patient calculated by the AAA Detection 
Program. Linear regression analysis was applied to determine whether there was any 
correlation between the AAA size and the presence of ILT with the program results.
The aim of the second section of the work was to investigate whether there was any 
correlation between each of the 6 individual indices: 1) Maximum Systolic Down- 
Stroke Bandwidth Index, 2) Systolic Spike Index, 3) Reverse to Systolic Height Ratio 
Index, 4) Reverse Power Density Index, 5) Integral Reverse Power Under Systolic 
Upstroke Index and 6) Integral Reverse Power Under Systolic Down-Sstroke Index 
calculated by the AAA detection program and AAA size. The MATLAB code in the 
AAA detection program was altered so that the levels for the 6 individual indices 
calculated for the right and left CFA waveforms for each patient were output before 
the weighting factors or thresholds were applied. The mean and maximum index 
levels for each patient were plotted against AAA size and linear regression analysis 
was applied to determine whether they provided any correlation.
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7.3 Results
7.3.1 Investigation of Total Patient Scores with AAA Size and ILT
The total patient scores for the 37 patients were plotted against AAA size as in Figure 
7.1. It can be seen that there is no significant correlation between the total patient 
score and the AAA size (R2=0.002, P=0.787).
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Figure 7.1: Total Patient Score calculated by the AAA detection program plotted against AAA Size.
The AAA sizes for AAAs with and without ILT are plotted in Figure 7.2. It can be 
seen that there is also no real difference in the total patient scores for AAAs with and 
without ILT.
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Figure 7.2: Total Patient Score calculated by AAA detection program plotted for AAAs with and
without ILT.
The indices and threshold levels used in the AAA detection program were selected to
optimise the discrimination between AAA and normal patients to provide a method to
detect AAA, not and not specifically to characterise the size or ILT status. Therefore,
it may be possible that a different selection of indices and threshold levels may
provide better characterisation of AAA size and ILT.
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7.3.2 Investigation of Individual Index Scores for AAA Size Characterisation
In order to investigate whether there was any correlation between each of the 6 
individual indices calculated by the AAA detection program and AAA size, the 
MATLAB code was altered so that the index levels calculated for the right and left 
CFA waveforms for each patient were output before the weighting factors or 
thresholds were applied.
For each patient, the maximum level between the right and left waveforms of the 
Maximum Systolic Down-Stroke Bandwidth Index, Systolic Spike Index, Reverse to 
Systolic Height Ratio Index, Integral Reverse Power Under the Systolic Upstroke 
Index and the Integral Reverse Power Under the Systolic Down-Stroke Index were 
plotted against the AAA size and linear regression analysis was applied. For the 
Reverse Power Density Index the minimum level between the right and left waveform 
values were plotted against AAA size. The plots for the 6 indices are given in Figures 
7.3 to 7.8.
On visual inspection of the graphs and application of linear regression analysis, there 
was no significant correlation between the AAA size and the maximum out of the 
values for the right and left waveforms for the Systolic Down-Stroke Bandwidth 
Index (R2=0.000, P=0.952), Systolic Spike Index (R2=0.001, P=0.876) and the 
Integral Reverse Power Under Systolic Down-Stroke Index (R2=0.003, P=0.740). 
There is some weak correlation that is statistically significant between the maximum 
of the Maximum Reverse to Systolic Height Ratio Index and AAA size plotted in 
Figure 7.5. For this index, there is a slight positive trend (R2=0.171, P=0.011) with
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AAA size. There is also weak correlation that approaches statistical significance 
between AAA size and the minimum Reverse to Power Density Index plotted in 
Figure 7.6 (R2=0.082, P=0.086), and the Integral Reverse Power Under Systolic 
Upstroke Index (R2=0.080, P=0.091). For the Reverse Power Density Index, there is a 
possible negative trend with AAA size and for the Integral Reverse Power Under the 
Systolic Upstroke Index there is a possible positive trend with AAA size.
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Figure 7.3: Maximum Maximum Systolic Down-Stroke Bandwidth Index for patient plotted against
AAA size.
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Figure 7.4: Maximum Systolic Spike Index for patient plotted against AAA size.
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Figure 7.5: Maximum Reverse to Systolic Height Ratio Index for patient plotted against AAA size.
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Figure 7.6: Minimum Reverse Power Density Index for patient plotted against AAA size.
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Figure 7.7: Maximum Integral Reverse Power Under Systolic Upstroke index for patient plotted
against AAA size.
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Figure 7.8: Maximum Integral Reverse Power Under Systolic Down-Stroke Index for patient plotted
against AAA size.
For each patient, the mean of the index values for the right and left CFA waveforms 
were calculated for each of the 6 indices and plotted against AAA size. The results 
were very similar to those for the maximum (and minimum) index levels for each 
patient discussed above. Visual examination and linear regression analysis did not 
show any significant correlation between the mean Maximum Systolic Down-Stroke 
Bandwidth Index, mean Systolic Spike Index and mean Integral Reverse Power Under 
the Systolic Down-stroke Index with AAA size. Again, there was a weak, statistically 
significant correlation between the mean Reverse to Systolic Height Ratio Index and 
AAA size, and weak correlations that approached statistical significance between 
AAA size and the mean Integral Reverse Power Under the Systolic Upstroke Index 
and the mean Reverse Power Density Index.
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7.4 Discussion
The results of this short investigation show that it was not possible to adequately 
characterise AAAs in term of size or ILT status using the AAA detection program. 
This may be because the program and the indices used in the program were optimised 
for AAA detection, not AAA characterisation. The results from the investigation of 
the 6 individual indices show that the reverse power density, reverse flow height and 
simultaneous forward and reverse flow under the systolic upstroke are features within 
the CFA waveform which may be useful for characterising AAA size. It may be 
possible to characterise the physical aspects of an AAA from the CFA waveform 
using a program optimised for the characterisation of AAA, possibly involving 
different analysis methods. In order to characterise AAA it is first necessary to be able 
to detect AAA, and most important result of the overall research project is that it is 
possible to detect AAA by analysis of the CFA waveform.
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Chapter 8: Summary and Conclusions
8.1 Research Summary
The main aim of this research project was to determine whether aneurysms of the 
abdominal aorta can be detected by analysis of the CFA Doppler waveform. Visual 
analysis of CFA waveforms from patients with no significant atherosclerotic disease 
of the iliac or femoro-popliteal arteries, discussed in Chapter 3, indicated that there 
are certain changes to the normal CFA Doppler waveform in the presence of AAA. 
There were 5 features noted, that were present predominantly in the waveforms from 
AAA patients. These were: 1) spectral broadening on the systolic down-stroke, 2) the 
appearance of spikes on the systolic down-stroke, 3) an irregular reverse flow pattern, 
4) simultaneous forward and reverse flow during systole and 5) elongation of the 
waveform during the cardiac cycle. It was possible to detect AAA by a method based 
on visual identification of these features for 30 patients with AAA and 30 patients 
without AAA with a sensitivity of 93.3% and a specificity of 70%. These results 
indicated that it may be possible to detect AAA by feature analysis o f the CFA 
Doppler waveform. Visual analysis of Doppler waveforms is subjective and requires a 
high level of training; therefore a more objective, automated analysis method was 
necessary. A MATLAB based computer program was written to automatically 
perform the CFA waveform analysis and determine whether or not an AAA was 
present. The CFA waveform Doppler waveform is a 2-dimensional representation of a 
3- dimensional data set of frequency, amplitude and time. Because the CFA Doppler 
waveform is so complex, a number of simplified vectors were calculated from the 
waveforms to represent certain waveform parameters, for example, the maximum
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frequency envelope and an envelope to represent band-width. These vectors were 
then used to calculate a number of different indices to provide a measure for different 
aspects of the 5 visual waveform features. Plots of these indices were visually 
inspected to determine which indices provided the best level of separation between 
the AAA and normal patients. A MATLAB program was then written to combine 
these indices in different combinations, with a number of different threshold levels 
and weighting factors applied to determine the optimum combination to provide the 
highest levels of sensitivity and specificity for AAA detection. The optimum 
combination involved 6 indices to describe the 5 visual features: Maximum Systolic 
Down-Stroke Bandwidth Index, Systolic Spike Index, Reverse Power Density Index, 
Reverse to Systolic Height Ratio Index, Integral Reverse Power Under Systolic 
Upstroke Index and Integral Reverse Power Under Systolic Down-Stroke Index. The 
program calculated a score for each patient based on where the index values 
calculated for the right and left CFA waveforms lay in relation to set threshold levels. 
A threshold was then placed on the total patient scores to best separate the AAA and 
normal patients. The program produced very promising results with a sensitivity of 
100% and a specificity of 73.3% for AAA detection in the 30 AAA and 30 normal 
patients without significant atherosclerotic disease. The program was then subjected 
to waveform data from blind test sets of waveform data, and produced a sensitivity of 
100% and specificity of 63.6% for 7 AAA and 11 normal test patients. The program 
also achieved a sensitivity of 100% for AAA detection in 9 patients with AAA and 
additional aneurysmal disease of the iliac or popliteal arteries.
The process was then applied to waveform data from patients with and without AAA 
with significant atherosclerotic disease of the iliac and femoral-popliteal arteries.
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Visual and MATLAB based analysis of the waveforms in Chapters 5 and 6 did not 
provide as good differentiation between the AAA and normal patients. The 5 features 
noted visually in patients with AAA, but no significant atherosclerotic disease were 
also present in the waveforms from patients with significant femoro-popliteal disease. 
However, additional waveform features set up by the atherosclerotic disease made it 
much more difficult to separate the patients with and without AAA. For the 15 AAA 
and 18 no AAA patients with significant femoro-popliteal disease, AAA detection 
based on visual identification of the 5 waveform features provided a sensitivity of 
100% but a specificity of only 27.7%. Automatic, objective analysis was performed 
using two different MATLAB programs. The original MATLAB AAA detection 
program achieved a sensitivity of 100% but a very poor specificity of only 11.1%. 
The disease group AAA detection program combined 5 out of the 6 indices with 
adjusted threshold levels and provided improved results with a sensitivity of 100% 
and a specificity of 33.3%. For the 6 AAA and 7 no AAA patients with significant 
atherosclerotic disease of the iliac arteries, visual analysis of the waveforms indicated 
that almost all the waveform features were removed. The features that were present in 
the waveforms were more likely to be set up by the atherosclerotic arterial disease 
rather than AAA. All the CFA waveforms had very high levels of spectral broadening 
and AAA detection based on visual feature analysis of the waveforms provided 100% 
sensitivity but no specificity. The MATLAB programs did not function for these 
patients because the waveforms were very damped. It was therefore not possible to 
adequately discriminate between patients with and without AAA with significant 
disease of the iliac arteries by feature analysis of the CFA waveform.
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A secondary aim of the research was to determine whether, in addition to detecting 
AAA, the information provided by the AAA detection program could also be used to 
provide information on the physical characteristics of the AAA such as the AAA size 
and the presence of ILT. The results of the short investigation, discussed in Chapter 7, 
indicated that it was not possible to adequately characterise AAAs in term of size or 
ILT status using the data provided by the AAA detection program. This may have 
been because the program and the indices used in the program were optimised for 
AAA detection, not AAA characterisation. The results did however indicate that the 
reverse power density, reverse flow height and simultaneous forward and reverse flow 
under the systolic upstroke are features within the CFA waveform which may be 
useful for characterising AAA size. It may be possible to characterise the physical 
aspects of an AAA from the CFA waveform, using a different program optimised for 
the characterisation of AAA, possibly involving different analysis methods.
8.2 Conclusions
The results of this research study suggest that automated feature analysis of the CFA 
Doppler waveform has potential as an alternative method to conventional B-mode 
ultrasound imaging for AAA screening. The overall response of the AAA detection 
program for the 46 patients with AAA and 41 patients without AAA and no 
significant atherosclerotic disease was a sensitivity of 100% for AAA detection with a 
specificity of 70.7%. If these results are projected onto to the general population with 
no significant aorto-iliac or femoro-popliteal occlusive arterial disease, assuming the 
prevalence of lower limb PAD is around 12%, this gives a sensitivity of around 100% 
and a specificity of around 70% for approximately 88% of the general population.
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Studies indicate that screening men over the age of 65 with B-mode ultrasound to 
detect AAA significantly reduces death rates and is cost-effective. However, although 
screening for AAA using conventional ultrasound techniques is cost effective, B- 
mode ultrasound scanning is hospital based, and requires a skilled operator to perform 
the investigation and analyse the images. CFA Doppler waveforms are measured by 
GPs and outpatient nurses using a simple hand held ‘Pocket Doppler system’. Based 
on the findings of this research, it may be possible in future work to incorporate 
automated AAA detection software, based on CFA waveform feature analysis, into a 
hand-held Doppler system. This may provide an alternative screening tool for AAA 
which could offer a quick and more cost effective method for screening in GP 
surgeries and outpatient clinics.
If the performance of the AAA detection program is projected onto the potential 
screened population, assuming 93% of the screened population would not have 
significant atherosclerotic arterial disease, the AAA detection program would provide 
a sensitivity of around 100% and a specificity of around 70% for approximately 93% 
of the screened population. For the remaining 7% of the screened population with 
significant atherosclerotic arterial disease the sensitivity would be high (around 
100%) but the specificity would be low. From experience in the Doppler Ultrasound 
department at UHW approximately 25% of patients with significant lower limb 
arterial disease have significant proximal disease. For the -5%  of screened patients 
with significant femoro-popliteal disease the specificity for AAA detection would be 
between 11% and 33%. The inability of the disease detection program to function for 
the significant proximal disease groups may not be not critical to the function of the
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program as a screening tool because the proportion of the population with significant 
aorto-iliac atherosclerotic disease is very low.
If the AAA detection programs were to be implemented as an alternative method for 
screening for AAA in men over 50 years old, the original AAA detection program 
would provide an overall sensitivity of around 100% and a specificity of around 68% 
for AAA detection. It may be possible to combine the use of the 2 MATLAB 
programs with a simple technique such as an ABPI measurement to assess whether 
significant PAD is present. If the ABPI measurement was normal, the original 
program could be implemented to analyse the CFA waveforms. If the ABPI 
measurement indicated significant disease, the ‘disease AAA detection program’ 
could be implemented. This combined technique would provide around 100% 
sensitivity and a marginally improved specificity of around 70% for AAA detection in 
the screened population. Further work would be necessary to determine the feasibility 
of implementing the two AAA detection programs in conjunction with a simple 
method for arterial disease detection such as an ABPI measurement. The combined 
method may provide a slightly better specificity to AAA in the screened population 
than the original AAA detection program. However, from a practical view point, the 
implementation of the single AAA detection program would be much simpler and 
because such a small percentage (-7%) of the screened population would have 
significant atherosclerotic disease, this slight reduction in specificity may not be 
critical to the overall performance of the device in a screening program. The 
sensitivity and specificity levels provided by both the single and combined AAA 
detection programs are probably adequate for a simple tool to screen for AAA and
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indicate that objective analysis of CFA waveform features is a promising, alternative 
technique to conventional ultrasound for AAA detection.
It was not possible to adequately characterise AAAs in term of size or ILT status 
using the AAA detection program. This may be because the program and the indices 
used in the program were optimised for AAA detection, not AAA characterisation. 
The results from the investigation of the 6 individual indices show that the reverse 
power density, reverse flow height and simultaneous forward and reverse flow under 
the systolic upstroke are features within the AAA waveform which may be useful for 
characterising AAA size. It may be possible to characterise the physical aspects of an 
AAA from the CFA waveform using a different program optimised for the 
characterisation of AAA. In order to characterise AAA it is first necessary to be able 
to detect AAA, and most important result of the overall research project is that it is 
possible to detect AAA by analysis of the CFA waveform.
8.3 Future Work
Feature analysis of the CFA Doppler waveform may provide a promising, alternative 
method for AAA detection. However, if the technique were to be implemented as a 
possible screening tool for AAA, there are several considerations that need to be 
addressed. The technique would need to be tested on a much larger sample size with 
the relative proportions of normal and AAA patients with and without significant 
atherosclerotic disease more representative of the respective prevalences in the 
general population. It may then be possible to transfer the technique to simple hand­
held device, for example a hand held continuous wave Doppler ‘pencil probe’ system
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for CFA waveform measurement with integrated AAA detection software. The use of 
automated CFA waveform analysis in conjunction with a simple method to screen for 
PAD, for example ABPI, may also need to be investigated.
Further work is also necessary to provide explanations as to how the CFA waveform 
features that are present with an AAA arise. The modelling studies discussed in 
Chapter 1 have examined flows within aneurysms but further work is necessary, 
possibly with the application of fluid dynamics modelling and finite element analysis 
techniques to investigate the development of the flow disturbances and the subsequent 
effect on the blood flow in iliac and femoral arteries distal to the aneurysm.
Although it was not possible to characterise the physical characteristics of the AAAs 
in the patients used in this study using the AAA detection program. The modelling 
studies indicated that the flow disturbances set up within AAA models were 
dependent on the AAA size and shape. It may therefore be possible to characterise the 
physical aspects of an AAA from the CFA waveform using a program optimised for 
the characterisation of AAA, possibly involving different analysis methods. The 
modelling studies also indicated that turbulent flows set up within an AAA increase 
the arterial wall stress. Therefore, further analysis of the CFA waveform may also 
provide an aid for the prediction of rupture risk in future studies.
In the future it may be conceivable to detect AAA, determine the size and presence of 
ILT and predict the risk of rupture using a single, simple hand held Doppler device 
with integrated software. Potentially, application of this technique could significantly 
reduce costs to the NHS and save lives.
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Appendix 1: Patient Data Summary for AAA Patient Groups with No Significant 
Iliac or Femoro-Popliteal Disease
Table Al.l: Patient Data Summary for AAA with No Significant Atherosclerotic 
Disease Study Group_________ _____ _________ ______ _ __ ___________________
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT
Residual
Lumen
(cm)
Leg
Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
1 81 5.0 Yes 2.5
Left
Very 
tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
Right
Very 
tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
2 68 3.8 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
3 71 5.0 Yes 2.8 Left No disease No diseaseRight No disease No disease
4 77 4.1 Yes 2.2 Left No disease No diseaseRight No disease No disease
5 66 4.0 Yes 3.2 Left No disease No diseaseRight No disease No disease
6 76 6.4 Yes 3.9
Left
Tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
Right
Tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
7 65 3.0 No - Left No disease No diseaseRight No disease No disease
8 54 5.8 No - Left No disease No diseaseRight No disease No disease
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Table A l.l continued:
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT Residual
Lumen
(cm)
Leg Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
9 68 4.1 No - Left No disease No diseaseRight No disease No disease
10 85 4.3 No -
Left
Tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
Right
Tortuous 
iliac arteries 
but no 
significant 
disease
Minor
calcification
11 71 5.0 No - Left No disease No diseaseRight No disease No disease
12 81 4.0 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
13 55 4.5 Yes 3.0
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
14 74 5.0 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
15 71 4.1 Yes 2.7
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
16 65 4.6 Yes 3.6 Left No disease No diseaseRight No disease No disease
17 85 4.0 No -
Left No disease Minorcalcification
Right No disease Minorcalcification
18 55 3.5 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
19 70 4.9 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
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Table A 1.1 continued:
Patient
Number
Age
(Years)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT Residual
Lumen
(cm)
Leg Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
20 77 4.4 Yes 2.5
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
21 40 5.2 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
22 68 5.8 Yes 2.0
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
23 69 5.4 Yes 2.3
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
24 83 6.0 Yes 2.0
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
25 85 4.5 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
26 67 3.2 No -
Left Moderatecalcification
Moderate 
calcification 
but no 
significant 
focal lesions
Right Minorcalcification
Minor
calcification
27 69 3.8 Yes 2.1
Left Moderatecalcification
Moderate 
calcification 
but no 
significant 
focal lesions
Right Moderatecalcification
Moderate 
calcification 
but no 
significant 
focal lesions
264
Table A 1.1 continued:
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT Residual
Lumen
(cm)
Leg Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
28 75 4.5 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
29 85 5.7 Yes 2.4
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
30 69 3.5 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
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Table A1.2: Patient Data Summary for AAA with No Significant Atherosclerotic 
Disease Test Group_______________________________________________
Patient
Number
Age
(Years)
Maximum 
Abdominal 
Aorta 
Diameter (cm)
ILT
Residual
Lumen
(cm)
Leg
Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
1 61 3.1 No - Left No disease No diseaseRight No disease No disease
2 83 4.6 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Moderate 
calcification 
but no 
significant 
focal lesions
3 73 3.5 No - Left No disease No diseaseRight No disease No disease
4 77 3.5 No -
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
5 83 5.2 No -
Left
Tortuous
EIA.
Moderate
calcification
Moderate 
calcification 
but no 
significant 
focal lesions
Right Minorcalcification
Minor
calcification
6 78 4.0 No -
Left Minorcalcification
Minor 
calcification 
but no 
significant 
disease
Right Minorcalcification
Minor
calcification
7 78 3.5 Yes 2.3 Left No disease No diseaseRight No disease No disease
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Table A1.3: Patient Data Summary for AAA with No Significant Atherosclerotic 
Disease with Additional Aneurysmal Disease Group__________________________
Patient
Number
Age
(Years)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT
Residual
Lumen
(cm)
Leg
Iliac Artery 
Disease 
State
Femoro-
Popliteal
Disease
State
Additional
Aneurysmal
Disease
1 68 5.7 Yes 3.6
Left No disease No disease
1.9cm
popliteal
aneurysm
Right No disease No disease
1.6cm
popliteal
aneurysm
2 69 3.7 Yes 3.3
Left No disease No disease 3.3cm CIA aneurysm
Right No disease No disease 2.2cm CIA aneurysm
3 76 3.7 No -
Left Minorcalcification
Minor
calcification -
Right Minorcalcification
Minor
calcification
1.7cm CIA 
aneurysm
4 76 5.1 Yes 3.1
Left No disease No disease 2.1cm CIA aneurysm
Right No disease No disease 2.5cm CIA aneurysm
5 77 4.7 Yes 3.1
Left Minorcalcification
Minor
calcification
1.6cm CIA 
aneurysm
Right Minorcalcification
Minor
calcification
1.9cm CIA 
aneurysm
6 75 3.5 No -
Left Minorcalcification
Minor
calcification
3.0cm
popliteal
aneurysm
Right Minorcalcification
Minor
calcification
1.9cm
popliteal
aneurysm
7 88 5.2 Yes 2.0
Left Minorcalcification
Minor
calcification
2.0cm CIA 
aneurysm
Right Minorcalcification
Minor
calcification
1.5cm CIA 
aneurysm
8 74 3.8 No -
Left Minorcalcification
Minor
calcification
1.8cm CIA 
aneurysm
Right Minorcalcification
Minor
calcification
1.6cm CIA 
aneurysm
9 78 3.0 No -
Left No disease No disease
1.5cm CIA 
aneurysm
Right No disease No disease 1.5cm CIA aneurysm
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Appendix 2: Patient Data Summary for Normal Patient Groups
Table A2.1: Patient Data Summary for Normal Study Group
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery Disease State
F emoro-Popliteal 
Disease State
1 60 1.8 Left No disease No diseaseRight No disease No disease
2 60 1.5 Left No disease No diseaseRight No disease No disease
3 52 1.9 Left No disease No diseaseRight No disease No disease
4 55 1.5 Left No disease No diseaseRight No disease No disease
5 72 2.0
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
6 72 1.3
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
7 51 1.4 Left No disease No diseaseRight No disease No disease
8 63 1.2
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
9 54 1.4 Left No disease No disease
Right No disease No disease
10 53 1.9 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
11 70 1.3 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
12 77 1.2 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
268
Table A2.1 continuec
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta Diameter
(cm)
Leg Iliac Artery 
Disease State
Femoro-Popliteal 
Disease State
13 57 1.3 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
14 80 1.7 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
15 72 1.7 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
16 81 1.8 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
17 83 1.5 Left No disease No disease
Right No disease No disease
18 61 1.4 Left No disease No disease
Right No disease No disease
19 74 1.4 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
20 69 1.5 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
21 92 1.1 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
22 67 1.5 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
23 58 2.1 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
24 65 1.8 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
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Table A2.1 continued
Patient
Number
Age
(Years)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery 
Disease State
F emor o- Popliteal 
Disease State
25 75 1.2 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
26 50 1.6 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
27 87 1.2 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
28 77 2.2 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
29 83 1.7 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
30 56 1.6 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
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TableA2.2: Patient Data Summary for Is ormal r"est Group
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery Disease State
F emoro-Popliteal 
Disease State
1 73 1.5
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
2 58 2.0
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
3 76 1.7
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
4 78 1.6
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
5 50 2.0 Left No disease No diseaseRight No disease No disease
6 76 1.7
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
7 72 1.4
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
8 83 2.2
Left Minorcalcification
Minor
calcification
Right Minorcalcification
Minor
calcification
9 73 2.3 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
10 69 1.7 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
11 72 1.8 Left Minor
calcification
Minor
calcification
Right Minor
calcification
Minor
calcification
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Appendix 3: Patient Data Summary for AAA Patient Groups with Significant 
Atherosclerotic Disease
Table A3.1: Patient Data Summary for AAA with Significant Femoro-Popliteal 
Disease Study Group ______________ ______ ____________ __________________
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT
Residual
Lumen
(cm)
Leg
Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
Additional
Aneurysmal
Disease
1 71 3.0 No -
Left Minorcalcification
Tight proximal 
SFA stenosis. 
Distal SFA 
short segment 
occlusion
No
Right Minorcalcification
~2cm 50% 
SFA origin 
stenosis. Distal 
SFA short 
segment 
occlusion.
No
2 81 3.9 No -
Left Minorcalcification
Short segment 
mid SFA 
occlusion
No
Right Minorcalcification
Minor
calcification No
3 55 3.6 No -
Left Minorcalcification
SFA occluded 
from origin. 
Adductor level 
reconstitution
No
Right Minorcalcification
SFA occluded 
from origin. 
Distal SFA 
reconstitution
No
4 74 3.7 No -
Left Minorcalcification
Short segment 
SFA origin 
occlusion
No
Right Minorcalcification
Distal SFA 
occlusion No
5 78 4.6 Yes 2.8
Left Minorcalcification
SFA occluded 
from origin. 
Distal SFA 
reconstitution
No
Right Minorcalcification
Mid SFA 
occlusion with 
popliteal 
reconstitution
No
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Table A3.1 continued
Patient
Number
Age
(Years)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT Residual
Lumen
(cm)
Leg Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
Additional
Aneurysmal
Disease
6 71 4.9 Yes 4.0
Left Minorcalcification
Tight SFA 
origin and mid 
SFA stenosis.
No
Right Minorcalcification
-50%  mid 
SFA stenosis No
7 70 3.7 Yes 2.1
Left Minorcalcification
SFA occluded 
from just 
distal to the 
origin with 
popliteal 
reconstitution
No
Right Minorcalcification
Extensive 
calcification 
with several 
moderate SFA 
stenoses
No
8 81 5.0
Yes
4.0 Left
Minor
calcification
Moderate 
diffuse 
calcification 
throughout 
with a tight 
mid popliteal 
stenosis
No
Right
Minor
calcification
Diffuse 
calcification 
throughout 
Several -50%  
SFA stenoses
No
9 67 5.1
Yes
4.0 Left
Minor
calcification
SFA occluded 
from origin. 
Adductor level 
reconstitution
No
Right
Minor
calcification
SFA occluded 
from the origin 
with popliteal 
reconstitution
No
10 76 5.8 No Left
Minor
calcification
CFA 
moderately 
calcified. SFA 
occluded from 
origin
No
Right Minor
calcification
Diffuse
calcification No
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Table A3.1 continued
Patient
Number
Age
(Years)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT Residual
Lumen
(cm)
Leg Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
Additional
Aneurysmal
Disease
11 62 3.3 Yes 1.7 Left Minor
calcification
Tight distal 
SFA stenosis No
Right Minor
calcification
Minor
calcification No
12 82 6.0 Yes 2.5 Left Minor
calcification
Minor
calcification No
Right
Minor
calcification
SFA occludes 
~15cm from 
the origin 
with 
adductor 
reconstitution
3.6cm CIA 
aneurysm
13 76 6.3 No Left
Minor
calcification
Diffuse 
disease with 
several 
moderate 
SFA stenoses
2.4cm CIA 
aneurysm
Right
Minor
calcification
Diffuse 
disease with 
several 
moderate 
SFA stenoses
2.0cm CIA 
aneurysm
14 80 3.9 No Left
Minor
calcification
SFA occluded 
from origin 
with popliteal 
reconstitution
No
Right
Minor
calcification
SFA occluded 
from origin 
with popliteal 
reconstitution
No
15 85 5.6 No Left Minor
calcification
50% mid 
SFA stenosis No
Right Minor 
calcification |
50-70% mid 
SFA stenosis No
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Table A3.2: Patient Data Summary for AAA with Significant Femoro-Popliteal 
Disease Test Group _______________________________________________________
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT
Residual
Lumen
(cm)
Leg
Iliac Artery 
Disease 
State
Femoro- 
Popliteal 
Disease State
Additional
Aneurysmal
Disease
1 76 4.8 Yes 2.5
Left Minorcalcification
Mid SFA 
occlusion No
Right Minorcalcification
SFA occluded 
from origin No
2 91 5.0 No -
Left Minorcalcification
Diffuse 
disease 
throughout 
with a tight 
proximal 
popliteal 
stenosis
No
Right Minorcalcification
SFA occludes 
~10cm from 
the origin 
with 
adductor 
reconstitution
No
3 88 5.6 No -
Left Minorcalcification
SFA 
narrowed 
throughout 
with several 
50-70% 
stenoses
No
Right Minorcalcification
SFA 
narrowed 
throughout 
with several 
50-70% 
stenoses
No
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Table A3.3: Patient Data Sum m ary for AAA with Significant Iliac Disease Group
Patient
Number
Age 
(Y ears)
Maximum
Abdominal
Aorta
Diameter
(cm)
ILT
Residual
Lumen
(cm)
Leg Iliac Artery Disease State
Femoro- 
Popliteal 
Disease State
Additional
Aneurysmal
Disease
1 76 3.6 Yes 1.9
Left Tight EIA stenosis
Tight SFA 
origin 
stenosis. SFA 
patent but 
very diseased
No
Right CIA and EIA occluded
SFA occluded 
from origin No
2 76 4.8 Yes 2.2
Left CIAocclusion
Minor
calcification No
Right Minorcalcification
Minor
calcification No
3 74 4.9 Yes 2.3
Left EIA stenosis
SFA occluded 
from the 
origin with 
popliteal 
reconstitution
No
Right Minorcalcification
SFA
moderately
narrowed
throughout
No
4 73 4.4 No Left Tight EIA 
origin and 
distal EIA 
stenosis
SFA occluded 
from origin No
Right Moderate 
EIA stenosis
Tight distal 
CFA stenosis. 
SFA occluded 
from origin
No
5 79 6.3 Yes 2.3 Left CIA 
occlusion 
with EIA 
reconstitution 
via IIA
Diffuse
disease
No
Right Minor
calcification
Diffuse
disease No
6 74 6.0 No Left EIA occluded CFA 
occluded with 
SFA origin 
reconstitution
No
Right Tight EIA 
stenosis
Tight mid 
SFA stenosis. 
Distal SFA 
occlusion
3.6cm CIA 
aneurysm
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Appendix 4: Patient Data Summary for Patient Groups with No AAA and
Significant Atherosclerotic Disease
Table A4.1: Patient Data Summary for No AAA with Significant Femoro-Popliteal 
Disease Study Group_______________________ ______________ _________________
Patient
Number
Age
(Years)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery Disease State
F emor o-Popliteal 
Disease State
1 83 2.2
Left Minorcalcification
Popliteal occlusion 
at trifurcation
Right Minorcalcification
Distal popliteal 
occlusion
2 80 1.6
Left Minorcalcification
Diffuse disease 
with several 
moderate SFA 
stenoses
Right Minorcalcification
Diffuse disease 
with several 
moderate SFA 
stenoses
3 81 1.6
Left Minorcalcification
Diffuse disease 
with at least one 
moderate SFA 
stenosis
Right Minorcalcification
Diffuse disease 
with tight mid SFA 
stenosis
4 67 1.7
Left Minorcalcification
Diffuse moderate 
disease
Right Minorcalcification
Diffuse disease 
with -50-70% 
proximal SFA 
stenosis
5 53 1.5
Left Minorcalcification
Diffuse disease 
with -50-70% mid 
SFA stenosis
Right Minorcalcification Minor calcification
6 90 1.5
Left Minorcalcification
SFA occluded 
from origin
Right Minorcalcification
SFA occluded 
from origin
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Table A4.1 continuec
Patient
Number
Age
(Years)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery 
Disease State
F emoro-Popliteal 
Disease State
7 95 2.5
Left Minorcalcification
Very calcified SFA 
with multiple tight 
stenoses
Right Minorcalcification
Very calcified SFA 
with multiple tight 
stenoses
8 50 1.6
Left Minorcalcification
Short segment 
popliteal occlusion
Right Minorcalcification Moderate disease
9 73 1.3
Left Minorcalcification
Two 50-70% SFA 
stenoses
Right Minorcalcification
At least two 50- 
70% SFA stenoses
10 76 1.5
Left Minorcalcification
Very calcified SFA 
with multiple tight 
stenoses
Right Minorcalcification
Very calcified SFA 
with multiple tight 
stenoses
11 76 1.3
Left Minorcalcification
Diffuse 
calcification with 
at least 1 50-70% 
mid SFA stenosis
Right Minorcalcification
Diffuse 
calcification but no 
significant focal 
lesions
12 73 1.2
Left Minorcalcification
SFA occluded 
from origin with 
adductor level 
reconstitution
Right Minorcalcification
Distal CFA 
occlusion with 
proximal popliteal 
reconstitution
13 96 1.6
Left Minorcalcification
Diffuse disease 
with distal SFA 
occlusion
Right Minorcalcification
SFA occluded 
from origin
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Table A4.1 continuec
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery 
Disease State
F emoro-Popliteal 
Disease State
14 70 2.1
Left Minorcalcification
Diffuse 
calcification with 
multiple 50-70% 
SFA stenoses
Right Minorcalcification
Diffuse 
calcification with 
multiple 50-70% 
SFA stenoses
15 65 1.87 Left
Minor
calcification
Diffuse 
calcification with 
at least 1 50-70% 
mid SFA stenosis
Right Minor
calcification
Minor calcification 
with SFA adductor 
level occlusion
16 85 1.3 Left
Minor
calcification
Diffuse 
calcification with 
at least 1 50-70% 
mid SFA stenosis
Right
Minor
calcification
Diffuse 
calcification with 
at least 1 50-70% 
mid SFA stenosis
17 67 2.0 Left
Minor
calcification
Diffuse 
calcification with 
multiple 50-70% 
SFA stenoses
Right
Minor
calcification
Diffuse 
calcification with 
multiple 50-70% 
SFA stenoses
18 56 1.2 Left Minor
calcification
SFA diffusely 
narrowed 
throughout
Right Minor
calcification
Moderate
calcification
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Table A4.2: Patient Data Summary for No AAA with Significant Femoro-Popliteal 
Disease test Group ________________ ______ ______________ _________________
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta Diameter 
(cm)
Leg Iliac Artery Disease State
F e mo ro- Popliteal 
Disease State
1 70 2.0
Left Minorcalcification
Diffuse disease 
with tight mid SFA 
and adductor level 
stenoses
Right Minorcalcification
Diffuse disease 
with tight distal 
SFA stenosis
2 73 1.2
Left Minorcalcification Moderate disease
Right Minorcalcification
Distal SFA 
occlusion
3 75 1.6
Left Minorcalcification
Diffuse moderate 
disease with 
significant disease 
at trifurcation
Right Minorcalcification
Diffuse moderate 
disease with 
significant disease 
at trifurcation
4 63 1.7
Left Minorcalcification
Diffuse disease 
with multiple tight 
SFA stenoses
Right Minorcalcification
Diffuse disease 
with multiple tight 
SFA stenoses
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Table A4.3: Patient Data Summary for No AAA with Significant Iliac Disease 
Group ________ _______________ ______ _________________________________
Patient
Number
Age 
(Y ears)
Maximum 
Abdominal 
Aorta 
Diameter (cm)
Leg Iliac Artery Disease State
F emoro-Popliteal 
Disease State
1 67 1.7
Left CIA occlusion Minor calcification
Right Minorcalcification Minor calcification
2 71 2.6
Left Tight CIA origin stenosis
Distal CFA 
occlusion with 
proximal popliteal 
reconstitution
Right Tight CIA origin stenosis
SFA occluded 
from origin
3 51 1.7
Left Minorcalcification Minor calcification
Right Tight EIA stenosis Minor calcification
4 87 1.5
Left Tight distal EIA stenosis
SFA occluded 
from origin
Right Minorcalcification
SFA occluded 
from origin
5 75 1.6 Left CIA occlusion Mid SFA occlusion
Right Significant 
distal CIA and 
proximal EIA 
disease
Mid SFA occlusion
6 52 1.2 Left Tight EIA 
stenosis
Minor calcification
Right Minor
calcification
Minor calcification
7 85 2.0 Left Tight CIA 
stenosis
Minor calcification
Right -50-70% CIA 
stenosis
Minor calcification
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Appendix 5: Explanation of Index Plot Form at
The levels for the indices calculated for the left and right CFA waveforms for each 
of the AAA and no AAA patients in the study and test groups are plotted in the 
format illustrated in Figure A1 below. In this example, the Maximum Down-Stroke 
Bandwidth Index levels are plotted for the 30 AAA and 30 normal patients in the no 
significant atherosclerotic disease study groups. Due to ‘font size limitation’ there 
was not enough space on the horizontal axes to label both the left and right 
waveforms for each individual patient. Therefore, the following method was used: 
The hatch above the number 1 indicates the left CFA waveform for patient number 
1 and the hatch immediately to the right indicates the right CFA waveform for 
patient number 1. The hatch above the number 2 indicates the left CFA waveform 
for patient number 2 and the hatch immediately to the right indicates the right CFA 
waveform for patient number 2 and so forth for the total number of patients in the 
group under investigation. This method of labelling is used for all the index plots 
throughout Chapters 4 and 6.
i
0.9
+ +- +
00 + +
+ +
+ +0.7
0.6
0.6
0.4
0.3
0.2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 26 27 20 29 30
AAA 
No AM
Palien! (Left and Right CFA Waveform)
Figure A1: Axes label example for the Maximum Down-Stroke Bandwidth Index for the 30 AAA and 
normal patients in the no significant atherosclerotic disease study groups.
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